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Haem is an essential molecule that is required for a wide variety of functions in all 
forms of life. This molecule is required for oxygen transport in humans as a 
prosthetic group of haemoglobin and myoglobin and is also an integral component of 
various cytochromes as well as being a cofactor for peroxidases and catalases. Until 
very recently it was generally accepted that the haem biosynthetic pathway was a 
conserved process in most organisms that synthesise haem. This dogma has changed 
with the discovery of two new pathways by which haem can be synthesised. The 
most recently discovered of these pathways, known as the coproporphyrin-dependent 
pathway, is utilised by many actinobacteria and firmicutes (including Staphylococcus 
aureus) and is now thought to be an ancestral pathway to the now more widely 
distributed classical pathway. In light of this discovery, the current work seeks to 
examine the biochemical and kinetic properties of the enzymes involved in the 
terminal stages of haem synthesis in S. aureus (HemY, HemH and HemQ).  
HemY from S. aureus, which is classically known as a protoporphyrinogen IX 
oxidase, catalyses the antepenultimate step in a coproporphyrinogen-dependant 
pathway in vivo was shown for the first time to catalyse the oxidation of 
coproporphyrinogen III as well as protoporphyrinogen IX, demonstrating that this 
enzyme can catalyse steps in both classical and coproporphyrin-dependant haem 
biosynthesis in vitro. Kinetic analyses revealed that the previously-observed 
stimulation of HemY activity by the terminal pathway enzyme HemQ (a coprohaem 
decarboxylase) occurred via a peroxidase-mediated mechanism resulting in the 
generation of superoxide, although this stimulation was not observable when HemY 
is utilising the native coproporphyrinogen III substrate. This generation of toxic free 
radicals could explain why HemQ enzymes have not been identified in organisms 
that synthesise haem via the classical protoporphyrin IX pathway.  
The HemH enzyme, also known as ferrochelatase, has also been further 
characterised with its in vivo substrates (Fe2+ and coproporphyrin III), where activity 
was shown to be diminished by a regulatory metal binding site. The activity of this 
enzyme with a variety of alternative metal substrates was also assessed, with the 




Kinetic constants for HemQ, a coprohaem decarboxylase, were determined for the 
first time and HemQ was further assessed for an ability to bind other tetrapyrroles: 
non-metallated porphyrins were found to bind much tighter than the 
metalloporphyrins that are the in vivo substrate and product for this enzyme.  
Together, these intriguing observations have implications for the divergent evolution 
of haem biosynthesis in ancestral microorganisms and provides new insights into the 





















AdoCbl - 5'-deoxyadenosylcobalamin 
ALA/5-ALA - į-aminolaevulinic acid 
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1.1 ± Structure and function of tetrapyrroles 
 
Tetrapyrroles are organic molecules that can perform a variety of functions and are 
essential for many forms of life. These molecules can perform a wide variety of 
functions depending on their overall structure, the proteins that they are associated 
with and if they have a metal associated with them. They can exist as either linear or 
cyclic molecules, and are usually strongly coloured due to the conjugated ring 
system contained within tetrapyrroles.  
Linear tetrapyrroles such as phytochromobilin mainly appear in plants and have 
important light sensing capabilities used by the photoreceptor phytochrome (Terry & 
Lagariass 1991; Terry et al. 1993; Han et al. 2010). Other linear tetrapyrroles such as 
biliverdin, which is also a precursor molecule to phytochromobilin (Franklin et al. 
2003), and bilirubin commonly arise as degradation product of cyclic tetrapyrroles, 
notably from haem, in other organisms (Bulmer et al. 2008; Minetti et al. 1998). 
Biliverdin and bilirubin have rather similar structures and have been shown to have 
beneficial antioxidant capabilities (Minetti et al. 1998). Bilirubin can also be toxic if 
it is present in high enough concentrations, caused by conditions such as neonatal 
hyperbilirubinemia in children, which can lead to acute or chronic neurological 
disorders (Bulmer et al. 2008).  
 Cyclic tetrapyrroles are derived from a common precursor, Uroporphyrinogen III, 
which is processed via a series of enzyme-catalysed reactions to yield the end 
products haem (or heme), chlorophyll, cobalamin, sirohaem (or siroheme), and 
Factor F430 (Martins et al. 2001). These molecules have different metals associated 
with the centre of the porphyrin ring and possess various side chain modifications 
present. These modifications can range from small vinyl and propionic acid side 
chains, as found in haem, or complex additions and alterations to the structure, as 
seen with chlorophyll and vitamin B12, which give rise to varying spectral features 
and colours. These tetrapyrroles, shown in Figure 1.1, are occasionally called the 
"pigments of life" because of the differences in colour and how essential they are to 




1.1.1 ± Haem 
The main distinguishing feature of haem is the presence of a ferrous ion (Fe2+) in the 
centre of the tetrapyrrole ring. Haem is required for many different functions,  
ranging from the transport of oxygen and carbon dioxide in multicellular organisms 
as part of the proteins haemoglobin and myoglobin, to being an integral component 
of the electron transport chain as a cofactor for various cytochromes. In addition, 
other enzymes such as peroxidases, catalases and cytochrome P450s also utilise 
haem as a cofactor. There are many forms of haem present in nature, with the most 
common form being haem b, also known as protohaem IX, which is the form of 
haem mostly associated with the functions mentioned above. Haem b is also used as 
the starting point for the synthesis of other forms of haem such as haem o, haem a 
and haem c (Brown et al. 2002; Kranz et al. 2009). These haem forms are utilised in 
YDULRXVGLIIHUHQWSURWHLQVUHODWHGWRF\WRFKURPHVZLWKWKH³c´IRUPEHLQJDQLQWHJUDO
part of cytochrome c (Kranz et al. 2009) DQGWKH³o´DQG³a´IRUPVEHLQJcofactors 
for cytochrome respiratory oxidases (Brown et al. 2002) 
 
Haem is a versatile co-factor, with many different functions available depending on 
the protein it is bound to. Whilst it is well known for oxygen and carbon dioxide 
transport, the ability to bind these diatomic gasses is also utilised by many organisms 
as gas sensors, being able to also bind carbon monoxide and nitric oxide in this 
capacity and able to initiate the biochemical response of the organism to the change 
in the availability of the gas ligand (Kobayashi et al. 2010; Rodgers 1999). There are 
three such proteins that have been characterised; the NO sensing soluble guanylate 
cyclase, FixL which is a bacterial O2 sensor-kinase and a bacterial CO sensor CooA. 
Binding of gasses to the haem in these proteins induces conformational changes 
which initiates their functions (Rodgers 1999). The binding of haem can also act as a 
redox-sensor with various proteins containing haem regulatory motifs that cause a 
change based on haem being present, such as the redox sensor protein PpsR from the 
photosynthetic bacterium Rhodobacter sphaeroides which binds haem as part of its 





Substrate binding and interactions is also a major factor in the catalytic cycle of 
cytochrome P450s, with the iron centre being involved in co-ordination of substrates 
and being heavily involved in the required reaction, which varies depending on the 
type of cytochrome P450 (Meunier et al. 2004). The ferric (Fe3+) state of the central 
iron in haem is also well known to be able to react very effectively with hydrogen 
peroxide, with the iron forming a reaction where the O-O bond is cleaved forming a 
strongly oxidising oxene intermediate, that quickly reacts with the heme molecule to 
form Compound I, an oxyferryl species [Fe(IV)=O], and water. Compound I is  
subsequently reduced back to the ferric iron state either by reacting with another 
oxyferryl group (Compound II, [Fe(IV)=OH]) or by a direct two-electron reduction  
(Vlasits et al. 2010).  The central iron also has the ability to form reactive oxygen 
species in the presence of hydrogen peroxide, as has been witnessed in haem-binding 
proteins that are not dedicated peroxidases or catalases, highlighting the ease at 
which this reaction can take place (Shepherd & Dailey 2009; Mayfield et al. 2013). 
These reactive oxygen species can cause damage to the cell, which shows how this 
essential molecule can also be cytotoxic to cells if left unregulated and reach 
























Figure 1.1 ± The cyclic tetrapyrroles. Uroporphyrinogen III (centre) and the different modified 
tetrapyrroles that it can form (Raux et al. 2000). In the synthesis of these modified tetrapyrroles, 
uroporphyrinogen III is the final common molecule to each pathway, causing it to be known as the 









1.1.2 ± Chlorophyll  
Chlorophylls have a central magnesium ion and are found in plants and 
cyanobacteria, and photosynthetic bacteria possess a very similar pigment called 
bacteriochlorophyll. These pigments are required to absorb solar energy to be used in 
photosynthesis. The synthesis of this molecule shares the majority of steps with the 
classical haem biosynthetic pathway, with dedicated chlorophyll synthesis occurring 
after magnesium insertion into protoporphyrin IX before major modifications to the 




Cobalamin, also known as vitamin B12, has a central cobalt ion and can only be 
synthesised by bacteria and archaea. There are two biologically active forms of this 
FRPSRXQG PHWK\OFREDODPLQ 0H&EO DQG ¶-deoxyadenosylcobalamin (AdoCbl), 
which are used as cofactors in methyltransferase and isomerase enzyme families, 
respectively. These forms differ with respect to the groups that coordinate the cobalt 
ion; MeCbl has a methyl group bound whilst AdoCbl has a deoxyadenosyl side chain 
(Gherasim et al. 2013). 
1.1.4 ± Sirohaem 
Sirohaem, which like haem also has a central iron atom, is required for the six-
electron reduction of sulphite to sulphide as a cofactor for several sulphite reductases 
(Murphy et al. 1974) in bacteria, archaea and fungi. This process is also part of the 
sulphur assimilation pathway in plants. Sirohaem is also required as a cofactor of 
ferredoxin-nitrite reductase, reducing nitrite to ammonia (Murphy et al. 1974). 
1.1.5 ± Factor F430 
Coenzyme F430, which has an associated nickel ion, is used in the enzyme methyl-
coenzyme M reductase as the final part of methanogenesis, and is only found in 




1.2 ± Haem Biosynthesis 
 
The haem biosynthetic pathway was until recently thought to be highly conserved 
throughout nature, although recent research has revealed a number of new pathways 
for haem biosynthesis. There are now three known routes that haem synthesis 
follows; the classical pathway, the alternative haem biosynthesis pathway that 
proceeds via the production of sirohaem, and the coproporphyrin-dependant pathway 
that is proposed to be an ancestral pathway to the classical pathway and does not 
utilise protoporphyrin IX intermediates (Dailey et al. 2015). These pathways are 
currently not known to co-exist in the same organism.  
All three pathways, which are described below, stem from the same tetrapyrrole 
precursor uroporphyrinogen III, which is believed to be synthesised from į-
aminolaevulinic acid via the same order of intermediates. Defects in haem 
biosynthesis can seriously inhibit growth of organisms or result in a shift to 
fermentative growth for survival  (Mayfield et al. 2013; Dailey et al. 2010). In 
humans, defects give rise to a class of disease states known as porphyrias which can 
elicit symptoms ranging from photosensitivity to abdominal pains or life threatening 












1.2.1 - Making the Macrocycle: Uroporphyrinogen III 
1.2.1.1 ± Synthesis of į-aminolaevulinic acid 
  
The two basic components for tetrapyrrole production in most eukaryotic cells are 
glycine and succinyl-CoA, which are  substrates for the enzyme į-aminolaevulinic 
acid synthase  (Beale et al. 1975) that produces į-aminolaevulinic acid (ALA, also 
known as 5-ALA) in the first dedicated step of tetrapyrrole biosynthesis. Plants and 
most prokaryotes (not including Į- proteobacteria) use glutamate, Į-ketoglutarate or 
glutamine in different pathways utilising a tRNA-dependent five-carbon pathway 
(Beale 1990), as opposed to the four-carbon pathway (Kresge et al. 2006) that 


















1.2.1.2 ± Porphobilinogen synthase 
  
The synthesis of ALA is the first dedicated step in haem biosynthesis, with the next 
step being the formation of a pyrrole ring from two molecules of 5-ALA. This 
reaction requires the enzyme porphobilinogen synthase (PBG synthase), which links 
the amino group on the first ALA with the carboxyl group on the second ALA 
(Figure 1.3). This results in the production of water and the formation of 
porphobilinogen (PBG), which contains a pyrrole ring.  
 
 
Figure 1.3 ± )RUPDWLRQ RI SRUSKRELOLQRJHQ IURP WKH K\GURO\VLV RI WZR PROHFXOHV RI į-
aminolaevulinic acid by PBG synthase. 
 
1.2.1.3 ± Porphobilinogen deaminase 
PBG molecules are deaminated by porphobilinogen deaminase to produce the 
tetrapyrrole hydroxymethylbilane, the first tetrapyrrole/porphyrin ring in the 
pathway. This enzyme, also known as HemC 3DQHN 	 2¶%ULDQ , acts by 
binding a dipyrromethane cofactor (made up of two molecules of PBG) that acts as a 
primer for the oligomerisation of four PBG molecules resulting in the formation of a 
protein-bound linear hexapyrrole (Layer et al. 2010). The formation of the 
hexapyrrole results in the formation of ammonia, as the amino groups are cleaved 
from the PBG molecules to form the macromolecule. This is then cleaved to produce 




1.2.1.4 ± Uroporphyrinogen synthase 
Hydroxymethylbilane is cyclised by uroporphyrinogen III synthase, which also 
inverts one of the end pyrrole rings, which is normally referred to as the D ring, 
before joining it to the pyrrole ring at the other end of the chain (the A ring) to form 
uroporphyrinogen III (Figure 1.4). Uroporphyrinogen III synthase works by first 
UHPRYLQJWKHK\GUR[\OJURXSRQWKH³$´ULQJWRIRUPDQD]DIXOYHQHLQWHUPHGLDWH 
7KLV LQWHUPHGLDWH UHDFWV ZLWK WKH VXEVWLWXWHG Į-SRVLWLRQ RI WKH ³'´ ULQJ WR IRUP D
VSLURF\FOLFS\UUROHQLQHZKHUHWKH³$´DQG³&´ULQJVDUHOLQNHGWRWKH³'´ULQJE\
the sDPHFDUERQDWRP7KHILQDOVWHSLVWKHUHDUUDQJHPHQWRIWKH³'´ULQJLQYROYLQJ
LQYHUVLRQDQGGHSURWRQDWLRQ UHVXOWLQJ LQERQG IRUPDWLRQEHWZHHQ WKH³$´DQG³'´
rings (Layer et al. 2010). 
 
  
Figure 1.4 ± Formation RI XURSRUSK\ULQRJHQ ,,, E\ XURSRUSK\ULQRJHQ ,,, V\QWKDVH 7KH ³'´ ULQJ
(coloured in grey) is inverted prior to IRUPLQJDERQGWKDWOLQNVWKH³$´DQG³'´ULQJV. 
 
This reaction is the final step that is common to all modified tetrapyrroles that occur 
in nature. From this point uroporphyrinogen III 8¶JHQIII) can proceed down several 






1.2.2 ± Classical Haem Synthesis Pathway 
Until very recently it was believed that most haem producing organisms synthesised 
haem using the same pathway. This pathway, now referred to as the classical 
pathway, proceeds from uroporphyrinogen III with two rounds of modifications to 
the side chains on the exterior of the macrocycle to form protoporphyrinogen IX 
before oxidation of the ring and finally insertion of iron to form haem. This metal 
chelation step is very important in photosynthetic organisms, as the chlorophyll 
biosynthesis branches from this pathway at this point where a Mg2+ ion is inserted 
into protoporphyrin IX by magnesium chelatase instead of a Fe2+ ion by 
ferrochelatase (Walker & Weinstein 1991). 
 
1.2.2.1 ± Uroporphyrinogen decarboxylase 
Uroporphyrinogen III is an important molecule in modified tetrapyrrole synthesis. 
As mentioned in Section 1.1, it is the common precursor for the biosynthesis of all 
modified tetrapyrroles that are used in nature (Figure 1.1). In the haem biosynthetic 
pathway, uroporphyrinogen III is processed by uroporphyrinogen III decarboxylase, 
which removes the carboxyl groups on the acetyl side chains in a stepwise manner 
(Bushnell et al. 2011), leaving methyl side chains. The mechanism for this reaction 
has not been fully elucidated, but is widely regarded to begin with the 
decarboxylation of the D ring of uroporphyrinogen III in what has been determined 
to be a fast reaction followed by the other three rings in a much slower set of 
reactions (Barnard & Akhtar 1979).  
Uroporphjyrinogen decarboxylase exists as a homodimer in both humans (Whitby et 
al. 1998) and in Nicotiana tabacum (Martins et al. 2001) based on their crystal 
structures, with proposals for the reaction mechanism involving the shuttling of 
intermediates between subunits (Heinemann et al. 2008). Later research suggests that 
each subunit can work independently for this reaction, with single chain proteins still 
able to fully convert uroporphyrinogen III to coproporphyrinogen III &¶JHQIII) when 
one active site is mutated (Phillips et al. 2009). Further experiments on the bovine 
enzyme yielded a Hill coefficient of approximately 1, suggesting a non-cooperative 
relationship between the two active sites (Straka & Kushner 1983). 
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1.2.2.2 ± Coproporphyrinogen oxidase 
Coproporphyrinogen III is oxidised by coproporphyrinogen III oxidase to 
protoporphyrinogen IX 3¶JHQIX) in a reaction that removes carboxyl groups from 
the propionates on rings A and B leaving vinyl substituents (Figure 1.5). This step is 
the final modification of the main side chains of the tetrapyrrole ring.  
There are two alternative enzymes that can catalyse this process, HemF and HemN, 
creating a branch in the pathway. The reaction involving HemF is oxygen-
dependent, with molecular oxygen being used as the final electron acceptor. This 
form of coproporphyrinogen oxidase is mainly found in eukaryotic organisms with 
there being very few bacteria that encode this enzyme, with examples being 
Salmonella typhimurium and Rhodobacter sphaeroides (Xu & Elliott 1993; Zeilstra-
Ryalls & Schornberg 2006). In addition to CO2, this reaction releases hydrogen 
peroxide (H2O2), where the protons react with the electron accepting oxygen 
molecule
.
 The HemN enzyme that is expressed in most bacteria is oxygen-






Figure 1.5 ± Conversion of coproporphyrinogen III to protoporphyrinogen IX by coproporphyrinogen 






1.2.2.3 ± Protoporphyrinogen oxidase 
The penultimate step in the synthesis of haem via the classical pathway is the 
oxidation of protoporphyrinogen IX to protoporphyrin IX by protoporphyrinogen IX 
oxidase (also known as PPO). This enzyme catalyses the six-electron oxidation of 
protoporphyrinogen IX, altering the pattern of the double bonds of the ring to 
produce a highly absorbent and fluorescent product and allowing for insertion of a 
variety of metal ions. As with the coproporphyrinogen oxidase reaction there are 
multiple forms of protoporphyrinogen oxidase, the oxygen-dependent HemY (T. A. 
Dailey et al. 1994), the oxygen-independent HemG (Nishimura et al. 1995; Boynton 
et al. 2009) and finally HemJ, which is proposed to use molecular oxygen as an 
electron acceptor, but the true mechanism is not fully understood (Kato et al. 2010; 
Kobayashi et al. 2014; Boynton et al. 2011). The presence of multiple enzymes 
creates the same kind of pathway branching as the alternative coproporphyrinogen 
oxidases and allows for use of this pathway under a range of environmental 
conditions.  
 
The oxygen-dependent reaction that is catalysed by the HemY enzyme (Figure 1.6) 
uses oxygen as the electron acceptor. This enzyme is the most commonly studied 
protoporphyrinogen oxidase and is mostly found in eukaryotic organisms, however it 
is also found in a number of bacterial species (Kobayashi et al. 2014). This protein 
has been purified and assayed in a large number of organisms including plants (e.g. 
barley (Jacobs & Jacobs 1987)), mammals (e.g. murine (Dailey & Karr 1987), 
bovine (Siepker et al. 1987), human (Dailey & Dailey 1996)), fungi (e.g. 
Saccharomyces cerevisiae (Poulson & Polglase 1975) and bacteria (e.g. Bacillus 
subtilis (Hansson & Hederstedt 1992)). 
Figure 1.6 ± Overview of conversion of protoporphyrinogen IX to protoporphyrin IX by the 




This form of protoporphyrinogen oxidase uses a flavin adenine dinucleotide (FAD) 
cofactor, which gives the protein a characteristic yellow appearance. This cofactor is 
responsible for initially receiving the electrons from the protoporphyrinogen 
molecule before transferring them to the molecular oxygen acceptor. The FAD can 
only transfer two electrons at a time, which reduces to FADH2, suggesting that the 
six electron oxidation occurs in three stages and progresses via two intermediates 
(tetrahydro- and dihydro- porphyrinogens).  
While a tautomerisation mechanism has been proposed whereby the tetrapyrrole 
remains bound to the enzyme during oxidation (Jordan 1991; Koch et al. 2004), it is 
currently unknown if partially oxidised intermediates dissociate from the enzyme 
during the course of the reaction. This reaction has also been shown to be stimulated 
by peroxidase-derived reactive oxygen species produced by enzymes such as 
cytochrome c (Shepherd & Dailey 2009), which is particularly relevant in 
mammalian systems where HemY and cytochrome c are co-localised to the 
mitochrondrial intermembrane space. Intriguingly, a similar stimulation of bacterial 
HemY has been observed by the terminal enzyme of the coproporphyrin-dependent 
pathway, HemQ (Dailey et al. 2010).  
The oxygen independent reaction, catalysed by the HemG enzyme, follows a 
different path. HemG shuttles electrons into the electron transport chain and uses 
compounds such as nitrate or fumarate as the terminal electron recipients (Jacobs & 
Jacobs 1976). The HemG protein from E. coli has been recently characterised and 
this protein was shown to bind flavodoxin and uses menaquinone as an electron 
acceptor (Boynton et al. 2009).  
The HemJ enzyme has been discovered very recently in organisms that have no 
homologues of hemG nor hemY yet still produce haem (Kato et al. 2010). This 
protein has been shown to function in an aerobic environment, and seems to be 
distantly related to a subunit of respiratory complex I (Kato et al. 2010). However, 
attempts to complement a hemG mutant of E. coli  with hemJ were unsuccessful 





The formation of protoporphyrin IX is the final step that is common to both the 
classical haem biosynthesis pathway and the chlorophyll biosynthesis pathway in 
organisms that contain both pathways. Following the formation of protoporphyrin 
IX, the porphyrin can either have an iron ion inserted by ferrochelatase, as outlined 
below, or have a magnesium ion inserted by magnesium chelatase, which is the first 
dedicated step towards the synthesis of chlorophylls and bacteriochlorophylls 
(Jensen et al. 1998). 
1.2.2.4 ± Ferrochelatase 
 
The final reaction in the classical haem synthesis pathway involves the insertion of 
an iron (II) ion (Fe2+) into protoporphyrin IX by the terminal enzyme in the pathway, 
ferrochelatase. Ferrochelatases have been shown to act on a range of porphyrins 
(Dailey et al. 1983; Dailey & Lascelles 1974), inserting a series of different metal 
ions in vitro (Karlberg et al. 2002; Lecerof et al. 2003; Hansson et al. 2006). 
However, their role in the biosynthesis of haem is to insert a ferrous ion into the 
middle of the porphyrin ring (Layer et al. 2010). This is achieved by distorting the 
planar porphyrin molecuOHLQWRDµVDGGOH¶FRQIRUPDWLRQEHIRUHDOORZLQJDPHWDOLRQ
to be inserted into the ring, which is coordinated by the nitrogen atoms on the 
pyrrole rings (Layer et al. 2010).  
While there is no oxygen-dependent nor independent isoforms, there are membrane-
associated and soluble ferrochelatases. Besides solubility there are other differences 
between amongst ferrochelatases, with the majority of membrane-associated 
enzymes containing a [2Fe-2S] iron sulphur cluster of unknown function, with the 
exception of Saccharomyces cerevisiae (Karlberg et al. 2002). A class of soluble 
[2Fe-2S]-containing bacterial ferrochelatases has also been identified that 
coordinates the cluster via three cysteine residues located in the centre of the primary 
sequence, rather than via three cysteine residues at the C-terminus as in mammalian 
ferrochelatases (Shepherd et al. 2006). Another functional variation can be found at 
the C-terminus, where membrane-associated forms have a longer sequence that is 
believed to be a factor involved in dimerisation of the enzyme (Wu et al. 2001; 
Karlberg et al. 2002). It is also in this region where S. cerevisiae has slight 
differences that do not allow for the formation of a [2Fe-2S] iron-sulphur cluster, but 
still allows for stable dimers to be formed (Karlberg et al. 2002). 
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Both soluble and membrane-bound forms of ferrochelatases have been shown to 
utilise protoporphyrin, mesoporphyrin and deuteroporphyrin as substrates as well as 
a variety of divalent metals, including zinc, copper and cobalt among the main 
metals tested (Dailey et al. 1983; Lecerof et al. 2003; Hansson et al. 2011). Zinc in 
particular has been used as a common alternative to iron in experiments as it has 
been shown to be more stable in an aerobic environment and also allows for 



















1.2.3 ± The Alternative Haem Biosynthetic Pathway 
An alternative pathway for haem biosynthesis was discovered very recently that 
produces haem via a very different pathway to the classical pathway (Buchenau et al. 
2006). This pathway, which has currently been observed in sulphate-reducing 
bacteria and methanogenic archaea (Bali et al. 2011; Lobo et al. 2014; Palmer et al. 
2014) , produces haem from sirohaem in a series of reactions that modify the side 





Figure 1.7 ± Overview of the alternative haem biosynthetic pathway starting from sirohaem. 
Sirohaem is first decarboxylated at the C12 and C18 positions (grey) by sirohaem decarboxylase 
(AhbA/B complex) before acetic acid residues are cleaved at positions C2 and C7 (orange) by a 
radical SAM enzyme (AhbC) and finally decarboxylation of the side chains at positions C3 and C8 










1.2.3.1 ± Sirohaem Decarboxylase 
The first dedicated step along the alternative pathway is the double decarboxylation 
of sirohaem by sirohaem decarboxylase to form 12, 18-didecarboxysirohaem carried 
out by the dimeric complex AhbA/AhbB (Palmer et al. 2014). This reaction is 
believed to occur in two steps, with the substrate leaving the protein following a 
single decarboxylation and entering in a different orientation to perform the second. 
This reaction modifies the side chains located on C12 and C18 of sirohaem, located 
on rings C and D respectively, leaving methyl groups at these positions (Palmer et al. 
2014). 
 
1.2.3.2 ± Transformation to coprohaem III 
Following decarboxylation of sirohaem on rings C and D, the acetic acid groups on 
rings A and B are cleaved off by AhbC (Bali et al. 2011). This reaction is proposed 
to be performed by a radical SAM enzyme, using radicals to cleave the acetate 
groups from C2 and C7 (Kuhner et al. 2014; Bali et al. 2011). 
 
1.2.3.3 ± Haem b Synthase 
The final reaction in the alternative haem biosynthetic pathway is the 
decarboxylation of coprohaem III to protohaem IX, aka haem b. This reaction is 
catalysed by AhbD, also known as haem b synthase, in this system, which is also a 
radical SAM enzyme (Bali et al. 2011). This protein, which has been shown to have 
two 4Fe-4S clusters, uses the deoxyadenosyl radical, dAdo, to cleave the propionate 
groups on rings A and B and transform them into vinyl groups, producing protohaem 







1.2.4 ± The coproporphyrin-dependent pathway 
A third branch to synthesise haem has been discovered even more recently than the 
alternative haem biosynthetic pathway and this progresses via coproporphyrin III 
rather than protoporphyrin IX (Dailey et al. 2015). The pathway (Figure 1.8), which 
has mostly been found in Gram-positive organisms of the Actinobacteria and 
Firmicutes, is ancestral to the classical pathway (Dailey et al. 2015).  
Whilst this pathway is the most recent to be discovered, clues as to its existence have 
been available for a number of years. The first clue occurred in experiments where 
coproporphyrinogen was being monitored for conversion to protoporphyrin in cell 
extracts. Cell extracts from organisms such as Staphylococcus aureus and 
Micrococcus lysodeikticus failed to produce protoporphyrin IX, but did accumulate 
coproporphyrin III (Jacobs et al. 1971). It was later discovered that HemY proteins 
from B. subtilis could oxidise coproporphyrinogen III as well as protoporphyrinogen 
IX (Hansson et al. 1997), which is the branch point where the coproporphyrin-
dependent pathway begins. 
 
Figure 1.8 ± Comparison between the classical pathway (green) and the coproporphyrin-based 
pathway (blue). 6WDUWLQJ ZLWK&¶JHQIII the main difference in reaction orders is the decarboxylation 
step, which occurs first in the classical pathway (catalysed by HemF or HemN) and last in the 
coproporphyrin-dependent pathway (catalysed by HemQ). 
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1.2.4.1 ± Oxidation of coproporphyrinogen III 
The first step in this pathway branch is oxidation of coproporphyrinogen III to 
coproporphyrin III, rather than the conversion to protoporphyrinogen IX that is seen 
in the classical pathway. This reaction is catalysed by HemY enzymes and the 
reaction is similar to the oxygen-dependent protoporphyrinogen oxidase reactions 
performed by HemY proteins in the classical pathway (mentioned in section 1.2.2.3 
and expanded on in chapter III). Indeed, the HemY enzyme from B. subtilis has been 
shown to oxidise both coproporphyrinogen III and protoporphyrinogen IX (T. A. 
Dailey et al. 1994; Hansson & Hederstedt 1994), which has implications for the 
evolution of the classical pathway from the ancestral coproporphyrinogen pathway 
(Dailey et al. 2015). 
1.2.4.2 ± Coproporphyrin III ferrochelatase 
As with the classical pathway, insertion of a ferrous iron atom into the tetrapyrrole 
ring follows oxidation of the macrocycle. This reaction is catalysed by enzymes 
annotated as HemH (as in the classical pathway), This reaction, inserting Fe2+ into 
coproporphyrin III, appears to occur in the same way as the classical reaction but 
produces coprohaem III as a product (Dailey et al. 2015; Lobo et al. 2015). 
Intriguingly, HemH ferrochelatases from Gram-positives have previously been 
shown to insert iron into both coproporphyrin III and protoporphyrin IX  (Dailey et 
al. 2015). 
1.2.4.3 ± Coprohaem III decarboxylation 
The final reaction in the coproporphyrin-dependent pathway is the decarboxylation 
of coprohaem III to form haem. This reaction is very similar to the reaction catalysed 
by AhbD of the alternative pathway, in that it is proposed to utilise radicals to cleave 
the propionate side chains on rings A and B (Celis et al. 2015). However, the HemQ 
enzyme that catalyses this reaction is not a radical SAM enzyme (Dailey et al. 2010) 
and is likely to rely upon a porphyrin or aromatic derived radical to activate the 
propionate carbon atoms (Celis et al. 2015). HemQ is unique to organisms that 
synthesise haem via the coproporphyrin-dependent pathway and can utilise 
peroxides to initiate a radical-based oxidative decarboxylation reaction (Dailey et al. 





Figure 1.9 ± Overview of haem biosynthesis via the three discovered pathways: The classical 
pathway (green), commonly utilised by Gram-negative bacteria and eukaryotic organisms, the 
Alternative Pathway (red), primarily utilised by sulphate reducing bacteria and methanogenic 
archaea, and the coproporphyrin-dependent pathway (blue), currently only discovered in Gram-
positive organisms such as S. aureus and B. subtilis. Reactions utilised by more than one pathway 




1.3 ± The importance of Staphylococcus aureus 
Discovered in 1880, Staphylococcus aureus is a Gram positive organism that can 
cause minor skin infections and post-operative wound infections (Deurenberg & 
Stobberingh 2008). This organism occurs as a commensal organism in a significant 
proportion of the human population (Wertheim et al. 2005; Casey et al. 2007) and is 
most commonly found inhabiting the anterior nasal passage or skin (Williams 1963) 
although it has been discovered colonising the gastrointestinal tract, vagina, oral 
cavity and axillae (Williams 1963; Guinan et al. 1982; Koukos et al. 2015). Whilst 
this organism can co-exist with humans without incident, S. aureus infections can 
range in severity from skin conditions such as impetigo bullosa, to more serious, life 
threatening conditions such as bacteremia (Archer 1998). This pathogen can be very 
dangerous to children and those with an impaired immune system with conditions 
such as staphylococcal scalded skin syndrome (Grama et al. 2016). S. aureus has 
also reacted quickly to penicillin based antibiotics, quickly acquiring resistance 
PHFKDQLVPVWRȕ-lactam antibiotics soon after widespread introduction (Deurenberg 
& Stobberingh 2008) with methicillin resistant S. aureus strains (MRSA) also being 
able to carry resistance genes to other classes of antimicrobials (Smith & Jarvis 
1999; Deurenberg & Stobberingh 2008). 
1.3.1 - Discovery and characteristics of S. aureus 
As mentioned above, S. aureus was discovered in 1880 by the surgeon Sir Alexander 
Ogston whilst viewing stained preparations of pus from patients with post-operative 
wound suppuration or abscesses under a microscope (Ogston 1882). Among the 
bacteria that were discovered was a coccus shaped bacterium, which was given the 
name Staphylococcus due to the grape-like clusters that they formed (Ogston 1882). 
A sample of this bacterial strain was later isolated and grown and were finally given 
the name Staphylococcus aureus due to the golden appearance of the colonies that 
were formed (van Belkum et al. 2009). This organism has a genome size of 
approximately 2.8 - 2.9 mega base pairs (Lowy 1998; Kim et al. 2014) with 
virulence and antimicrobial resistance genes being found both in the chromosomal 
and extra chromosomal elements of the genome (Lowy 1998).  
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For many years, identification of S. aureus relied on using a coagulase agglutination 
assay, where the protein coagulase converts fibrinogen (contained in plasma) to 
fibrin, which gives rise to a clumping effect in comparison with a saline control. This 
clumping used to be regarded as a positive result for S. aureus (Turutoglu et al. 
2005), which at the time was the only coagulase-positive Staphylococcus species that 
had been discovered, with other Staphylococcus species (e.g. Staphylococcus 
epidermidis) being classified as coagulase-negative Staphylococcus species (Casey et 
al. 2007). There are reports of other species of Staphylococcus that have been found 
to be coagulase-positive, such as Staphylococcus shleiferi subspecies coagulans 
(Thibodeau et al. 2012), which could render classical identification practices 
inaccurate, however there are now modernised molecular techniques that give more 
accurate identifications. An example of these techniques is pulsed-field gel 
electrophoresis which is now considered the gold-standard test for detecting S. 
aureus in clinical settings (Deurenberg & Stobberingh 2008). 
S. aureus belongs to the Firmicute phylum of bacteria, a phylum that has a low G+C 
content in its genome (Charneski et al. 2011) when compared with other phyla such 
as actinobacteria, that can have a G+C content as high as 70% (Ventura et al. 2007). 
In general, Staphylococci belong to the staphylococcaceae family, of the bacilliales 
order from the bacilli class of firmicutes. This family is one of the major branch 
points where the coccus shape of the bacterium begins to form, as opposed to rod-
shaped bacteria such as Bacillus subtilis (which also belongs to the bacillales order). 
1.3.2 - Clinical importance and antibiotic resistance 
6LQFHLWVGLVFRYHU\LQWKH¶VS. aureus has been recognised as a pathogen that 
has been very likely to cause infections of wounded tissues (Ogston 1882) and even 
in the 1990s, it remained the most common organism that was isolated from wound 
and soft-tissue infections (Smith & Jarvis 1999). Infections by this pathogen usually 
originate following colonisation, which occurs in approximately 30% of healthy 
individuals (Archer 1998), before potentially causing a range of infections. Common 
infections mostly include superficial conditions (e.g. carbuncles, cellulitis and 
impetigo) whilst less common afflictions can include pneumonia, endocarditis and 
bacteremia (Smith & Jarvis 1999).  
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Should an infection progresses to the bacteremia stage, S. aureus can spread to 
peripheral sites in distant organs which increases the potential for septic shock to 
occur, which has a high mortality rate if not treated (Archer 1998). Other serious 
conditions that can arise from S. aureus infections include staphylococcal scalded 
skin syndrome, which mostly affects children due to their lack of immunity (Grama 
et al. 2016), toxic shock syndrome and food-borne gastroenteritis (Archer 1998). 
Antimicrobial resistance of S. aureus has become as big problem in the clinical 
setting, as it has quickly adapted to new forms of penicillin based antimicrobials to 
form resistant strains. In 1942 the first penicillin resistant isolate of S. aureus was 
observed, 2 years after the widespread use of penicillin for medical use, and by 1960 
around 80% of strains were penicillin resistant (Deurenberg & Stobberingh 2008). 
7KHJHQHUHVSRQVLEOHIRUWKLVUHVLVWDQFHSURGXFLQJȕ-lactamase, has been discovered 
on transmissible genetic elements, most commonly plasmids, with the form 
expressed by S. aureus being stable for over 50 years (Medeiros 1997). A similar 
pattern was seen after the introduction of methicillin, a penicillinase resistant form of 
penicillin, where resistant strains had been detected 2 years after introduction. This 
was later found to be due to acquisition of a 2.1 kb gene called mecA (Deurenberg & 
Stobberingh 2008), which produces an altered penicillin binding protein 
3%3¶3%3D DQG LV EHOLHYHG WR KDYH RULJLQDWHG LQ D FRDJXODVH-negative strain 
Staphylococcus sciuri  (Smith & Jarvis 1999).  
Methicillin-resistant S. aureus (MRSA) strains also tend to multi-drug resistant, as 
the plasmid-borne transposon can also carry resistance genes for many other 
antimicrobials, including erythromycin and tetracycline (Smith & Jarvis 1999). 
These resistance genes appear to be collected on a mobile genomic island called the 
staphylococcal cassette chromosome mec (SSCmec), of which seven types have been 
recognised ranging from 20.9 kb to 66.9 kb in size (Deurenberg & Stobberingh 
2008). Of these seven cassette types, only types II and III (53.0 kb and 66.9 kb in 
size respectively) contain genes responsible for multiple classes of antibiotics. The 
emergence of these resistant strains is currently contributing the impending 
antimicrobial resistance crisis, which will eventually see epidemics break out for 
which there are few effective treatments without the discovery of novel ways of 
combatting pathogenic organisms (Michael et al. 2014). 
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1.3.3 - Iron acquisition and haem metabolism 
S. aureus has the ability to uptake haem from the environment, which is its main 
source of iron. The acquisition of this nutrient is essential for the survival the 
majority of pathogens in their host organism, without it pathogens will be unable to 
grow efficiently and will be eliminated by host defences (Ratledge & Dover 2000). 
The presence of iron in host organisms is very tightly regulated, with iron being 
sequestered to the carrier proteins (such as ferritins, transferrin and lactoferrin) or 
bound to protoporphyrin as haem in hemoproteins, leaving virtually no free iron in 
the host (Wandersman & Delepelaire 2004).  
Faced with the scarce amounts of iron available in hosts, pathogens such as S. aureus 
have developed mechanisms to acquire iron from these sources. Previous studies on 
S. aureus has shown that the preferred iron source for acquisition is haem, which is 
the most abundant form of iron in the body (localised to haemoglobin and 
myoglobin) (Skaar, Humayun, et al. 2004). Gram-positive bacteria intake haem 
using cell wall anchored proteins to relay haem from host proteins to an ABC 
transporter system, which delivers the metalloporphyrin to the cytoplasm (Cavallaro 
et al. 2008). In S. aureus, this system is made up of nine different proteins, forming 
the well-characterised Isd system. This system involves three different stages to 
acquire and degrade the haem molecule. The first stage involves the transfer of haem 
across the cell wall, performed by the haem-binding IsdA, IsdB, IsdC and IsdH 
proteins (Grigg et al. 2007; Maresso & Schneewind 2006; Pluym et al. 2008). The 
second process is the transport of haem across the cell membrane, performed by the 
IsdDEF complex before finally being degraded by the haem oxygenases IsdG and 
IsdI (Maresso & Schneewind 2006). Gram-negative organisms have to transport 
haem across two separate membranes, with these two actions being performed using 
two different systems. To transport iron-siderophore complexes across the outer 
membrane, Gram-negative organisms (such as E. coli) use the TonD-dependent 
energy transduction system which is composed of the proteins: TonB, ExbB, ExbD 
and FepA (Higgs et al. 2002). Transport across the inner membrane involves 
different families of ABC transporters, resembling the Gram-positive system, that 
appear to vary according to specific organisms (Cavallaro et al. 2008). 
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Once inside the cell, haem is degraded by haem monoxygenases, in a reaction that 
appears to be conserved throughout mammals and bacterial speces that contain them, 
producing biliverdin, carbon monoxide and releasing the iron contained within the 
porphyrin ring (Maresso & Schneewind 2006). As of 2006, two types of haem 
oxygenase systems have been described in Gram-positive pathogens: the HmuO 
system characterised in Corynebacterium diphtheriae, which is homologous to the 
human haem oxygenase enzyme (Wandersman & Delepelaire 2004) and the 
IsdG/IsdI system that has been characterised from S. aureus, which has a lack of 
amino acid sequence identity to other bacterial haem-degrading enzymes and has 
homologues in Listeria monocytogenes, Bacillus anthracis and Staphylococcus 
epidermidis (Skaar, Gaspar, et al. 2004). Following haem breakdown, the iron is 
stored by the pathogen in ferritins and haem-containing bacterioferritins (the latter of 
which is unique to prokaryotes) before being used. The iron can also be re-formed 
into haem via the biosynthetic pathway, where it is then used as a co-factor in 













1.4 ± Aims of the Project 
The overarching aim of this project was to increase the understanding of how haem 
is synthesised in the cutaneous pathogen Staphylococcus aureus. At the start of the 
project, the two recently discovered branches to the haem biosynthetic pathway had 
not been reported, and it was thought that the role of HemQ was to facilitate HemY-
mediated oxidation of protoporphyrin IX in the classical pathway (Dailey et al. 
2010) rather than catalysing the terminal step of the coproporphyrin-dependent 
pathway. Hence, the initial aims of the current project were to: 
x Measure the impact of S. aureus HemQ upon HemY kinetics. 
x Determine whether the mechanistic basis for HemQ-mediated stimulation of 
HemY relies upon the generation of reactive oxygen species. 
x Determine whether HemQ required bound haem for stimulation of HemY to 
occur. 
x Measure the affinities of different tetrapyrroles for HemQ. 
Following the discovery of the pathway branches outlined in sections 1.2.3 and 
1.2.4, the research aims switched to the bona fide in vivo reactions for the HemY, 
HemH and HemQ enzymes:  
x Determine if HemQ-mediated stimulation of HemY occurs when 
coproporphyrinogen III is used as a substrate. 
x Isolate recombinant purified S. aureus HemH and perform kinetic 
characterisation. 
x Investigate how structural features of HemY, HemH, and HemQ are adapted 
to their in vivo function. 
This thesis is set out in a logical order that follows the coproporphyrin-dependent 
pathway (i.e. HemY, HemH, HemQ), and the data are discussed in terms of how 
substrate specificities and interactions between pathway enzymes may have 








































2.1 ± Strains List 
The following strains (Table 2.1) were either made during the project or acquired 
from the laboratories of Prof. Martin Warren (University of Kent) or Prof. Harry 
Dailey (University of Georgia). Bacterial strains were grown as outlined in Section 
2.3 before purifying the relevant proteins as described in Section 2.4. 
 






















MS51 JM109 - Transformation with 
a HemQ containing 
plasmid 
- - 
MS122 BL21 pET14b-S. aureus 
hemQ, pLysS 











MS76 JM109 pTrcHis-P. acnes 
hemY 


















MS84 BL21 DE3 pET14b-M. 
thermautotrophicus 
hemB - B. 
megaterium hemC 
hemD 
Expression of haem 
synthesis proteins: 






MS117 JM109 pTrcHis-M. 
tuberculosis hemQ 
Plasmid recovery for 




MS41 JM109 pTrcHis-B. subtilis 
hemH 
Plasmid recovery for 
S. aureus hemH 
cloning 






MS116 JM109 pTrcHis-P. acnes 
hemHQ 
Plasmid recovery for 
S. aureus hemH 
cloning /  




MS368 JM109 pTrcHis-S. aureus 
hemH 
Expression of S. 
aureus HemH 
Ampicillin This Work 
 
2.2 ± Plasmids 
The following plasmids were either made during the project or acquired from the 
laboratories of Prof. Martin Warren (University of Kent) or Prof. Harry Dailey 
(University of Georgia). Plasmid stocks were transformed into chemically-competent 
E. coli cells as outlined in Section 2.11. Plasmids that were to be used as the vector 
for the cloning of S. aureus hemH were extracted from E. coli overnight starter 
cultures as outlined in Section 2.10.2. 
 
Table 2.2 - Bacterial plasmids used during this study with their purposes and origins 
Plasmid Gene Organism Usage Origin 
pET-28a-S. 
aureus hemY 










hemY Human Expression of Human HemY Dailey Lab 
pTrcHis-P. 
acnes hemY 
hemY P. acnes Expression of P. acnes HemY 




hemH B. subtilis Expression of B. subtilis 
Ferrochelatase 





hemQ M. tuberculosis Cloning of S. aureus hemH Dailey Lab 
pTrcHis-S. 
aureus hemH 
hemH S. aureus Expression of S. aureus HemH This work 
pET-14b-
Human hemE 










Expression of haem synthesis 
enzymes: 





2.3 ± Bacterial Growth 
2.3.1 - Starter cultures 
Strains were streaked out on agar plates containing the appropriate antibiotics 
(working concentrations are detailed in Table 2.3 below). Single colonies were used 
to inoculate 10 mL of LB media (10g/L NaCl, 10g/L Tryptone, 5g/L Yeast Extract) 
in sterile falcon tubes (50 mL). These were then placed in a Innova 3100 shaking 
waterbath (New Brunswick Scientific, USA) at 37 °C and 180 rpm for approximately 
16 h (overnight). 
 
         Table 2.3 ± Stock and working concentrations of antibiotics used during this study 




Ampicillin 125 0.125 
Chloramphenicol 34 0.034 
Kanamycin 50 0.05 
 
         
2.3.2 ± Protein overexpression 
A starter culture of the desired strain was grown as described above, with appropriate 
antibiotics. This was then transferred to a 2L baffled flask containing 1L of sterile 
LB, for strains containing pET-based plasmids, or 1L of sterile Circlegrow  medium 
(MP Biomedicals, USA), for strains containing pTrcHis plasmids, and was incubated 
at 37°C and 160rpm. Flasks containing LB were monitored via optical density at 
600nm (OD600), with ,VRSURS\O ȕ-D-1-thiogalactopyranoside (IPTG) being added 
(final concentration = 400mM) when cells reached an OD600 of 0.6. Flasks were then 
incubated at 19°C and 160 rpm for 16 h. Flasks containing cells that overexpressed 
S. aureus HemY also had riboflavin added at this point to promote FAD cofactor 
incorporation (final concentration = 0.75 µg/mL). Flasks containing Circlegrow were 
grown for 24 h at 37°C and 160 rpm without any extra growth supplements. Cells 
were then harvested by centrifugation in a Beckman Coulter Avanti J series 
centrifuge (Rotor: JLA 9.1 (Beckman Coulter), 4000 rpm, 4 °C, 20 min) and the cell 
pellets collected and placed in a sterile 50 mL falcon tube. Cells were stored at -20°C 
if they were not to be immediately used. 
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2.4 ± Protein purification  
All proteins purified contained a His6-tag for affinity chromatography. Cell pellets 
from 1L cultures of cells overexpressing HemY or HemQ were re-suspended in 30 
mL of protein storage buffer containing 50mM Tris/ 3-(N-
morpholino)propanesulfonic acid (MOPS) pH 8.0, 100mM KCl, 0.2% (v/v) Tween 
20. Cultures (1L) overexpressing HemH were re-suspended in 30 mL of protein 
storage buffer containing 50mM Tris/MOPS pH 8.0, 100mM KCl, 1% (w/v) sodium 
cholate.  Cell suspensions were sonicated in a Soniprep150 Sonicator (MSE, UK) for 
6 x 30 s bursts on ice at an amplitude of 10 microns, with a 30 s interval between 
bursts, to break open the cells. The suspension was then centrifuged (Rotor: JA 
25.50 (Beckman Coulter), 18,000rpm, 4°C, 20 mins) to remove insoluble cell debris. 
The supernatant was applied to a column containing Talon metal affinity resin 
(Clontech Laboratories Inc., USA) with a 2.5 mL column volume, which had been 
pre-equilibrated with 5 column volumes of protein storage buffer (12.5 mL). 50 mL 
of protein storage buffer was then passed through the column to remove any 
unbound proteins from the column. 10 mL of wash buffer (protein storage buffer 
including 15 mM imidazole) was then added to the column to remove any weakly-
bound protein. The solution that was eluted from the column at this stage was 
collected to be concentrated (this sample will later be referred to as the "Wash" 
sample). 10 mL of elution buffer (protein storage buffer including 300 mM 
imidazole) was then added to the column to elute the protein of interest (this sample 
will later be referred to as the "Elution" sample). 10 mL of protein storage buffer 
including 1M imidazole was then added to remove any remaining protein from the 
column. 12.5 mL of protein storage buffer was then added to re-equilibrate the 
column for storage. The 10 mL wash and elution samples were placed in 10 kDa cut-
off spin concentrators (Millipore, USA) and centrifuged at 5,000 x g to concentrate 
the samples down to a volume between 0.5 mL and 1 mL. The samples were then 
passed through PD10 de-salting columns (GE Healthcare, UK), equilibrated with 
protein storage buffer, and transferred into fresh protein storage buffer to remove any 
imidazole from the buffer. Samples (50 µL) were collected throughout all steps for 





Table 2.4 ± Recipes for manufacturing 10 mL of 4% (v/v) and 
12% (v/v) acrylamide gels for SDS-PAGE. 
2.5 ± SDS-PAGE 
Sodium Dodecylsulphate-Polyacrylamide Gel Electrophoresis (SDS-PAGE) was 
used to assess the purity of protein samples. SDS-PAGE gels were cast freshly 
before use using a BIORAD mini-protean gel system (BIO-RAD Laboratories, 
USA). The gels utilised for this work were cast with a 12% (v/v acrylamide) 
resolving gel and a 4% (v/v) stacking gel prepared according to the following recipe 
for 10 mL of gel solution: 
 
                         
 
Chemical Volume Required (mL) 
 4% 12% 
Water 6.3 4.3 
40% (v/v)  Acrylamide 1 3 
1.5M Tris pH8.8 2.5 2.5 
10% (w/v) SDS 0.1 0.1 
10% (w/v) APS 0.1 0.1 
Temed 0.01 0.004 
  
  
Cast gels were transferred to the gel tank and filled with a running buffer (250mM 
glycine, 25mM Tris, 0.1% (w/v) SDS, pH 8.3). Protein samples were then diluted 
1:1 with loading dye (50mM Tris, 2% (w/v) SDS, 0.5% (w/v) Bromophenol Blue, 
10% (v/v) Glycerol, 100mM dithiothreitol (DTT) [added just before use]) and 
applied to the wells. Sample volumes used in the wells were 5 µL for samples direct 
from the purification column, with concentrated samples added in different volumes 
(up to 20 µL). 5 µL of a size marker (NEB Colour Protein Standard Broad Range, 
New England Biolabs, USA) was also included in a separate lane. The gels were run 
DW9XQWLO WKHORDGLQJG\HKDGUHDFKHGWKHERWWRPRIWKHJHO§PLQEHIRUH
being stained for 1 h in a solution containing 50% (v/v) methanol, 10% (v/v) acetic 
acid, 2.5g/L coomassie brilliant blue. Gels were then de-stained (in 10% (v/v) 
methanol, 10% (v/v) acetic acid) until the gel matrix became colourless. 
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2.6 ± Markwell Assay 
Protein solutions were quantified using a Markwell assay as previously described 
(Markwell et al. 1978). Markwell reagents A (20g/L Na2CO3, 4g/L NaOH, 1.6g/L 
Sodium tartrate, 10g/L SDS) and B (4% (w/v) CuSO4.5H2O) were mixed in a 49:1 
ratio to form reagent C. 1 mL of reagent C was then added to test tubes containing 
0.25 mL of either diluted protein sample or bovine serum albumin (BSA) standards 
of known concentrations (diluted in distilled H2O). Samples were vortexed and then 
left on the bench top for 60 min. 75 µL of a diluted )ROLQ 	 &LRFDOWHX¶V SKHQRO
reagent (Sigma, USA) solution (1:1 in dH2O) was then added and vortexed to mix 
before a 45 min incubation at room temperature. Samples were then inverted and the 
appearance of blue chromophore (Figure 2.1) was measured at 660 nm, with dH2O 
used as to blank the spectrophotometer (Cary 60 UV/Vis, Agilent Technologies, 
USA). 
 
The absorbance of the BSA standards was plotted on a standard curve (Figure 2.2) 
which was used to convert the absorbance values for test samples into µg/mL 
concentrations by comparing to the linear regression fit for the standards. The 
concentration was then converted to molar concentrations usLQJ WKH SURWHLQ¶V
molecular mass and corrected for dilution. Unknown samples were measured in 
triplicate and the concentrations averaged to provide a measure of reproducibility, 
with BSA standards being single repeats which were performed alongside each assay 

















Figure 2.1 ± Example of a set of BSA standards (0-250µg/mL left-right) used during each Markwell 
assay. A blue chromophore develops during the assay which was detected using UV/Vis spectroscopy 




Figure 2.2 ± Example of a BSA standard curve produced from a Markwell assay. Linear regression 
parameters (shown in the equation) were used to convert test sample absorbance values for this 
dataset by re-arranging the formula to find a value for the x variable using a known y value. Standard 
























2.7 ± Reducing porphyrins to porphyrinogens 
Protoporphyrin IX and coproporphyrin III powders (Frontier Scientific, USA) were 
reduced to protoporphyrinogen IX and coproporphyrinogen III respectively using 
potassium hydroxide and sodium amalgam. 
 
2.7.1 ± Preparation of sodium amalgam 
Sodium amalgam was produced under nitrogen from elemental sodium (Sigma) and 
mercury (Sigma). 1.17g of dried and scored sodium was added to 25g of mercury in 
a side-arm, round bottom flask under a constant stream of nitrogen and gently mixed 
until the metals reacted. A stainless steel spatula was quickly used to further mix the 
amalgam and prevent large chunks of amalgam from forming. The amalgam was 
then crushed using a mortar and pestle. The amount of amalgam produced was 
sufficient for reduction of one sample of porphyrin to porphyrinogen. Mercury was 
recovered by dissolving amalgam in 25% (v/v) acetic acid, followed by washing 
with large volumes of water to remove any impurities. 
 
2.7.2 ± Reduction of porphyrins 
3 mg of porphyrin powder was solubilised in a few drops of ammonium hydroxide 
and then added to 3 mL of a solution containing 10 mM KOH and 20% (v/v) 
ethanol. A further 3 mL of 10 mM KOH solution was then added prior to being 
transferred to a conical flask covered with foil. The amalgam was the added to the 
flask, which was promptly stoppered and vigorously shaken to allow for reduction to 
occur, with the stopper gently released periodically allowing for gaseous release. The 
reaction was allowed to proceed until no gas could be detected leaving the flask. 
Following the reaction, the mixture was transferred to a 10 mL syringe with a small 
amount of glass wool placed at the bottom to filter out the amalgam from the 
mixture. The solution was collected in a covered glass flask and adjusted to pH 8.0 
with a 4 M MOPS solution that had been degassed with nitrogen to remove oxygen. 
The solution was then stored for 30 mins under nitrogen before use. Following use, 
the stock solution was left overnight open to oxygen to allow the porphyrinogen to 
fully oxidise for quantification (see Section 2.9). The solution was stored in the dark 
during this time to prevent light-induced breakdown of the porphyrin. 
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2.8 ± HemY activity assays 
HemY was assayed for activity with both protoporphyrinogen IX and 
coproporphyrinogen III using a continuous fluorimetric method, essentially as 
previously described (Shepherd & Dailey 2005). Reactions were performed in clear, 
flat bottomed 96-well plates with a total reaction volume of 100 µL comprising assay 
buffer (50mM NaH2PO4, 0.2% (v/v) Tween 20, pH 8.0), 0.5 µM HemY, 0 ± 30 µL 
of porphyrinogen substrate, and dH2O to bring the reaction volume up to 100 µL.  
 
The porphyrinogen substrate was added in low light levels just before placing the 
plate into a FLUOstar OPTIMA plate reader (BMG Labtech, Germany) to prevent 
auto oxidation as much as possible due to its sensitivity to light and oxygen. 
Reactions were performed with measurements every 30 seconds using an excitation 
wavelength of 520 nm and emission detected at 620 nm.  
 
4 measurements were taken for each sample, with nonenzymatic auto-oxidation 
controls for each reaction condition also being recorded for subsequent background 
subtractions. HemY assays also containing other proteins (e.g. HemQ, horseradish 
peroxidase (HRP), catalase etc.) were performed using 1 µM of the second protein, 

















2.9 ± Spectroscopic quantification of tetrapyrroles 
2.9.1 ± Protoporphyrin IX and Coproporphyrin III 
Protoporphyrin IX stock solutions were diluted and quantified in 2.7 M HCl 
spectrophotometrically XVLQJ DQ H[WLQFWLRQ FRHIILFLHQW RI ڙ408 = 262 mM-1cm-1. 
(Smith 1975). Coproporphyrin III stock solutions were diluted in 0.1 M HCl and 
quantified spectrophotometrically using an H[WLQFWLRQFRHIILFLHQWRIڙ399.5 = 489 mM-
1cm-1 (Smith 1975). 
 
2.9.2 ± Haem 
Protohaem IX was quantified using a pyridine haemochrome assay. Protohaem IX 
solutions were prepared by solubilising haemin powder (Sigma) in dimethyl 
sulfoxide (DMSO, Fluka [via Sigma]) followed by dilution with dH2O. Protohaem 
IX solutions were mixed in a 1:1 ratio with a solution containing 4.2 M pyridine 
(Sigma) and 0.4 M NaOH. The resultant solution was then pipetted into two cuvettes 
with one containing a few grains of sodium dithionite and the other containing a few 
grains of potassium ferricyanide, for reduction and oxidation of the samples, 
respectively. Absorption spectra were recorded between 500 nm and 600 nm, with 
the oxidised sample being used to blank the spectrophotometer so that a reduced-
oxidised spectrum was obtained. The difference between the peak at 557nm and the 
trough at 541nm was used as the absorbance reading with an extinction coefficient of 
ڙ557-541 = 20.7 mM-1cm-1 being used for quantitation (Smith 1975). 
 
Coprohaem III stocks were made to a required concentration by re-suspending a 
known quantity of coprohaem III powder (Frontier Scientific) DMSO and diluting to 










Table 2.5 ± PCR program used for amplifying S. aureus hemH 
from genomic DNA and plasmid preparations. 
2.10 ± Cloning of S. aureus hemH 
2.10.1 ± Amplification of hemH fragment 
The hemH gene was amplified from S. aureus USA300 genomic DNA using the 
polymerase chain reaction (PCR) and DNA primers that contained restriction sites 
for NheI and HindIII (forward and reverse primers, respectively). Reactions 
contained 25 µL of 2x Q5 master mix (NEB), 300 nM of each primer (1.5 µL of 10 
µM stocks), 0.5 µL S. aureus genomic DNA and 21.5 µL of MilliQ-H2O. The 






Initial DNA denaturation 95 120 
40 cycles of: 
DNA denaturation 95 30 
Primer annealing 55 30 
DNA elongation 72 60 
Final stage and sample storage 
Final elongation 72 300 




5 µL of the PCR reaction was then analysed on a 1% (w/v) agarose gel, produced 
using a tris/acetic acid/EDTA buffer (TAE) alongside a 1kb DNA marker (Promega, 
USA) to check the fragment size. PCR products were purified using a PCR 
purification kit (Qiagen, Germany) and analysed on a 1% (w/v) agarose TAE gel 
alongside a 1kb Hyperladder (Bioline, UK) for quantification. Once quantified, 
samples were stored at -20°C until use. Samples were digested with NheI and 
HindIII prior to ligation into the plasmid vector, procedures outlined in sections 





2.10.2 ± Plasmid vector preparation and restriction digests 
 
A pTrcHis plasmid containing M. tuberculosis hemQ in the NheI and HindIII 
restriction sites was recovered from a 10 mL overnight E. coli starter culture (strain 
MS117) using a Qiagen spin miniprep kit and was digested by NheI and HindIII. 
Conditions used for digests were (for a 10 µL digestion):  
 
x 3 µL plasmid DNA sample 
x 1 µL 10x NEBuffer 2 (1 mM DTT, pH 7.9 [NEB])  
x 5 Units NheI (NEB) (0.5 µL volume) 
x 5 Units HindIII (Promega) (0.5 µL volume) 
x 5 µL sterile MilliQ-H2O 
 
Reactions were placed in a 37°C incubator for 3 hours 
 
For whole miniprep sample digestion, reagents were scaled up, but using no more 
than 1 µL of each restriction enzyme, and left on the bench at room temperature 
overnight.  
 
Following digestion of whole miniprep samples, the digested fragments were 
cleaned using a PCR purification kit (Qiagen) and run on a 1% (w/v) agarose TAE 
gel alongside a 1kb Hyperladder (Bioline) to quantify the amount of plasmid vector 














2.10.3 ± Ligation of the S. aureus hemH fragment 
 
Ligation of the DNA fragment was adapted from usual protocols, where there would 
usually only be one type of vector and one fragment for insertion, due to potential 
chemical contamination of samples following agarose gel extraction of the DNA 
which inhibited the activity of the T4 DNA Ligase that was used. Two potential 
fragments, the original M. tuberculosis hemQ fragment and desired S. aureus hemH 
fragment, were present in the ligation, with the hemH fragment being in a higher 
quantity in an attempt to out-compete the original the hemQ fragment.  
Conditions for the ligations were (for a 20 µL reaction):  
 
x 2 µL 10x T4 ligation buffer (Roche) 
x 1 Unit T4 Ligase (Roche, Switzerland) (1 µL volume) 
x 50 ng plasmid vector DNA (roughly 3 µL) 
x §QJIUDJPHQW'1$for a 10:1 fragment : vector ratio) 
x nuclease free water to make up to 20 µL (if required) 
 
 Reactions were left on the bench top at room temperature overnight, and stored at     
-20°C if not immediately needed. Ligation mixtures were subsequently transformed 















2.11 ± Competent cells and transformation of 
plasmids 
BL21 and TOP10 E. coli cells were made chemically competent to allow for 
transformation of plasmids from stocks or ligation mixtures into cells. 
 
Cells were made chemically competent by taking a 10 mL overnight starter culture 
and centrifuging at 1789 x g, 4°C for 10 minutes. The resulting cell pellet was re-
suspended in 7.5 mL of sterile 15% (v/v) glycerol and put on ice for 10 minutes, 
before being centrifuged (2795 x g, 4°C for 30 mins). The pellet was then gently re-
suspended in 25 mL of a buffer containing 100 mM MgCl2, 15% (v/v) glycerol and 
centrifuged again (2795 x g, 4°C, 30 mins). The pellet was finally gently re-
suspended in 25 mL of a buffer containing 75mM CaCl2, 6 mM MgCl2, 15% (v/v) 
glycerol before being stored at -80°C in 100 µL aliquots. 
 
For transformations, 100 µL of competent cells were incubated on ice with either 0.5 
µL plasmid DNA or 1-2 µL of ligation product for 30 mins before heat shocking the 
cells at 42°C for 30 seconds. Following heat shock, 1 mL of LB media was added to 
the cells, followed by incubation with shaking at 37°C for 1 hour to allow the cells to 
recover. 100 µL of cells were then spread onto a fresh LB plate containing 
appropriate antibiotics and incubated at 37°C overnight. The remaining cells were 
then centrifuged (5,000 x g, 5 min) and re-suspended in 100 µL of fresh LB media, 
before being spread onto another LB plate and incubated at 37°C. Any colonies that 
formed were struck out onto fresh LB plates (with appropriate antibiotics) to further 
check for resistance before being grown in liquid media to an OD600 of 1.5 and stored 
in a 1:1 ratio with sterile 50% (v/v) glycerol (final 25% (v/v)) at -80°C. 
 
Colonies were screened for the pTrcHis-S. aureus hemH plasmid using colony PCR, 
where a bacterial colony was suspended in 50 µL of dH2O and 1 µL of this was 
added to the PCR mixture instead of a DNA template (as in section 2.10.1). This was 
performed using primers that anneal to the plasmid vector 100bp either side of the 
hemH insert, and the amplification of the hemH gene was detected using agarose gel 
electrophoresis. Positive colonies were further verified for the correct insert DNA 
sequence by Sanger sequencing (Beckman Coulter Genomics, UK), to ensure that 
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the protein produced would not contain any mutations. Plasmid DNA was extracted 
from 10 mL starter culture using a Qiagen spin miniprep kit and sent with a series of 
sequencing primers VWDUWLQJ ES XSVWUHDP RI WKH ¶ HQG RI WKH hemH gene and 
spaced 200bp apart. A map of these primer locations is shown in Figure 2.3, with the 





Figure 2.3 ± Map of sequencing primer locations on the pTrcHis-hemH plasmid. Primers (red arrows) 
are spaced 200 bp apart covering the hemH gene. 
 
 
2.12 ± Enzymatic production of coproporphyrin III 
&RSURSRUSK\ULQ ,,, ZDV V\QWKHVLVHG IURP į-aminolaevulinic acid (Sigma) using a 
series of haem synthesis proteins from different organisms (M. thermautotrophicus 
HemB, B. megaterium HemC + HemD, Human HemE and S. aureus HemY) 
recombinantly produced and purified from E. coli. The reaction, a 10 mL total 
volume, contained 50 µL of a HemB/HemC/HemD combined solution (giving a final 
concentration of 120 µg/mL in the reaction) as well as 1 µM of HemE and 1 µM of 
HemY. The reaction was performed in a buffer consisting of 50 mM Tris/HCl pH 
8.0, 150 mM NaCl, 20% (v/v) glycerol, 5 mM DTT, 0.2% (v/v) Tween 20, and 1.5 
mM 5-ALA (100 µL of a 150 mM stock). Reactions were incubated overnight at 
37°C in a 30 mL glass bell jar covered with foil, with a magnetic stirrer gently 




Synthesised coproporphyrin was then extracted into an equal volume of diethyl ether 
(10 mL) and shaken vigorously to allow for transfer of the porphyrin into the ether 
phase (Figure 2.4). The aqueous and ether phases were then allowed to settle before 
freezing the aqueous phase at -20°C and recovery of the ether phase into a 15 mL 
falcon tube. The ether solution was then transferred, in small amounts, to a 
microcentrifuge tube and placed in a fume hood in the dark to evaporate the ether to 
leave a precipitate of coproporphyrin III.  The precipitate was re-suspended and 









Figure 2.4 ± Enzymatically synthesised coproporphyrin III before (A) and after (B) extraction into 











2.13 ± Ferrochelatase activity assays 
HemH was assayed with a porphyrin substrate (either coproporphyrin III or 
protoporphyrin IX) and a divalent metal (Fe2+, Zn2+, Co2+, Cu2+ or Ni2+) using a 
spectrophyotometric assay. Porphyrin solutions were quantified as described in 
section 2.9.1. Iron solutions, containing ascorbic acid to maintain the reduced state, 
were quantified spectroscopically using a small amount of ferrozine solution and an 
extinction co-HIILFLHQW RI ڙ562 = 27.9 mM-1cm-1 (Berlett et al. 2001). Other metal 
solutions were diluted down from 0.1M stocks made from commercially available 
powders for ammonium nickel (II) sulphate (Sigma), cobalt (II) chloride (Aldrich, 
USA), copper (II) chloride (Aldrich) and zinc sulphate (Sigma). 
 
HemH (50 nM) was assayed in a 1 mL cuvette in a ferrochelatase assay buffer (0.1M 
Tris-HCl pH 8.1, 0.5% (w/v) sodium cholate, 0.5% (v/v) 7ZHHQ  P0 ȕ-
mercaptoethanol) with up to 10 µL of  concentrated metal solution and porphyrin 
solution (volume dependent on the concentration of stock solutions). Reactions were 
performed at 30°C in a Cary 60 UV/Vis spectrophotometer (Agilent Technologies) 
and were started by the addition of metal solution and inversion of the cuvette. 
Absorbance at 392 nm was recorded to monitor kinetic parameters for iron insertion 
into coproporphyrin III, looking at the change in absorbance at this wavelength using 
DQH[WLQFWLRQFRHIILFLHQWRIǻ$392 = 115 mM-1cm-1 (Lobo et al. 2015) to determine 
the kinetics for this enzyme. Other metals and protoporphyrin IX were observed for 
insertion by taking a scan between 375 nm and 600 nm every 6 s. Samples to be 
analysed by High-Performance Liquid Chromatography (HPLC) were quenched to 
stop enzymatic activity by diluting 1 in 10 in a solution of 80% (v/v) acetone, 0.02% 









2.14 ± High Performance Liquid Chromatography 
(HPLC) 
HPLC analysis of porphyrins from HemH and HemQ activity assays were performed 
on an Agilent Technologies 1100 series HPLC system connected to a TELOS C-18 
column. Buffers used for this process were A: 0.1% (v/v) TFA and B: Acetonitrile. 
The column was initially equilibrated in a combination of 80% buffer A and 20% 
buffer B, with the percentage increasing to 100% B using a linear gradient over 30 
min following injection of the sample. The buffer levels remained at 100% B for 10 
min before returning to 20% B to re-equilibrate the column. 5 µL of samples or 5 µL 
of a 5 µM porphyrin standard solution (containing one of: coproporphyrin III, 
coprohaem III, protoporphyrin IX or protohaem IX) were injected onto the column 
and porphyrin products were detected using absorbance spectroscopy at 400 nm. 
 
A haem standard curve, for HemQ assays, was generated by analysing several haem 
concentrations from 0 ± 5 µM and plotting the concentration against the peak 
magnitudes and can be seen in Appendix 4.  
 
 
2.15 ± HemQ activity assays 
HemQ (50 nM) was assayed for activity with varying concentrations of coprohaem 
III and H2O2 in the same reaction buffer as was used for HemH reactions (0.1 M 
Tris-HCl pH 8.1, 0.5% (w/v) sodium cholate, 0.5% (v/v) Tween 20, 1 P0 ȕ-
mercaptoethanol). Assays were performed in microcentrifuge tubes at 30°C and 
started by the addition of protein and mixing by inversion of the tube. 50 µL samples 
of the reaction were quenched in 450 µL of quenching solution (80% (v/v) acetone, 
0.02% (v/v) TFA) at 5, 10 and 15 seconds before being analysed for haem formation 








2.16 ± Fluorescence quenching titrations for HemQ  
 
Fluorescence titrations were performed using a Perkin-Elmer LS50B Luminescence 
spectrometer (Perkin-Elmer, USA) using 3 mL of 75 nM unloaded HemQ protein 
(diluted in protein storage buffer) in a 4 mL quartz fluorescence cuvette (Helma 
Analytics, Germany). Porphyrin and haem stocks were prepared and quantified as 
described in section 2.9, with protoporphyrin IX and coproporphyrin III stocks 
diluted (in protein storage buffer) to concentrations of 2.5 µM and 13 µM, 
respectively. The protein was scanned for fluorescence over a wavelength range of 
310 ± 400 nm with an excitation wavelength of 280 nm for an initial fluorescence 
reading. The protein solution was then titrated with small volumes of the ligand of 
interest (10 µL aliquots), followed by gentle mixing by pipetting. Fluorescence 
emission scans were recorded between successive additions of ligand. Ligand was 
added until there was no apparent change in fluorescence. The titration was then 
repeated using the same amounts of ligand from the same stocks and the fluorescent 
compound N-acetyl-tryptophanamide (NATA, Sigma) as a control reaction to 
account for inner filter effects resulting from absorbance of the tetrapyrrole ligands. 
The NATA was added until the fluorescence at 340 nm was equal to that of the 
original protein before adding the same quantities of ligand as before. The 
fluorescence intensities at 340 nm were obtained for both sets of titrations, and the 
corrected results were plotted using Sigmaplot 9 (Systat Software Inc., USA) for 



















































Haem is synthesised via a series of tetrapyrrole intermediates including non-
metallated porphyrins such as protoporphyrin IX, which is well-known to generate 
reactive oxygen species (ROS) in the presence of light and oxygen. S. aureus has an 
ancient haem biosynthetic pathway that proceeds via the formation of 
coproporphyrin III, a less reactive porphyrin. Herein, it is reported for the first time 
that HemY of S. aureus is able to generate both protoporphyrin IX and 
coproporphyrin III, and structural modelling confirms that the tetrapyrrole binding 
pocket is capable of binding both tetrapyrrole products. In addition, the terminal 
enzyme of this pathway, HemQ, is shown to stimulate the generation of 
protoporphyrin IX (but not coproporphyrin III). Assays with hydrogen peroxide, 
horseradish peroxidase, superoxide dismutase, and catalase confirm that this 
stimulatory effect is mediated by superoxide, suggesting Fenton chemistry as a likely 
route for the superoxide-mediated stimulation of protoporphyrinogen IX oxidase 
activity of HemY.  This generation of toxic free radicals could explain why HemQ 
enzymes have not been identified in organisms that synthesise haem via the classical 
protoporphyrin IX pathway. This work has implications for the divergent evolution 















3.1 ± Introduction 
The HemY protein is one of three proteins (along with HemG and HemJ) that can 
catalyse the penultimate reaction in haem synthesis: oxidation of protoporphyrinogen 
IX to protoporphyrin IX. These proteins are oxygen-dependent; requiring molecular 
oxygen to function as the terminal electron acceptor and are not present in organisms 
that encode the HemG protein, which use nitrate or fumarate as electron acceptors. 
HemY proteins appear to have different structures, being either membrane-
associated or soluble, with the soluble structures being able to oxidise extra 
substrates (T. A. Dailey et al. 1994; Hansson et al. 1997). The membrane-associated 
form, found mainly in eukaryotic organisms such as Humans and Nicotiana tabacum 
and also in some Gram-negative bacteria such as Myxococcus xanthus, has been 
shown to follow the classical haem-synthesis pathway. The soluble form, found in 
Gram-positive bacteria, has been shown to be able to follow the classical pathway 
and oxidise protoporphyrinogen IX (Hansson & Hederstedt 1994; Dailey et al. 2010) 
as well as having the ability to oxidise coproporphyrinogen III and 
mesoporphyrinogen IX (T. A. Dailey et al. 1994). The discovery of the 
coproporphyrin-dependent pathway of haem synthesis (Dailey et al. 2015) has 
shown that the soluble HemY proteins utilise coproporphyrinogen III as its primary 
substrate instead of protoporphyrinogen IX, making this subset of proteins 
coproporphyrinogen  oxidases instead of protoporphyrinogen oxidases. This pathway 
(Figure 3.1, blue route) has been reported to be more widely distributed and older 
than the classical protoporphyrin IX pathway (Figure 3.1, red route), pre-dating 
oxygenic photosynthesis (Dailey et al. 2015).  
 
It has long been known that certain Gram-positives such as S. aureus accumulate 
coproporphyrin III and not protoporphyrin IX (Jacobs et al. 1971) . Interestingly the 
enzyme HemY from Bacillus subtilis has been shown to oxidise both 
coproporphyrinogen III and protoporphyrinogen IX (Hansson et al. 1997). Further 
studies reported that a haem-binding protein HemQ that is required for the terminal 
steps of haem synthesis in species of Actinobacteria and Firmicutes had peroxidase 
and catalase activity and could stimulate the oxidation of protoporphyrinogen IX by 
HemY (Dailey et al. 2010; Mayfield et al. 2013). S. aureus hemQ mutants were then 
shown to accumulate coproporphyrin III and the HemQ enzyme was reported to lyse 
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haem in the presence of peroxide/chlorite (Mayfield et al. 2013). Structural analyses 
then confirmed the HemQ family of proteins to be distinct from the original 
assignment to the family of chlorite dismutase enzymes (Celis & DuBois 2015), 
these differences defined by variations in conserved proximal/distal pocket residues 
(Hofbauer et al. 2016).  However, an overlay of chlorite dismutase coordinates with 
the crystal structure of apo-HemQ from Listeria monocytogenes revealed the chlorite 
dismutase haem docks neatly in the HemQ active site cleft (Hofbauer et al. 2015). 
The true in vivo role for HemQ was revealed  in 2015 when HemQ was confirmed to 
catalyse the decarboxylation of coprohaem for the noncanonical coproporphyrin-
dependent pathway (Dailey et al. 2015; Lobo et al. 2015).  Bona fide 
coproporphyrinogen oxidases were shown to be absent in Actinobacteria and 
Firmicutes explaining the lack of protoporphyrin IX in these organisms observed 
over four decades earlier (Jacobs et al. 1971). The lack of a functional 
coproporphyrinogen oxidase in S. aureus was then validated by report of a lack of 
activity for the purified HemN protein (Lobo et al. 2015), which appears to have 
been mis-annotated (Dailey et al. 2015). Finally, the HemQ reaction was later shown 
to proceed via an unusual peroxide-dependent reaction via a harderohaem III 
intermediate (Celis et al. 2015), and flavin mononucleotide (FMN) has also been 
shown to be an effective electron acceptor (Dailey et al. 2015). 
 
The current study seeks to investigate mechanisms that have driven the evolution of 
the classical protoporphyrin IX-dependent pathway present in proteobacteria and 
eukaryotes. Since the HemQ component of the coproprophyrin pathway has been 
identified in evolutionarily early-branching (Acidobacteria and Planctomyces) and 
transitional (Deinococcus-Thermus group) diderm phyla (Dailey et al. 2015; Gupta 
1998; Gupta 2011), it is highly likely that this pathway is an evolutionary precursor 
to the classical protoporphyrin IX pathway. However, the presence of non-functional 
HemN homologues in the vast majority of Firmicutes/Actinobacteria (Dailey et al. 
2015), the identification of hemF genes in a small proportion of these families 
(Dailey et al. 2015), and demonstrations that Gram-positive HemY enzymes can 
oxidise both protoporphyrinogen IX and coproporphyrinogen III (Dailey et al. 2015; 
T. A. Dailey et al. 1994; Hansson & Hederstedt 1994), all suggest that ancestral 
species of Firmicutes/Actinobacteria may have once produced both coproporphyrin 
III and protoporphyrin IX intermediates.  The reported lack of protoporphyrin IX in 
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Actinobacteria and Firmicutes (Jacobs et al. 1971) indicates that HemQ cannot 
convert coproporphyrin III to protoporphyrin IX, which is consistent with the 
requirement for a metallated porphyrin to participate in the peroxide-dependent 
HemQ mechanism (Celis et al. 2015).   
 
Hence, one plausible route for the protoporphyrin-dependent pathway to have 
evolved is: i) the necessary appearance of HemN/HemF enzyme(s) that 
decarboxylate coproporphyrinogen III to protoporphyrinogen IX, ii) emergence of 
HemY variants that can oxidise both coproporphyrinogen III and 
protoporphyrinogen IX, iii) emergence of HemH ferrochelatases that can catalyse 
iron insertion into coproporphyrin III and protoporphyrin IX, and finally iv) loss of 
Fe-coproporphyrin III decarboxylases (HemQ/AhbD). Since there is a requirement 
for haem (or a significant growth advantage to synthesising it) in most organisms 
that have a functional haem biosynthetic pathway, it is plausible that the 
protoporphyrin- and coproporphyrin-dependent pathways co-existed before the 
protoporphyrin-dependent pathway came to predominate in proteobacteria and 
eukaryotes. Following this branching event, major clades have some interesting 
characteristics: HemQ/AhbD enzymes are largely absent from proteobacterial 
species that oxidise protoporphyrinogen via the classical pathway, and 
Firmicutes/Actinobacteria possess HemQ/AhbD enzymes yet do not oxidise 
protoporphyrinogen IX to protoporphyrin IX. This exclusive presence of a classical 
or a coproprophyrin-dependent haem pathway is particularly intriguing in light of 
demonstrations that HemQ stimulates protoporphyrinogen oxidation by 
Propionibacterium acnes HemY (Dailey et al. 2010). Since HemQ of S. aureus 
decarboxylates Fe-coproporphyrin III via a peroxide-dependent mechanism (Celis et 
al. 2015), it was hypothesised that that radical generation by HemQ has a greater 
impact upon protoporphyrinogen oxidation compared to coproporphyrinogen 
oxidation (Figure 3.1), resulting in the generation of reactive oxygen species that are 
toxic to the cell. It was therefore of interest to re-evaluate substrate specificity in S. 
aureus HemY and to examine how the likely co-existence of HemY and HemQ 
influenced flux through the protoporphyrin IX (classical) and coproporphyrin III 
pathways. Herein, we investigate this ancestral process in terms of how a 
combination of metalloporphyrin-bound HemQ and hydrogen peroxide influences 





Figure 3.1. - The classical and coproporphyrin-dependent pathways of haem synthesis. This figure 
depicts haem synthesis in a hypothetical ancestral organism where the oxidation of 
coproporphyrinogen III to coproporphyrin III (blue) and the classical route involving a protoporphyrin 
IX intermediate (red) both take place. HemQ is hypothesised to generate reactive oxygen species 
(ROS), which in turn are hypothesised to impact upon protoporphyrinogen IX oxidation to a greater 




3.1.1 - Spectroscopic and kinetic properties of HemY 
proteins 
Spectral analysis of HemY proteins from other organisms highlights a few common 
characteristics of the purified protein. Besides the protein absorbance peak at roughly 
280nm, absorption peaks at approximately 410nm have been reported for human 
HemY (Dailey & Dailey 1996) and Saccharomyces cerevisiae HemY (Poulson & 
Polglase 1975), and it has been proposed that these features result from bound 
protoporphyrin IX. Human HemY was also shown to have absorbance at 375nm and 
a broader absorbance peak at 450nm, a characteristic of oxidised FAD. 
 
Kinetic data for HemY can vary greatly across different organisms and a selection of 
the published Km and kcat values can be found in Table 3.1. Various 
protoporphyrinogen oxidases have been shown to be inhibited by a variety of 
molecules, including diphenyl ethers such as acifluorfen, and the linear tetrapyrrole 
bilirubin (Ferreira & Dailey 1988; T. A. Dailey et al. 1994). Both of these are 
believed to be competitive inhibitors of protoporphyrinogen oxidases, with 
acifluorfen confirmed as an active site inhibitor via crystallisation studies with B. 
subtilis HemY (Qin et al. 2010). 
 
Acifluorfen is not a planar molecule and is smaller than protoporphyrinogen IX, 
although was shown to occupy the active site cleft with part of the molecule in the 
tetrapyrrole-binding site adjacent to the FAD cofactor. It has been suggested that 
acifluorfen mimics half of a protoporphyrinogen IX molecule, as can be seen in 
Figure 3.2, with structural comparisons of the two molecules showing that the 
torsion angles at either oxygen in acifluorfen are comparable to the methylene 
bridges between pyrrole rings in protoporphyrinogen IX (Corradi et al. 2006). In 
addition, mouse HemY has been shown to be inhibited by haem breakdown products 
such as bilirubin, a linear tetrapyrrole that exhibits competitive inhibition patterns 






Figure 3.2 ± Comparison of protoporphyrinogen IX (left) and its commonly used inhibitor 
Acifluorfen (right). Whilst the ring structures  making up the individual sections of the molecule are 
different, the overall shape of the two molecules follow a similar pattern and presence of ±COOH 
groups, allowing for  acifluorfen to reside in the HemY active site. 
 
It has previously been shown that haem-binding proteins can have an effect on the 
activity of HemY proteins from Drosophila melanogaster and Propionibacterium 
acnes, increasing the observed maximal rate (Shepherd & Dailey 2009; Dailey et al. 
2010). According to studies performed using cytochrome c, stimulation of the 
protoporphyrinogen oxidase activity appears to require the hydrogen peroxide that is 
produced during the reaction. It has been hypothesised that this stimulation is due to 
radicals produced during peroxidase breakdown of hydrogen peroxide. It has been 
noted that the redox state of the iron in the bound haem becomes reduced during the 
reaction (Shepherd & Dailey 2009), a process that also happens during the 
breakdown of hydrogen peroxide by a peroxidase mechanism. Addition of 
superoxide dismutase to the assays appears to abolish the stimulatory effect, further 
supporting the theory of radical stimulation (Shepherd & Dailey 2009). Studies on 
the HemY from P. acnes utilised the haem-bound HemHQ as a stimulant to the 
reaction. These assays suggested that the presence of the haem-bound form of this 
protein can increase the maximal rate by a factor of over 6-fold (from 3.0 min-1 to 
19.8 min-1), whilst the Km decreases by almost half (19µM to 10.1µM)  (Dailey et al. 
2010). Since cytochrome c and HemQ are found in the same subcellular 
compartments in eukaryotes (mitochondrial intermembrane space) and certain 
prokaryotes (cytoplasm), respectively, these observations have implications for the 




   
Table 3.1 ± Kinetic data for previously characterised HemY proteins from various organisms.  
3.1 ± Reference 
(Shepherd & Dailey 2005) 
(Shepherd & Dailey 2005) 
(Shepherd & Dailey 2005) 
(Shepherd & Dailey 2005) 
(Shepherd & Dailey 2005) 
(Shepherd & Dailey 2005) 
(Poulson & Polglase 1975) 
(Qin et al. 2010) 
(Dailey et al. 2010) 
(Corrigall et al. 1998) 
(Corrigall et al. 1998) 
(Corrigall et al. 1998) 
(Lobo et al. 2015) 
(Ferreira & Dailey 1988) 







































5.7 ± 0.2 
3.1 ± 0.2 
0.4 ± 0.009 
- 
0.784 ± 0.011 
3.0 
0.19 ± 0.03 
0.05 ± 0.005 
2.69 ± 0.6 
1.33 ± 0.04 
450h-1(7.5min-1) 





3.8 ± 0.3 
3.6 ± 0.5 
1.0 ± 0.1 
4.8 
1.0 ± 0.09 
19 
1.0 ± 0.15 
5.29 ± 0.36 
4.92 ± 0.75 
0.31 ± 0.01 
6.5 



















3.1.2 ± Crystal structures of HemY enzymes  
Published crystal structures exist for HemY proteins from three different organisms: 
Bacillus subtilis, Nicotiana tabacum and Myxococcus xanthus. The structures for N. 
tabacum and B. subtilis were resolved to a resolution of 2.9 Å, with the structure for 
M. xanthus being resolved at 2.3 Å with acifluorfen bound and 2.7 Å with 
acifluorfen absent (Qin et al. 2010; Koch et al. 2004; Corradi et al. 2006). These 
structures possess a substrate binding domain, an FAD binding domain and a third 
domain that is associated with membrane binding in N. tabacum and M. xanthus. 
The latter domain is different in B. subtilis HemY, which is a soluble isoform. These 
modifications to the membrane binding domain consist mainly of a deletion of 
roughly 40% of the amino acids in this region, making it noticeably smaller and is 
thought to explain why the B. subtilis HemY enzyme is soluble (Qin et al. 2010). 
The general secondary structure of each domain appears to be conserved across all 
WKUHHSURWHLQV2QHGRPDLQLVPRVWO\PDGHXSRIĮ-helices, and is referred to as the 
membrane binding domain (this domain is much smaller in B. subtilis HemY). The 
VHFRQG GRPDLQ LV SULPDULO\ PDGH XS RI ȕ-sheets DQG FRQWDLQV RQH Į-helix; this 
domain has been shown to bind the inhibitors acifluorfen (Corradi et al. 2006; Qin et 
al. 2010) and 4-bromo-3-(50-carboxy-40-chloro-20-fluoro-phenyl)-1-methyl-5-
trifluoromethyl-pyrazo (INH) (Koch et al. 2004) and is therefore regarded to be the 
substrate binding domain. Modelled structures for protoporphyrinogen IX and 
protoporphyrin IX (the substrate and product of the enzymes) have also been 
successfully docked into this domain in N. tabacum, which further supports the role 
for substrate binding (Koch et al. 2004). The final domain consists of a mixture of 
the two secondary structures and is shown in all three proteins to bind the FAD 
cofactor.  
HemY from N. tabacum forms a loosely associated dimer structure, with the two 
monomers interacting at the membrane binding domain (Koch et al. 2004). The M. 
xanthus protein was proposed to also have a dimeric structure based on gel filtration 
data, although the crystal structure did not possess the interactions required to form a 
dimeric structure (Corradi et al. 2006). HemY from B. subtilis differs from these two 
membrane bound forms, as it exists as a monomer instead of a dimer (Qin et al. 
2010). This may be due to the deletion in the membrane bound domain, as this is 




The active site regions of the proteins exhibit subtle differences between the 
membrane-bound and soluble forms of HemY, as the inhibitor acifluorfen binds to 
different sites on the two proteins¶ forms. In M. xanthus HemY, the inhibitor binds 
deep into the active site cleft, with the 2-nitrobenzoic acid part of the molecule being 
held tightly in place by the residues: Arg-95, Phe-329 and Leu-332. The 2-chloro-4-
trifluoromethylphenoxy part of the molecule resides in a larger space between 
residues Met-365 and Gly-167, and also sits at an angle of 45o relative to the active 
site plane and the FAD cofactor (Corradi et al. 2006). In contrast, HemY from B. 
subtilis (shown in Figure 3.3) has a set of amino acids at the analogous positions that 
have smaller sidechains (Ser-95, Thr-330 and Val-333). This appears to cause 
binding to a different region, with the 2-nitrobenzoic acid moiety sitting adjacent to 
the FAD cofactor (Qin et al. 2010). Binding in this region seems to weaken the 
affinity of the inhibitor, as it is a strong inhibitor of the membrane-bound HemY 
proteins and a weak inhibitor of the soluble HemY of B. subtilis.  
 
Figure 3.3 ± A view of the B. subtilis HemY crystal structure active site with important residues 
visible (cyan). Protoporphyrin IX (yellow) has been modelled into the active site alongside the 
defined location of FAD (orange). Image originally published in the Journal of Structural Biology 





3.1.3 ± Aims of the chapter 
The initial research aim of this chapter was to investigate the HemY enzyme from S. 
aureus. Particular attention was made to these hypotheses: 
 
x S. aureus HemY can oxidise both protoporphyrinogen IX and 
coproporphyrinogen III.  
o Determine kinetic parameters for these reactions.  
 
x The presence of haem-loaded HemQ will stimulate the HemY-mediated 
oxidation of both substrates. 
o Stimulation will change the kinetic parameters of the reactions. 
 
 
Once these points had been established, aims shifted to determine the mechanism of 
the HemQ-mediated stimulation of the HemY reaction, including the investigation of 
the hypotheses that: 
 
x The presence of exogenous hydrogen peroxide will inhibit both reactions. 
 
x Dedicated peroxidases/catalases will stimulate the HemY reaction. 
 










3.2 ± Results 
3.2.1 ± Analysis of the sequence and predicted structural 
model for S. aureus HemY 
3.2.1.1 - Amino acid sequence comparisons 
 The HemY protein from S. aureus was subjected to a NCBI BLASTp search to 
check for amino acid sequence identity with other organisms. This enzyme was 
found to have a high sequence identity at the amino acid level to protoporphyrinogen 
oxidases from other Staphylococcus species (excluding S. aureus), with sequence 
identities in the 80%-95% range. However, it has a rather low sequence identity with 
protoporphyrinogen oxidases from other genera, with the closest match being 
Macrococcus caseolyticus at 61% followed by protoporphyrinogen oxidases from a 
variety of Bacillus species (including B. subtilis), which all range in the high 40% 
amino acid sequence identity range. Surprisingly, some organisms that are known to 
possess the coproporphyrin-dependent pathway (P. acnes and M. tuberculosis) have 
a very low sequence identity, with scores in the 20%-30% range. Output from the 
NCBI BLASTp search can be found in Table 3.2, whilst a multiple sequence 
alignment of these HemY enzymes is shown in Figure 3.4. 
 
Table 3.2 - Results of a NCBI BLASTp search of HemY protein similarity from various 
organisms. All organisms have been confirmed to utilise the coproporphyrin-dependent pathway 
with the exception of M. caseolyticus. HemY protein amino acid sequences do not appear to be 
highly conserved throughout organisms that use this branch of the haem biosynthetic pathway. 













(USA300) PPO 958 598 100 0 100 EES92498.1 
S. 
epidermidis PPO 806 806 100 0 82 WP_002476967.1 
M. 
caseolyticus PPO 584 584 99 0 61 WP_041636144.1 
B. subtilis PPO 434 464 99 3.00x E-153 47 WP_015483036.1 
P. acnes PPO 159 159 99 3.00x E-47 27 EFD07069.1 
M. 
tuberculosis PPO 119 119 99 
6.00x 





Figure 3.4 ± Multiple sequence alignment of HemY protoporphyrinogen oxidases from: S. aureus, 
Staphylococcus epidermidis, Macrococcus caseolyticus, B. subtilis, P. acnes and M. tuberculosis. 
Background colours represent sequence identity (black) similar amino acids (grey) and no identity 
(white). Residues highlighted in red are mentioned in more detail in subsequent modelling sections.  
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 3.2.1.2 ± Structural modelling of S. aureus HemY 
A predicted structure of S. aureus HemY was obtained using the RaptorX structure 
prediction program, which uses the protein sequence to generate 3D models based on 
structural homology protein structures in the Protein Databank (PDB) (Peng & Xu 
2011). The HemY protein from B. subtilis (PDBid = 3I6D (Qin et al. 2010)) was one 
of the top hits that the predicted structure was based on. The structural model was 
then analysed in CCP4MG (McNicholas et al. 2011), a molecular graphics program, 
which can be used to directly compare and superimpose proteins based on the 
similarity of their secondary structures. The predicted model of the S. aureus HemY 
was directly compared with the B. subtilis model, which contained the FAD cofactor 
and the inhibitor acifluorfen (Figure 3.5$ 6XSHUSRVLWLRQ RI WKH &Į DWRPV
demonstrates very similar overall tertiary structures, with the exception of an extra 
set of helices in the S. aureus protein that is not present in the B. subtilis HemY 
(bottom left corner of panel A). Using the positions for the FAD and acifluorfen 
from B. subtilis with the superimposed S. aureus model (Figure 3.5B), it is possible 
to see that the S. aureus model can accommodate these molecules with minimal 
steric clashes, suggesting that these active site probes could bind to similar locations 




Figure 3.5 ± Structural images of: (A) B. subtilis HemY, (PDBid = 3I6D (Red)), with bound FAD 
and acifluorfen (gold and purple respectively) superimposed with the S. aureus HemY structural 
model (Blue). (B) Close up surface representation of the S. aureus HemY FAD binding site with FAD 





Work on the B. subtilis protein has shown that the binding site cavity appears to be 
much larger in this organism than other forms of HemY that have been crystalized, 
with a volume of 1,173Å3 compared with 440Å3 and 627Å3 for N. tabacum and M. 
xanthus respectively. This cavity is also more positively charged in B. subtilis than in 
the other mentioned HemY proteins. Together these factors support the ability for 
coproporphyrinogen III, which has two extra negatively charged side chains and is a 
larger molecule compared to protoporphyrinogen IX, to bind in this area (Qin et al. 
2010).  
The acifluorfen molecule that was bound to the B. subtilis HemY was used as a 
template to superimpose both protoporphyrin IX and coproporphyrin III, products of 
the HemY reaction, into the active site of the predicted S. aureus HemY structure 
(Figure 3.6). The modelled porphyrins (of which only coproporphyrin III is shown) 
appear to fit into the site with very few steric clashes with the surfaces of the proteins 
or the FAD cofactor, which could be overcome in vivo due to the flexibility of both 
the protein and the porphyrin molecules. The negatively charged carboxylate groups 
on the coproporphyrin molecule appear to be positioned close to the blue regions of 
the electrostatic surface model of HemY, which are representing positively charged 
areas of the protein. This matches predictions by Qin et al. (2010) that the larger and 
more positively charged pocket allows for the binding of coproporphyrinogen III, 
which is held in place better by the increased positive charge on the surface. 
To investigate whether S. aureus HemY has a tetrapyrrole-binding cleft that is well-
suited to the oxidation of coproporphyrinogen III, the modelled acifluorfen in Figure 
3.6 was overlaid with coproporphyrin III (Figure 3.6A). While there is only 48% 
sequence similarity in the primary sequence between the S. aureus and B. subtilis 
proteins, several residues that are important for catalysis in B. subtilis (including 
K71, P64, I176, F227 and Y366) are only conserved in their locations on the tertiary 
structure (Figure 3.6B), whilst being at sometimes vastly different locations on the 
amino acid chain.  The conserved location of these residues appears to explain why 





These amino acids interact with the substrate and FAD co-factor in different ways 
and many have a profound impact on the activity of the enzyme, with activity levels 
in mutant proteins ranging from slight decreases to almost a 100-fold decrease in 
activity when Y366 is mutated to a glutamine residue (Qin et al. 2010). K71 is 
believed to interact with the propionate side chains of the porphyrinogen molecule 
using charge-charge interactions. P64 is located behind (relative to the 
porphyrinogen substrate) and interacts with the FAD co-factor. I176, together with 
the FAD co-IDFWRUDLGLQVWDELOLVLQJWKH³'´ULQJRIWKHVXEVWUDWHDOORZLQJLWWREH
close enough to the accepting N5 atom of FAD for electron transfer to take place 
(Qin et al. 2010). Y366 and F227 are LQYROYHGLQVWDELOLVLQJWKH³$´DQG³&´ULQJV
respectively, with Y366 seemingly the most important residue for activity as 




Figure 3.6 ±Modelling of coproporphyrin III (purple) into the active site of the predicted S. aureus 
HemY model. Location of the porphyrin is based on the inhibitor acifluorfen from the B. subtilis 
crystal structure (with FAD present in gold). (A) Surface model of the protein, showing electrostatic 
potential (where blue = positive charge, red = negative and white = neutral for amino acids). Active 
site cavity gives no apparent steric inhibition to the presence of coproporphyrin III, with positive 
residues able to associate with ±COOH side-chain groups (B) Comparative locations for proposed 
catalytic residues between B. subtilis (red) and S. aureus (blue). Amino acid location numbers are 





3.2.2 ± Biochemical analysis of purified HemY 
3.2.2.1 ± SDS-PAGE analysis of S. aureus HemY 
S. aureus HemY was overexpressed in E. coli BL21 STAR cells and purified by 
affinity chromatography as described in Sections 2.3 and 2.4, with purity determined 
by SDS-PAGE as described in Section 2.5. Results from the resolved gels (example 
shown in Figure 3.7) show that a relatively pure protein that migrates at a rate 
corresponding to the predicted molecular mass of HemY (approximately 52 kDa) 
was present in the 15 mM imidazole wash or 300 mM imidazole elution fraction 
(sample analysed in Figure 3.7 only has protein in the 15 mM imidazole wash 
fraction). 
 
Figure 3.7 ± SDS-PAGE analysis of the purification of S. aureus HemY. 5 µL of marker (NEB 
Colour Protein Standard, Broad Range) and 10 µL of labelled samples were used for the first six 
lanes. The final four lanes contained protein after spin concentration of the 15mM imidazole sample, 
and was added (left to right) in volumes of 2.5, 5, 10 and 20 µL. 
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3.2.2.2 ± Spectroscopic analysis of purified HemY 
Analysis of the purified S. aureus HemY via UV/Vis spectroscopy shows that the 
protein has porphyrin bound, with a sharp peak at 400 nm and two smaller peaks at 
540 nm and 565 nm, typical of absorbance maxima for a porphyrin. There is also a 
broad absorbance feature from 450 nm ± 520 nm, typical of an oxidised FAD 
cofactor. FAD has two characteristic peaks, one being a sharp peak at 375 nm and 
the other a broad peak around 450 nm. It is likely that the 375 nm peak of FAD is 
masked by the large porphyrin peak as a slight shoulder can be seen at 375 nm. 
These data strongly suggest that there is FAD bound to the protein, albeit at a sub-




Figure 3.8 ± Absorption spectrum of purified S. aureus HemY in its storage buffer (50mM 
Tris/MOPS pH 8.0, 100mM KCl, 0.2% (v/v) Tween 20). The inset shows a magnified view of the 
spectrum from 450nm to 700nm. A porphyrin peak can be seen at 400nm, with a slight shoulder at 




3.2.3 ± Optimisation and analysis of HemY assays 
3.2.3.1 - Optimisation of the kinetic assay for protoporphyrinogen 
oxidase and coproporphyrinogen oxidase activities 
HemY enzymes from B. subtilis (a Firmicute), P. acnes, and M. tuberculosis (both 
Actinobacteria) have previously been shown to catalyse the oxidation of both 
protoporphyrinogen IX and coproporphyrinogen III (Hansson et al. 1997; Dailey et 
al. 2010), supporting the hypothesis that the classical haem pathway evolved from 
the coproporphyrin-dependent route. Hence, it was hypothesized that HemY from S. 
aureus (a Firmicute) could oxidise both protoporphyrinogen IX and 
coproporphyrinogen III. To test this hypothesis it was necessary to optimise a 
continuous fluorescence assay to detect the fluorescent products protoporphyrin IX 
and coproporphyrin III. Neither protoporphyrinogen IX nor coproporphyrinogen III 
absorb light in the visible spectrum and appear colourless in solution; however 
protoporphyrin IX and coproporphyrin III do absorb light in the visible spectrum and 
are also fluorescent. Protoporphyrin IX has an absorbance maximum at 408 nm 
(Soret peak) with minor peaks at 558 nm and 600 nm plus minor spectral features 
between 600 nm and 700 nm (Smith 1975). When excited, this molecule emits light 
at 635 nm, and this property has been used during development of a continuous 
fluorescence assay for protoporphyrinogen oxidases (Shepherd & Dailey 2005). 
 
Coproporphyrin III has a similar absorption spectrum to protoporphyrin IX (Figure 
3.9), with the three peaks being shifted 10nm towards the UV end of the spectrum. 
Coproporphyrin III has an absorbance maximum at 399.5nm (Soret peak) with two 
minor peaks at 548 nm and 590 nm. There are also some minor spectral features 
between 600 nm and 700 nm, as previously observed (Smith 1975). Like 
protoporphyrin IX, coproporphyrin III is a fluorescent molecule with an emission 
wavelength in the same range as protoporphyrin IX (~620-635nm). The excitation 
wavelength has previously been reported to have a dramatic effect upon the auto-
oxidation rate (Shepherd & Dailey 2005), presumably due to radical generation 
through photo-oxidation of porphyrin products. Hence it was necessary to optimise 





Figure 3.9 ± Absorption spectra of protoporphyrin IX (green) and coproporphyrin III (blue). Inset 
shows a magnified view of the spectrum between 500 nm and 700 nm where smaller absorption peaks 
are located.  
 
Optimisation of the HemY kinetic assay mainly involved minimising the rate of 
auto-oxidation. Of all of the excitation filters available in the plate reader used for 
the assays, only two were compatible with the absorption properties of 
protoporphyrin IX and coproporphyrin III: 400 nm and 520 nm band pass filters. 
Initial experiments were performed using protoporphyrinogen IX and the 400 nm 
filter, which produced variable levels of data quality, with a high and variable 
background oxidation rate detected. Trials testing the effect of using a 520 nm filter, 
as opposed to a 400 nm showed that the background oxidation rate was much lower 
with the 520 nm filter when comparable porphyrinogen concentrations were used 
(1.15µM and 1.5µM for the 400 and 520 nm filters respectively), as shown in Figure 
3.10. The amount of protoporphyrin IX that is produced per minute when the 520 nm 
filter is used is 80% less than the amount produced when the 400 nm filter was used 
(1.19 µmol/min produced compared with 5.75 µmol/min). The datasets obtained 
using the 520 nm filter were less scattered, showing that the substrate was less prone 




Figure 3.10 ± Comparison of auto-oxidation rates of protoporphyrinogen IX when excited using 
either a 400 nm or 520 nm wavelength (purple and green respectively). A 5-fold higher auto-oxidation 
rate can be observed when the 400 nm filter was used when compared with the 520 nm filter. 
Equations represent the parameters for the linear regression lines plotted. 
 
Based on the above comparison, the 520 nm filter was chosen to be used as the 
excitation filter used throughout the HemY activity assays as it would reduce the 
energy of the excitation light, and to diminish the amount of light absorbed by the 
photolabile porphyrins, therefore making the substrate more stable in the assays. 
This had the effect of not only slowing the auto-oxidation (compared to the 400 nm 
filter), but also diminishing the fluorescence signal. The lower signal was 
compensated for by adjusting the signal gain on the plate reader and was therefore 
determined to be an acceptable consequence of using the 520 nm filter. A 620 nm 
band pass filter was placed at the emission side for detection of fluorescence from 







3.2.3.2 Kinetic analysis of S. aureus HemY 
 
Purified recombinant HemY from S. aureus was assayed as described in Section 2.8 
for oxidase activity with protoporphyrinogen IX and coproporphyrinogen III as 
substrates. Figure 3.11 shows typical traces from these assays alongside their 
respective auto-oxidation controls and corrected data with a linear regression over 
the first 5 minutes of the reaction. This raw data shows that S. aureus HemY does 
oxidise both substrates, as the change in magnitude for the HemY reaction data (in 
red) is greater than that of the auto-oxidation reaction data (shown in grey). These 
results had three additional repeats done using the same stocks of protein and 
substrate and performed in the same 96-well plate, giving a total of four results for 
the same concentration of substrate.  
 
A total of seven different substrate concentrations were measured at the same time to 
provide data to determine Km and kcat values using the Michaelis-Menten equation. 
Coproporphyrinogen oxidase assays had better signal:noise compared with 
protoporphyrinogen oxidase assays, and the auto-oxidation levels were generally 








Figure 3.11 ± Oxidase activities of purified S. aureus HemY.  Assays using protoporphyrinogen IX 
(A) and coproporphyrinogen III (B) substrates are shown as raw unprocessed HemY data (red) with 
auto-oxidation controls (grey), and background subtracted data (corrected) with linear regressions of 





3.2.4 ± Kinetic analysis of S. aureus HemY 
3.2.4.1 ± S. aureus HemY exhibits similar maximal rates for the oxidation of 
protoporphyrinogen IX and coproporphyrinogen III  
Kinetic analyses revealed kcat values of 0.44 ± 0.03 and 0.46 ± 0.02 min-1 for 
protoporphyrinogen IX and coproporphyrinogen III, respectively (Figure 3.12). The 
Km for coproporphyrinogen III was determined to be 6.7 ± 0.8 µM, whereas the Km 
for protoporphyrinogen IX is likely to be lower than this, based on Lineweaver-
Burke plots (Figure 3.14), but could not be accurately determined due to detection 




Figure 3.12 - Kinetic analysis of the HemY protoporphyrinogen oxidase utilising protoporphyrinogen 
IX and coproporphyrinogen III substrates. Nonlinear regression analysis reveals kcat values of 0.44 ± 
0.03 and 0.46 ± 0.02 min-1 for protoporphyrinogen IX and coproporphyrinogen III, respectively. The 




3.2.4.2 - Haem-bound HemQ stimulates HemY-mediated oxidation of 
protoporphyrinogen but not coproporphyrinogen III 
A major focus of this study was to investigate why the classical pathway and 
coproprophyrin-dependent pathways have not yet been shown to co-exist. One 
hypothesis was that haem-bound HemQ produces toxic free radicals in the presence 
of protoporphyrin IX and peroxide, whereas the less reactive coproporphyrin III 
product will not support this radical generation. There has been a precedent for this, 
as the generation of superoxide by cytochrome c has previously been shown to 
stimulate the oxidation of protoporphyrinogen IX by an eukaryotic HemY enzyme 
(Shepherd & Dailey 2009). We therefore aimed to test the hypothesis that any 
stimulation of HemY-catalysed protoporphyrinogen oxidation by haem-loaded 
HemQ, as observed previously for P. acnes HemY/HemQ (Dailey et al. 2010), could 
only be observed when protoporphyrin IX is a reaction product (and not 
coproporphyrin III) and HemQ is specifically binding its haem product. This data 
has demonstrated that the presence of haem-loaded HemQ increased the kcat for 
protoporphyrinogen oxidation by 2.6-fold (Figures 3.13/3.14), whereas the same 
experiment when coproporphyrinogen III was used as a substrate yielded no 
significant increase in activity in the presence of HemQ. To support the hypothesis 
that peroxidase type chemistry of HemQ was contributing to this rate stimulation, 
HemY was assayed in the presence of HemQ that was loaded with bound haem, 
protoporphyrin IX, and coproporphyrin III (Figure 3.15). These data demonstrate 
that only haem-bound HemQ stimulates the HemY reaction, suggesting the 



















Figure 3.13 ± Haem-loaded HemQ stimulates HemY-mediated oxidation of protoporphyrinogen but 
not coproporphyrinogen III. Steady state kinetics showing the effect of 1µM haem-loaded HemQ 
(white) on the activity of HemY using protoporphyrinogen IX and coproporphyrinogen III substrates 
compared to HemY only controls (black). Nonlinear regression analysis reveals HemQ-mediated 2.6-
fold increase in kcat when protoporphyrinogen IX is used as a substrate, and a HemQ-mediated 1.1-






Figure 3.14 ± Lineweaver-Burke plots of HemY activity data. Top plot shows data for 
protoporphyrinogen IX assays, with the bottom plot showing data for coproporphyrinogen III assays 
coproporphyrinogen III both in the presence (white) or absence (black) of haem-loaded HemQ. Plots 
show a big difference in kinetic parameters for protoporphyrinogen IX oxidation in the presence of 












Figure 3.15 ± HemQ must bind haem for stimulation of protoporphyrinogen oxidase activity. 
Protoporphyrinogen oxidase activity of HemY was assayed in the presence of HemQ (1 µM) and 
protoporphyrinogen IX (10 µM) with different tetrapyrroles bound. Error bars represent SD values 















3.2.4.3 ± Hydrogen peroxide participates in the HemQ-mediated stimulation of 
protoporphyrinogen IX oxidation via the generation of superoxide 
It was hypothesised that hydrogen peroxide produced during HemY catalysis was 
participating in the HemQ-mediated rate stimulation. To confirm the involvement of 
hydrogen peroxide, HemY-catalysed protoporphyrinogen IX oxidation was assayed 
in the presence and absence of haem-loaded HemQ at various concentrations of 
peroxide (Fig. 3.16). In the absence of HemQ, peroxide elicited a gradual decrease in 
activity, whereas in the presence of HemQ the peroxide caused a significant 
stimulation of protoporphyrinogen IX oxidation. The same experiment was 
performed with coproporphyrinogen III as a substrate, and peroxide did not elicit any 
changes in HemY catalysis in the presence or absence of HemQ (Figure 3.16). 
Background rates for these reactions (Figure 3.17) were also measured to assess the 
effect of extra H2O2 on the substrates. These show an increased level of auto-
oxidation of for protoporphyrinogen IX compared with coproporphyrinogen III, but 
also showed that extra H2O2 increased the amount of non-enzymatic 
protoporphyrinogen IX oxidation but not coproporphyrinogen. Background rates 
measured with HemQ present displayed an increase in the amount of porphyrin 
formed for both substrates, compared to rates without HemQ present, with a larger 
increase consistently seen for protoporphyrinogen IX. 
To test the hypothesis that peroxidase chemistry was involved in the HemQ-
mediated stimulation of HemY, protoporphyrinogen IX oxidation was measured in 
the presence of horseradish peroxidase (HRP, Figure 3.18), which demonstrated the 
same pattern of rate stimulation as haem-loaded HemQ (i.e. only when 
protoporphyrinogen IX was used as a substrate). To confirm that superoxide 
generation was involved in the HemQ-mediated stimulation of HemY, 
protoporphyrinogen IX oxidation was measured in the presence of superoxide 
dismutase (SOD) (Figure 3.18), which completely abrogated the stimulatory effect of 
HRP. Since exogenous peroxide caused some inhibition of HemY in the absence of 
HemQ (Figure 3.16), it was necessary to verify that the HRP stimulatory affect was 
not due to removal of peroxide. The presence of catalase in HemY assays did not 
elicit a stimulatory effect (Figure 3.18), confirming that peroxide removal was not 






Figure 3.16 ± Hydrogen peroxide stimulates protoporphyrinogen oxidase activity in the presence of 
HemQ. Protoporphyrinogen oxidase activity of HemY was assayed in the presence (1 µM) and 
absence of HemQ at various [hydrogen peroxide] using (A) 9.5 µM protoporphyrinogen IX and (B) 
5.8 µM coproporphyrinogen III as substrates. Error bars represent SD values based on four repeats. 
Data has been normalised to the activities of HemY (either with or without HemQ) without hydrogen 













Figure 3.17 ± Auto-oxidation rates of protoporphyrinogen IX (9.48 µM - green) and 
coproporphyrinogen III (5.78 µM - blue). Assays performed with various [hydrogen peroxide] and in 
the presence (light colours) and absense (dark colours) of haem-loaded HemQ. Overall porphyrinogen 
oxidation increases with addition of haem-ORDGHG+HP4ZKLOVWEDFNJURXQG3¶JHQIX oxidation also 














Figure 3.18 ± Peroxidase-derived superoxide stimulates HemY-mediated oxidation of 
protoporphyrinogen IX. Kinetic assays showing the effect of HRP (1 µM), superoxide dismutase (1 
µM) and catalase (1 µM) upon the activity of HemY (0.5 µM) using protoporphyrinogen IX (8.6 µM) 
and coproporphyrinogen III (8.2 µM) substrates. Data has been normalised to HemY only controls to 











3.3 ± Discussion 
This work examines the hypotheses that S. aureus HemY can participate in both the 
coproporphyrin-dependent and classical pathways and that the generation of ROS by 
the HemQ enzyme has a more profound effect upon macrocycle oxidation in the 
classical pathway compared to the coproporphyrin-dependent pathway. These 
investigations will aid our understanding of how the classical pathway evolved from 
the more ancient coproporphyrin-dependent pathway (Dailey et al. 2015).  
 
Kinetic analysis of S. aureus HemY (Figure 3.12) revealed kcat and Km values of 0.46 
± 0.02 min-1 and 6.7 ± 0.8 µM for coproporphyrinogen III oxidation compared to 
previous measurements of 1.33 ± 0.04 min-1 and 0.31 ± 0.01 µM (Lobo et al. 2015), 
respectively. Previously, the oxidation of protoporphyrinogen IX for S. aureus 
HemY could not be detected (Lobo et al. 2015), so this reaction was re-examined. 
Structural modeling supports the hypothesis that S. aureus HemY can accommodate 
coproporphyrinogen (Figure 3.6), and the kinetic data described herein clearly show 
activity for the protoporphyrinogen IX substrate (kcat = 0.44 ± 0.03 min-1). However, 
the background rate and signal:noise was significantly higher for the 
protoporphyrinogen IX reaction (Figure 3.10), which initially led to optimizing the 
assay to use an excitation wavelength of 520 nm as opposed to 400 nm. This use of 
the 520 nm excitation filter dropped the levels of auto-oxidation to 20% of the level 
observed when the 400 nm filter was used (Figure 3.10). This difference in the assay 
procedure may provide some insight into why enzymatic activity could not be 
detected in previous studies (Lobo et al. 2015).  
 
The pattern of substrate specificity is consistent with previous observations for 
HemY enzymes from numerous Actinobacteria/Firmicutes (Dailey et al. 2015; 
Hansson & Hederstedt 1994; Dailey et al. 2010), and supports the hypothesis that 
evolutionary precursors to these HemY enzymes may once have also oxidized 
protoporphyrinogen IX in vivo in ancestral organisms. This is also supported by 
previous observations that the HemH ferrochelatases from Gram-positives can insert 




If we accept the compelling evidence that the classical pathway evolved from the 
coproporphyrin-dependent pathway, an important question presents itself: why do 
the majority of Actinobacteria/Firmicutes now lack a functional coproporphyrinogen 
oxidase that prevents the formation of protoporphyrinogen IX and protoporphyrin 
IX? One potential explanation would be that the peroxide-dependent mechanism of 
HemQ can generate free radicals, which will have a greater cytotoxic effect in 
combination with protoporphyrin IX compared to the less reactive coproporphyrin 
III. This is consistent with a previous report that the more reactive protoporphyrin IX 
causes greater cellular damage (Aravind Menon et al. 1989). Hence, it was 
hypothesised  that stimulation of HemY-mediated protoporphyrinogen IX oxidation 
by HemQ (Dailey et al. 2010) was due to the evolution of ROS, as previously 
reported for cytochrome c and eukaryotic HemY (Shepherd & Dailey 2009), and that 
this stimulation would be exacerbated when protoporphyrin IX is a reaction product 
(compared to the less reactive coproporphyrin III). HemY assays with both 
substrates in the presence and absence of HemQ were consistent with this hypothesis 
(Figure 3.13), and yielded the surprising observation that HemQ did not stimulate 
the oxidation of coproporphyrin III at all. Further kinetic analysis with 
haem/porphyrin loaded ligands confirm that haem, the product of the HemQ 
reaction, must be present for the stimulation of HemY activity (Figure 3.15). Further 
assays with varying hydrogen peroxide demonstrate that this ROS-generator 
stimulates the HemY reaction only when HemQ is present, but causes inhibition in 
the absence of HemQ (Figure 3.16, top). The most simple explanation for the 
inhibition of HemY by peroxide in the absence of HemQ is due to classical product 
inhibition. However, it is not clear why this does not take place when 
coproporphyrinogen III is used as a substrate (Figure 3.16, bottom), although 
conformational differences in active site structure are likely to exist when additional 
propionates are present on the porphyrinogen substrate.  
 
The stimulation of HemY activity by peroxide and HRP combined with the 
abrogation of this rate enhancement by SOD (Figure 3.18) provide clear 
confirmation that it is the peroxidase activity of HemQ that enhances HemY-
mediated protoporphyrinogen IX oxidation. If we return to the model in Figure 3.1, 
the current data are consistent with ROS generation by HemQ stimulating the 
HemY-catalysed oxidation of protoporphyrinogen IX only (and not the HemY-
 85 
 
mediated stimulation of coproporphyrinogen III oxidation). However, one should not 
overlook the profound effect that HemQ has on the nonenzymatic oxidation of 
protoporphyrinogen IX (Figure 3.17). While HemQ does appear to also elevate the 
nonenzymatic oxidation of coproporphyrinogen III, the overall rates are an order of 
magnitude lower than those for protoporphyrinogen IX that are comparable to the 
HemY-catalyzed turnover rates in Figure 3.12. This additional nonenzymatic rate 
enhancement is very likely to involve superoxide (from HemQ and possibly 
porphyrin-derived), adding weight to the hypothesis that peroxidase activity by 
HemQ will enhance the production of ROS in combination with tetrapyrrole 
intermediates of the classical pathway. From an evolutionary perspective, this 
generation of toxic ROS would provide a selection pressure to retain either the 
coproporphyrin-dependent pathway or the classical pathway, but not both. This 
model is also consistent with observations that HemQ enzymes may utilise 
alternative electron acceptors such as FMN, negating the requirement for HemY-
derived peroxide in the coproporphyrin-dependent pathway. This may also explain 
why in proteobacteria that commonly utilise the classical pathway, HemJ or HemG 
enzymes that do not require oxygen nor produce hydrogen peroxide are the most 















Chapter IV: Characterisation of HemH as a 







































HemH enzymes are known to catalyse the final step of classical haem synthesis, 
inserting ferrous iron into a protoporphyrin IX. However, for the recently discovered 
coproporphyrin-dependent pathway, HemH catalyses the penultimate reaction and 
inserts ferrous iron into coproporphyrin III instead of protoporphyrin IX. While 
many organisms have been tested in the past using classical pathway substrates or 
analogues (protoporphyrin based), only M. tuberculosis, B. subtilis and S. aureus 
have currently been tested for insertion of a divalent metal into coproporphyrin 
(Dailey et al. 2015; Lobo et al. 2015). This reaction has also been shown, in B. 
subtilis and S. aureus, to be partially inhibited by its own iron substrate.  
The worked described herein provides a more detailed kinetic characterisation of S. 
aureus HemH. It has previously been reported that the HemH enzyme of S. aureus 
can utilise several divalent metals (Fe2+, Zn2+, Co2+, Cu2+ and Ni2+) and the current 
work confirms that metal insertion occurs only with coproporphyrin III, not 
protoporphyrin IX. This enzyme works at a similar rate to other ferrochelatases when 
assayed with an iron concentration below 0.8 µM, above which substrate inhibition 
occurs. A more detailed look at the kinetics of the reaction revealed that while 
HemH catalysis occurs irrespective of which substrate binds first, the Km for iron is 
lower when the porphyrin binds first. Structural modelling of S. aureus HemH 
suggests the existence of multiple binding sites for metals around the active site, 
based on comparisons with the close structural homologue from B. subtilis (Lecerof 
et al. 2000; Lecerof et al. 2003). These data are consistent with a model whereby 
inhibition by iron is due to the occupation of multiple metals sites resulting in a 








4.1 ± Introduction 
The HemH enzyme, or ferrochelatase as it is commonly known, is responsible for 
the insertion of a ferrous iron ion (Fe2+) into the centre of porphyrin rings. It has 
always been thought that this protein was the final step in the classical haem 
synthesis pathway, where the Fe2+ was inserted into a protoporphyrin IX molecule 
(Figure 4.1). While this is the case for the majority of organisms that express this 
enzyme, some organisms which utilise the coproporphyrin-dependent pathway have 
been shown to insert Fe2+ into coproporphyrin III instead, making metal insertion the 
penultimate reaction in the pathway (Dailey et al. 2015). This class of HemH 
enzyme has been reported to exhibit broad substrate specificity, leading to a range of 
different combinations of substrates being used to study this protein, with the most 
common in vitro assays utilising zinc and deuteroporphyrin IX, both of which are 
not native substrates in vivo (Dailey et al. 2000): zinc is used as this enables the use 





Figure 4.1 ± Overview of the classical ferrochelatase reaction where Fe2+ is inserted into the centre of 





4.1.1 ± Kinetic parameters for HemH enzymes 
As is the case with HemY, HemH is a membrane-bound protein in eukaryotes and 
many prokaryotes, but Gram-positive bacteria have been shown to encode a soluble 
form of the protein (Hansson & Hederstedt 1992; Dailey & Dailey 2002; Dailey et 
al. 1983; Wu et al. 2001). All of these forms of HemH have been shown to insert a 
variety of divalent metals into the centre of porphyrin molecules, with zinc being the 
most common metal used in in vitro assays due to being more stable in an aerobic 
environment than the natural Fe2+ substrate (Camadro et al. 1984) and allows for 
fluorescence-based assays to be utilised. Other metals that have been shown to be 
inserted by HemH enzymes are cobalt, copper and nickel (Dailey et al. 2000; Dailey 
et al. 2015; Hansson et al. 2011; Dailey & Dailey 2002), although not all 
ferrochelatases can insert these ions. It has been reported that the soluble and 
membrane-associated forms of HemH can utilise different metals for insertion, with 
the B. subtilis protein being able to insert Cu2+, but not Co2+, which can be utilised 
by the majority of membrane associated ferrochelatases (Hansson et al. 2011). This 
is not always the case however, as it has been shown that the membrane-associated 
HemH from Caulobacter crescentus cannot utilise Co2+, but instead uses Ni2+ 
(Dailey & Dailey 2002). In addition, the soluble HemH from M. tuberculosis has the 
ability to insert Cu2+, Co2+ and Ni2+ into its natural porphyrin substrate, 
coproporphyrin III (Dailey et al. 2015). Kinetic data available for ferrochelatases, 
summarised in Table 4.1, varies greatly due to the variety of substrates that have 
been used. This can make direct comparisons between organisms difficult as the 
enzymes may behave differently with different substrates. Maximal rates for 
ferrochelatases also appear to vary, with kcat values typically ranging from 0.11 min-1 
to 15.3 min-1, with a surprisingly high rate recently reported for S. aureus HemH 
utilising coproporphyrin III and Fe2+ which is reported to be 165 min-1 (Lobo et al. 
2015). This rate was not experimentally observed, but obtained after the data was 
fitted to a substrate inhibition curve, which also identified 0.8µM as the 
concentration where Fe2+ inhibition occurs (Lobo et al. 2015). The fastest rate 
measured in this study was roughly 28 min-1, which is one sixth of the value of the 
fitted kcat. Parallel experiments performed for the B. subtilis HemH gave another high 
kcat value, 78 min-1 (Lobo et al. 2015) compared with 0.11 min-1 (Dailey et al. 2015) 





Table 4.1 ± Summary of available kinetic data for ferrochelatases from various organisms, including substrates used and other metal substrates that can be utilised. MIX 
represents Mesoporphyrin IX where it has been used as a porphyrin substrate 
Reference 
(Wu et al. 2001) 
(Dailey et al. 2015) 
(Dailey et al. 2015) 
(Lobo et al. 2015) 
(Dailey & Dailey 2002; 
Shepherd et al. 2006) 
(Shepherd et al. 2006) 
(Shepherd et al. 2006) 
(Shepherd et al. 2006) 
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4.1.2 ± Structural analysis of HemH crystal structures 
While it appears that HemH proteins exhibit poor amino acid sequence identity (e.g. 
<10% between Human and B. subtilis ferrochelatases), the secondary and tertiary 
structures of these enzymes are quite similar in the core region (Wu et al. 2001). 
Comparisons between the three available ferrochelatases structures, B. subtilis 
(Lecerof et al. 2000), Human (Wu et al. 2001) and S. cerevisiae (Karlberg et al. 
2002), suggest that the overall structures for all three ferrochelatases are very similar, 
with some small differences between them.  
Structural differences between these proteins appear to be located towards the N- and 
C-termini, with Human and S. cerevisiae HemH having a helical region located close 
to the exterior of the active site which appears to be hydrophobic in nature and may 
be involved in association with the mitochondrial membrane, which points the active 
site towards the membrane (Karlberg et al. 2002; Wu et al. 2001). In comparison, B. 
subtilis HemH does not have this helix, giving it a more open active site. The lack of 
this membrane-associated helix could explain why this form of the protein is soluble 
rather than associated with a membrane (Lecerof et al. 2000).  
Human and yeast ferrochelatases also have an extended C-terminal region when 
compared with the B. subtilis protein. The Human enzyme contains a [2Fe-2S] iron-
sulphur cluster in this region, which is not present in the S. cerevisiae enzyme. This 
cluster is maintained by one residue in the core of the protein (Cys 196) and three in 
the extended C-terminal region (Cys 403, 406, 411), and at the time was thought to 
be responsible for anchoring the extended C-terminal to the rest of the monomer, and 
was also suggested to be indirectly involved in stabilising the dimer form of the 
protein (Wu et al. 2001). S. cerevisiae does not contain the necessary residues in the 
same location to form a cluster and the dimer stability is reportedly not affected 
(Karlberg et al. 2002). Other bacterial ferrochelatases have been found to ligate [2Fe-
2S] clusters via an extra insertion, and are suggested to enhance Fe2+ binding at low 
Fe2+ concentrations (Shepherd et al. 2006). However, removal of these clusters does 
not result in a loss of activity, as has been seen with eukaryotic forms (Shepherd et 




There are also differences in the structure of the C-terminal region between the 
human and yeast ferrochelatases, with a coil and helix loop structure seemingly 
being reversed between the two proteins, which are in the area of the [2Fe-2S] 
cluster in the Human protein. It is proposed for both enzymes that the helix in this 
region is one of the secondary structures that forms the hydrogen bonds required for 
dimerisation to occur, which means that the [2Fe-2S] cluster would have another role 
in the protein (Karlberg et al. 2002; Wu et al. 2001). While the B. subtilis HemH 
does not possess this region on the C-terminus and is a monomeric protein, it is 
likely that this region is the main factor involved in dimerisation of the protein. The 
core structure, which appears to be structurally conserved, consists of two similar 
shaped domains each folded into a Rossmann-W\SHIROG IRXUSDUDOOHOȕ-sheets with 
Į-helices of each side, between which the porphyrin-binding cleft resides.  
Many of the residues that are involved in the binding of the porphyrin substrate 
appear to be rather well conserved in their location and function (Medlock et al. 
2008; Lecerof et al. 2000; Karlberg et al. 2002). One of the major conserved amino 
acid locations appears to be an invariant histidine residue that forms a hydrogen 
bond with a conserved glutamic acid residue, with this bond being broken upon 
porphyrin binding and the histidine forming an interaction with a protonated part of 
the pyrrole ring, supposedly ring B (Medlock et al. 2008). This histidine is also 
thought to be important for initiating secondary structure conformation change that 
initiates the distortion of the porphyrin ring (Medlock et al. 2008), although these 
residues are also reported to be involved in the binding of the metal substrate 
(Lecerof et al. 2003), with the mechanisms for how these residues are involved still 
to be completely determined. An invariant tryptophan residue is also present in all 
known ferrochelatases and has been suggested to be involved in stabilising the C 
ring of the porphyrin in the B. subtilis enzyme (Lecerof et al. 2000), although it is 
suggested that in the human enzyme that this tryptophan (along with L92, L98 and 
V305) is involved in the closing of the active site mouth via hydrophobic 
interactions (Medlock et al. 2008). These residues, also appear to be present in the S. 
cerevisiae protein, suggesting that the membrane-associated ferrochelatases act in a 




HemH structures exhibit a degree of variability with respect to the residues present 
on the opposite side of the porphyrin binding cleft to the metal binding sites. In the 
B. subtilis protein a series of residues reported to be involved in porphyrin binding 
are different when compared to the same locations in the human or S. cerevisiae 
structures. The leucine residues in the membrane-bound structures are not present in 
the B. subtilis protein as these appear to form part of the hydrophobic lip that covers 
the active site pocket. However, R30 and R31 (B. subtilis) appear to occupy a similar 
spatial location to the human L96 and L98, and both residues interact with the 
porphyrin substrate, with R30 interacting with the propionate group on ring D via a 
water molecule and R31 interacting with the propionate group on ring C along with 
K188. These residues also form a small enclosure over the porphyrin binding cleft, 
along with R33 and K188, although this not as large as the lid that covers the active 
site in the membrane-associated form (Lecerof et al. 2000; Wu et al. 2001). 
The Y13 residue in B. subtilis HemH, which has been determined to aid the 
conserved histidine residue in stabilisation of the B ring of the porphyrin 
macrocycle, is not present in the membrane-associated ferrochelatases (Lecerof et al. 
2000). The residue in this position in the other enzymes is a methionine whose role 
is not entirely understood (Wu et al. 2001; Karlberg et al. 2002). The presence of this 
methionine is further puzzling when it is considered that it and the histidine residue, 
on the opposite side of the porphyrin ring, are both ligands that can bind the haem 
iron and could therefore make product release difficult (Medlock et al. 2008). The 
tyrosine residue in B. subtilis has been implicated in a metal-binding function in the 
catalytic metal binding site along with the conserved histidine and glutamic acid 
residues (Lecerof et al. 2000; Lecerof et al. 2003) and it is possible that the 
methionine residue in this position aids in the insertion of metals into the porphyrin 
ring in a similar manner to the tyrosine residue found in the soluble form of 
ferrochelatase. The amino acid in this position has also been linked to the type of 
metal that can be inserted into the ring, with a Y13M mutation of the B. subtilis 
enzyme being able to insert Co2+ at a much higher rate than the wild type but the 
ability to insert Cu2+ drops to below detectable levels (Hansson et al. 2011). This 
would seem to suggest that the amino acid at this position is important for 
interactions with different metals, with a tyrosine residue seemingly important for 
Cu2+ insertions and a methionine favouring Co2+ insertion. 
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Soluble ferrochelatases have been crystalized with a variety of metals present in the 
metal binding cleft, and have been shown to have two separate sites in the same 
region where metals can bind; one close to the porphyrin binding site, held by the 
conserved histidine and glutamic acid residues and one closer to the surface of the 
protein, roughly 7Å from the H183 residue (Lecerof et al. 2003). This outer site has 
been shown to bind magnesium ions (Mg2+), which are co-ordinated by the residues 
R46, D268 and E272. These residues are poorly conserved, although the human 
enzyme does contain residues that occupy the same space as those in B. subtilis 
ferrochelatase (Q122, E347 and E351) with the S. cerevisiae enzyme lacking an 
acidic sidechain (G322 instead of E272 and E351 in B. subtilis and human, 
respectively), but otherwise having the same overall structure as the human enzyme. 
This metal site has only been observed with a magnesium ion occupying it in B. 
subtilis and it has been reported that the presence of magnesium stimulates zinc 
insertion into deuteroporphyrin IX, with a mutation removing the ability to bind 
magnesium (E272S) showing no stimulation (Lecerof et al. 2003). The mechanism 
for this stimulation is not entirely understood, but it is proposed to be due to 
repulsion between metal ions present at both sites pushing the catalytic metal closer 
to the porphyrin ring (Lecerof et al. 2003). Studies on the human protein have not 
focussed on this potential metal site, and the S. cerevisiae enzyme does not seem 
able to bind metals in this site due to the glycine residue instead of a glutamate 
residue at position 322. It has been suggested that the S. cerevisiae ferrochelatase can 
bind the inhibitor Cd2+ at two sites, with one site slightly further away from the 
active site than the proposed outer metal binding site, and is proposed to have a 
lesser effect on activity compared to the Mg2+ binding site in B. subtilis (Karlberg et 
al. 2002). The inner binding site is suggested to bind and utilise several different 
divalent metals (see section 4.1.1), as well as metals such as Cd2+ and Pb2+ that have 
been shown to be inhibitors of ferrochelatases (Lecerof et al. 2003; Medlock et al. 
2008). Residues that are predicted to be predominantly involved in metal binding in 
B. subtilis, where Zn2+ and Cd2+ have been observed, are the conserved residues 
H183 and E264 and the unique Y13 residue that resides on the other side of the 
porphyrin binding site (Lecerof et al. 2003). Cd2+ has been shown to also bind to the 
nearby H262, which is located underneath the porphyrin substrate and is proposed to 




4.1.3 ± Aims of this chapter 
The aims of this chapter were to address the following hypotheses: 
 
x The HemH enzyme from S. aureus will insert Fe2+ into both protoporphyrin 
IX and coproporphyrin III. 
o Determine kinetic parameters for these reactions. 
 
 
x HemH will be able to insert zinc, cobalt, copper and nickel into the porphyrin 
ring. 
 
Following the realisation that the insertion of iron into coproporphyrin can be 
inhibited at higher iron concentrations, research focus turned to determining the 
mechanism behind this inhibition using kinetic parameters from the following 
reaction conditions: 
 
x Varying iron concentration at set coproporphyrin III concentrations. 
 
x Varying coproporphyrin III concentration at set iron concentrations. 
 
x Assaying in the presence of magnesium to simulate occupation of a metal 






4.2 ± Results 
4.2.1 ± Sequence analysis and structure prediction for S. 
aureus HemH  
4.2.1.1 ± Multiple sequence alignment of HemH enzymes 
As with the HemY protein, HemH from S. aureus displays high amino acid sequence 
identity with other members of the Staphylococcus genus when analysed in a NCBI 
BLASTP search, with identities typically >80%. Outside of this genus, the search 
gives a variety of ferrochelatases from a wide range of organisms with the top hits 
being between 60% and 70% identity, including M. caseolyticus (70%) and B. 
subtilis (63%), which is a higher degree of similarity than was seen for the HemY 
enzymes (Section 3.2.1.1). As with HemY, comparisons with P. acnes and M. 
tuberculosis yielded very poor sequence identities, with 27% identity for both P. 
acnes and M. tuberculosis.  
A multiple sequence alignment of the protein sequences from S. aureus, S. 
epidermidis, B. subtilis, P. acnes and M. tuberculosis can be seen in Figure 4.2, 
















Figure 4.2 ± Multiple sequence alignment of HemH proteins from S. aureus, S. epidermidis, B. 
subtilis, P. acnes and M. tuberculosis. Background colours represent fully conserved residues (black) 







4.2.1.2 ± Structural modelling of S. aureus HemH 
A predicted structure for the S. aureus HemH protein was obtained using the 
RaptorX program (Peng & Xu 2011) using the existing B. subtilis ferrochelatase 
crystal structure (PDBid = 1DOZ, (Lecerof et al. 2000)) as a template. The resultant 
structural model was analysed using the CCP4 molecular graphics program 
(McNicholas et al. 2011) and was compared to the closest template, B. subtilis 
ferrochelatase (Lecerof et al. 2000).  The solved structures for the B. subtilis enzyme 
include a variety of substrates including protoporphyrin IX, N-methylmesoporphyrin 
IX, and various metals. The presence of these ligands facilitated the modelling of 
coproporphyrin III, the natural substrate, into both the existing B. subtilis structure 
and the predicted S. aureus structure.  
Preliminary analysis of the two structures (Figure 4.3 A) shows that the overall 
structure of the S. aureus ferrochelatase model is similar to the B. subtilis enzyme, 
ZLWKDYHU\JRRGRYHUOD\RI&ĮUHVLGXHV(RMS = 0.43/304) and no major differences 
in the size or number of secondary structural features between the two enzymes. 
Closer inspection of the binding sites for the two substrates (Figure 4.3 B) reveals 
that the amino acid residues that have been implicated in porphyrin binding in the B. 
subtilis structure (Lecerof et al. 2000) are largely conserved in both tertiary 
structures. Two of the residues that are involved in binding the porphyrin ring in B. 
subtilis, R31 and K188, are different in the S. aureus sequence: R31 in B. subtilis 
aligns to H30 in the S. aureus enzyme, whilst a glutamic acid residue just before 
K188 of B. subtilis (K185 in S. aureus HemH) that is absent in the S. aureus enzyme 
shifts these lysine residues to slightly different locations, with the sidechain of the S. 
aureus model predicted to be in a different orientation compared to the B. subtilis 
structure, as shown in Figure 4.3 B. These two residues are proposed to be involved 
in stabilising ring C of the porphyrin macrocycle by interacting with the propionic 
acid chain on the ring (Lecerof et al. 2000) and structural changes in this region are 





Figure 4.3 ± Analysis of a structural model for S. aureus ferrochelatase. (A) Comparison of the 
structures of the HemH from B. subtilis (red) and S. aureus (blue) with coproporphyrin III (purple) 
and Mg2+ (grey) modelled into their binding sites. (B) View of the binding sites, rotated 90° and 
magnified, with residues indicated to be involved in binding of substrates in B. subtilis (red, (Lecerof 
et al. 2000)) with the corresponding residues and  from S. aureus (blue) for comparison.  
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Analysis of surface electrostatics for S. aureus HemH model, superimposed with the 
zinc and magnesium ions from the B. subtilis structure and a model of 
coproporphyrin III, shows that the binding sites for both the porphyrin and metal 
display significant negative charge, shown as red surface areas in Figure 4.4 A. The 
metal-binding sites were also compared between the B. subtilis and S. aureus 
organisms due to the difference in residues observed in various crystalized 
ferrochelatases, with the different residues present being linked to the substrate 
specificity, as shown in Section 4.1.2. There is also the observation in B. subtilis that 
presence of Mg2+ ion in the outer metal binding site is required for crystals to form 
and is also able to increase the catalytic activity of the enzyme (Lecerof et al. 2003).  
These metal binding sites, shown in Figure 4.4 A, are part of a large open cleft with 
the magnesium ion (black) located in the outer metal binding site, and the inner site 
occupied by a zinc ion (yellow) that is located much closer to the porphyrin ring 
(Lecerof et al. 2003). Given the high level of sequence identity with the B. subtilis 
HemH active site cleft, it is predicted that the H181 and E263 of the S. aureus HemH 
model will be involved in metal binding at the inner site with Y12 also being 
predicted to interact with the metal with the enzyme being likely to utilise the same 
metal substrates for insertion as B. subtilis. The magnesium ion in the outer site is 
held in place by residues R46, D268 and E272 in B. subtilis HemH, and it is 
therefore also likely that the corresponding residues in S. aureus (R45, D267 and 










Figure 4.4 ± (A) View of the electrostatic surface of the predicted S. aureus HemH model with Mg2+ 
(black), Zn2+ (yellow) and coproporphyrin III (purple) modelled into their binding sites based on the 
B. subtilis model. (B) Close up of the metal binding sites with the relevant residues for binding from 
both B. subtilis (red) and S. aureus (blue) with the same ligands as described for panel A. 
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4.2.2 ± Engineering an expression plasmid for S. aureus 
HemH 
The pTrcHis vector was used for hemH cloning as other recombinant HemH 
enzymes have successfully been overexpressed using this vector (Dailey et al. 2010). 
The S. aureus hemH gene was amplified from S. aureus USA300 genomic DNA via 
PCR as described in Section 2.10.1. A pTrcHis plasmid containing the M. 
tuberculosis hemQ gene, approximately 620 bp, was cut with NheI and HindIII and 
the hemH gene (950 bp) was ligated into NheI/HindIII-cut pTrcHis (Section 2.10.3) 
and transformed into chemically competent E. coli TOP10 cells (as described in 
Section 2.11). 
As mentioned in Sections 2.10.2 and 2.10.3, the ligation step included the original 
hemQ gene fragment which could compete with the gene of interest and result in 
false positive colonies; therefore ampicillin-resistant colonies were screened via 
colony PCR using primers that anneal 200bp either side of the insertion site. 
Potential results from the colony PCR would include a 1000bp band for the presence 
of the original hemQ fragment, with the desired hemH fragment giving a band at 
1300bp.  
A PCR product at the expected size for a hemH-containing plasmid was found 
(highlighted in red in Figure 4.5), and this plasmid was extracted using a Qiagen spin 
miniprep kit and digested with NheI and HindIII to confirm the presence of a 900 bp 
hemH gene insert (Figure 4.6). The plasmid was confirmed to contain the correct 





Figure 4.5 ± Colony PCR of cells that have taken up a pTrcHis plasmid and were resistant to 
ampicillin. Highlighted lane shows a positive hit for a hemH gene fragment (1300bp). Other lanes 
contain either M. tuberculosis hemQ (band at roughly 950bp) or a lack of an insert (bands at roughly 
400bp). All bands include plasmid DNA that has been amplified either side of the NheI and HindIII 
restriction sites (roughly 200bp each side). 
 
         
Figure 4.6 ± (Left) Agarose gel showing the result of a restriction digest of miniprepped pTrcHis-
hemH plasmid DNA. The desired fragment size of  924bp in the double digest lane confirms that the 
hemH gene is present. (Right) Plasmid map of the pTrcHis-hemH constructed plasmid showing 
restriction sites and important features of the plasmid 
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4.2.3 ± Biochemical/spectroscopic analysis of purified 
HemH 
E. coli JM109 cells containing the pTrcHis-hemH plasmid were harvested and the 
protein was purified via affinity chromatography as described in section 2.4. The 
purified protein was assessed for purity using SDS-PAGE and UV-Vis spectroscopy 
was used a preliminary assessment of porphyrin/haem binding. SDS-PAGE analysis 
(Figure 4.7) shows that a protein with a size of approximately 35kDa has been 
expressed and purified, which corresponds to the size of His-tagged S. aureus HemH 
protein (predicted size of 35.05 kDa). The purified HemH is very pure, with only 
very minor contamination in the concentrated elution samples. The HemH that was 
eluted with the 10 mM imidazole wash buffer exhibited the greatest purity, and was 
the protein fraction used in subsequent spectroscopic and kinetic studies. 
The absorption spectra of the concentrated protein (Figure 4.8) does not appear to 
show any major spectral features other than the usual protein peak at 280nm. The 
lack of any significant spectral features other than this peak suggests that this protein 
is purified without bound tetrapyrroles or cofactors such as iron-sulphur clusters.  
 
Figure 4.7 ± SDS-PAGE of purified recombinant S. aureus HemH. Lanes marked with (C) are 
concentrated samples. 5 µl of un-concentrated samples and 10 µl of concentrated samples were 
loaded. A protein of roughly 35 kDa can be seen in both the Wash and Elution fractions, 










Figure 4.8 ± UV/Vis absorption spectra of purified recombinant S. aureus HemH in its storage buffer 
(50 mM Tris/MOPS pH 8.0, 100 mM KCl, 0.1% sodium cholate). Inset shows a magnified view of 









4.2.4 ± Substrate Specificity of S. aureus HemH 
4.2.4.1 ± Porphyrin Specificity 
HemH was assayed for activity in the presence of coproporphyrin III and 
protoporphyrin IX to investigate substrate specificity and kinetic variations that 
result from different porphyrin substrates. Coproporphyrin was initially tested for 
iron insertion by HemH following the same protocol used in experiments on 
ferrochelatases by the Dailey lab (Sellers et al. 2001; Shepherd et al. 2006)  as 
described in Section 2.13. This method observed changes in the three absorbance 
peaks in the 500-600 nm range, with a decrease in absorbance at 495 nm and an 
increase at 575 nm. Initial assays using high concentrations of iron did not produce 
enzymatic activity. However, a recent article reported that the HemH protein from S. 
aureus is inhibited by iron concentrations above 0.8µM (Lobo et al. 2015). When the 
iron concentration was dropped below this threshold, ferrochelatase activity was 
observable for S. aureus HemH, with the expected spectral changes being observed 
(Figure 4.9). HPLC analysis was also performed to detect coprohaem III evolution 
using a stopped assay (Section 2.13), with a quenched reaction mixture being 
compared to coproporphyrin III and coprohaem III commercial standards (Figure 
4.10). The HPLC spectra show peaks at roughly the same positions as 
coproporphyrin III and coprohaem III, as well as a much larger unidentified peak 
between the two standards, detected at approximately 14 min.  
  
S. aureus HemH was also assayed for iron chelatase activity using protoporphyrin 
IX, although no significant spectral changes could be observed to support the 
formation of proto-haem (Figure 4.11). This was consistent with HPLC analysis 
(Figure 4.12), which also demonstrated no activity with the protoporphyrin substrate: 
only a peak corresponding to protoporphyrin IX was observed when comparing 





Figure 4.9 - Spectral changes of minor coproporphyrin peaks during the first 5 minutes of the 
ferrochelatase assay. The peak at 495nm diminishes, whilst the peak at 565nm increases and shifts to 
approximately 570nm, indicating successful insertion of iron into coproporphyrin III.  
 
Figure 4.10 ± HPLC analysis of iron insertion into coproporphyrin III by S. aureus HemH (blue). 
Assay has been compared with coproporphyrin III (black) and coprohaem III (grey) standards, which 
have been offset for clarity. HPLC conditions started with a solution containing 80% TFA (0.1% v/v) 
and 20% acetonitrile, rising to 100% acetonitrile in a linear gradient over 30 minutes with absorbance 




Figure 4.11 ± Assay for iron insertion into protoporphyrin IX by S. aureus HemH. The lack of any 
noticeable change in spectral characteristics suggests that no reaction is taking place. 
 
Figure 4.12 ± HPLC analysis of iron insertion into protoporphyrin IX (red). Assay has been 
compared with protoporphyrin IX and protohaem IX standards (black and grey respectively, offset for 
clarity). No peak corresponding to protohaem IX can be observed in the reaction, suggesting that 
chelation is not occurring. HPLC conditions started with a solution containing 80% TFA (0.1% v/v) 
and 20% acetonitrile, rising to 100% acetonitrile in a linear gradient over 30 minutes with absorbance 
at 400 nm being detected. 
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4.2.4.2 ± Metal Specificity  
With other ferrochelatases being known to chelate a variety of metals, it was of 
interest to investigate the repertoire of metal chelation that is catalysed by S. aureus 
HemH. Many characterised ferrochelatases have been shown to catalyse the insertion 
of zinc and nickel, with copper and cobalt being inserted by some ferrochelatases. 
All metals that were tested appeared to be inserted into the coproporphyrin III 
molecule by S. aureus HemH, each reaction producing different spectral features for 
the different metalloporphyrins (described below).  
Zinc insertion (Figure 4.13) produces a large increase and peak shift from 393 nm to 
406 nm, as well as a decrease in the 500 nm peak, a large increase in the peak at 535 
nm and a large increase and shift in the 562 nm peak to 572 nm. Cobalt insertion 
also produces a peak shift from 393 nm, this time to 413 nm, however with a 
decrease in absorbance (Figure 4.14). The minor peaks show a decrease in 
magnitude at 500 nm, a subtle increase at 535 nm and 562 nm, with a concomitant 
broadening of these peaks. Copper insertion elicited a decrease in the 393 nm peak 
(Figure 4.15), with a broadening of this peak due to a shoulder emerging at roughly 
380 nm indicating an incomplete reaction. The 500 nm peak decreases, but is not 
fully diminished, suggesting that the reaction is slower than for the other metals 
mentioned so far. There is also a slight decrease in the 535 nm peak which is not 
seen in other metal insertions, and a slight increase in the 562 nm peak. Nickel 
insertion also elicited a decrease in the 393 nm peak with a shoulder forming at 401 
nm, also indicating incomplete conversion to the metalloporphyrin and a slower 
reaction (Figure 4.16). In the minor peaks, the 500 nm peak decreased slightly, as 
with copper, and the two peaks at 535 nm and 562 nm increased in magnitude and 
moved closer together.  
Whilst kinetic analyses of these extra metal substrates were not performed, a 
comparison of all four of the spectra shown in Figures 4.13-16 does give a clear 
indication that insertion of zinc and cobalt progresses much faster than that of copper 
and nickel. This can be seen in the complete shifting of the 393 nm peak in the zinc 
and cobalt spectra, whereas the peak still exists in the copper and nickel spectra 
although it is slightly smaller with a peak shoulder forming indicating that insertion 





Figure 4.13 - Spectral changes during zinc insertion into coproporphyrin III by S. aureus HemH after 
10 minutes of incubation. Inset shows and expanded view between 455 nm and 600 nm. Full 
conversion of peaks indicates complete insertion of zinc into the porphyrin. 
    
Figure 4.14 ± Spectral changes observed during insertion of cobalt into coproporphyrin III by S. 
aureus HemH over the course of 10 minutes. Inset shows an expanded view of the spectrum between 
450 nm and 600 nm. Complete conversion of substrates can be inferred from the complete shifting of 
the absorption peaks 
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Figure 4.15 ± Spectral changes observed during insertion of copper into coproporphyrin III by S. 
aureus HemH over the course of 10 minutes. Inset shows an expanded view of the spectrum between 
450 nm and 600nm. Formation of a shoulder to the 393 nm peak indicates that there is incomplete 
conversion and therefore slower insertion has taken place (compared to Zn2+ and Co2+).  
 
Figure 4.16 ± Spectral changes observed during nickel insertion into coproporphyrin III by S. aureus 
HemH over 10 minutes. Inset shows an expanded view of the spectrum from 450 nm to 600 nm. 
Incomplete conversion of coproporphyrin III can be seen by the formation of a shoulder to the 393 nm 
peak indicating that this, like for copper, is a slow progressing insertion.  
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4.2.5 ± Kinetic analysis of S. aureus HemH 
Kinetic assays detected the formation of iron coproporphyrin by S. aureus HemH by 
measuring the decrease in absorbance at 392 nm using an extinction coefficient of 
115 mM-1cm-1 (Lobo et al. 2015). This approach was adopted to further investigate 
the kinetic properties of S. aureus HemH. 
 
4.2.5.1 ± High iron concentrations inhibit HemH activity 
Kinetic analyses confirmed the previously published observations that the HemH 
protein is partially inhibited at iron concentrations above 0.8µM (Figure 4.17). This 
inhibition does not completely abolish activity, with the rates dropping to between 
1.5 and 2.5 min-1, depending on the coproporphyrin concentration.  
 
When the iron concentration was kept constant and coproporphyrin concentrations 
were varied, typical Michaelis-Menten kinetics were observed with no observable 
substrate inhibition (Figure 4.18). The reaction was performed using an iron 
concentration of 0.7 µM to maximise activity while ensuring that iron-mediated  
inhibition was kept to a minimum. These preliminary observations show that the 







Figure 4.17 ± V vs. S kinetics for S. aureus HemH varying iron concentration in a constant 
coproporphyrin concentration. 1µM of coproporphyrin and 50nM of HemH protein was used during 
these assays. Iron concentrations above 0.8 µM appear to partially inhibit HemH activity. Error bars 
represent SD values based on 3 repeats. 
    
Figure 4.18 ± V vs S kinetics for the S. aureus HemH with varied coproporphyrin III concentrations 
and a fixed iron concentration. 0.7µM of iron was used, to keep under the 0.8µM inhibitory iron 
concentration, with 50 nM of HemH being used in all assays. kcat = 10.5 ± 0.4 min-1, apparent Km = 
1.5 ± 0.2 µM. Error bars represent SD values based on 3 repeats. 
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4.2.5.2 ± v vs. [S] plots for S. aureus HemH provide a preliminary 
kinetic model 
The HemH enzyme was assayed under various conditions to determine if the kinetic 
parameters could be used to provide information on the order of substrate binding. 
Using freshly purified protein, HemH was assayed across a range of substrate 
concentrations, whilst keeping the second substrate concentration constant, as 
performed in section 4.2.5.1. This was then repeated using the same protein, iron and 
coproporphyrin stocks at two different concentrations of the second substrate, e.g. if 
iron was the substrate being varied, this experiment would be repeated using three 
different coproporphyrin concentrations. The fixed concentrations tested for the 
second substrates were 0.3 µM, 0.5 µM and 0.7 µM. These were chosen so that they 
would be below the inhibitory iron concentration of 0.8 µM. When iron was varied 
(Figure 4.19) using fixed coproporphyrin concentrations, the Vmax values did not 
vary significantly (5.0 ± 0.26 min-1, 5.7 ± 0.37 min-1 and 5.5 ± 0.22 min-1 for 0.3µM, 
0.5µM and 0.7µM respectively). However, as the coproporphyrin concentration 
increases, the apparent Km value for iron decreases. When the coproporphyrin 
concentration was varied at three fixed iron concentrations (Figure 4.20), the Vmax 
values did not vary significantly, whilst the Km values for coproporphyrin increase as 

























Figure 4.19 ± v vs. [Fe2+] kinetics at three fixed coproporphyrin III concentrations. The maximal rates 
are similar for the different concentrations, but the Km decreases as more coproporphyrin III is 
present. Inset shows a Lineweaver-Burk plot for these datasets, further highlighting the changes in Km 
during these assays. To avoid common problems associated with Lineweaver-Burk plots, regression 
lines are defined by the kinetic parameters obtained using nonlinear regression analysis in the primary 















Figure 4.20 ± v vs. [CIII] kinetics at three different, set iron concentrations. Maximal rates appear to 
be similar with an increase in Km seen as the iron concentration rises. Inset shows a Lineweaver-Burk 
plot for the datasets, which further highlights the change in Km. To avoid common problems 
associated with Lineweaver-Burk plots, regression lines are defined by the kinetic parameters 








4.2.5.3 ± Magnesium lowers the threshold for iron-mediated 
inhibition of HemH catalysis 
It has previously been reported that magnesium can stimulate the activity of B. 
subtilis HemH when assayed with Zn2+ and deuteroporphyrin IX substrates (Lecerof 
et al. 2003), so it was of interest to investigate the effect of magnesium upon S. 
aureus HemH catalysis. To determine whether magnesium affected iron binding, 
kinetic analyses were performed whereby the iron concentration was varied and the 
coproporphyrin concentration was kept constant (Figure 4.21). Surprisingly, rather 
than stimulating this reaction, iron-mediated substrate inhibition was observed at a 
lower iron concentration when magnesium was present: ~0.4 µM compared to 0.8 




Figure 4.21 ± v vs. [Fe2+] kinetics of the HemH reaction in the presence (orange) and absence (black) 
of 4mM Mg2+. 50nM of HemH and 2µM of coproporphyrin III were used, with the Fe2+ concentration 
being varied. Presence of magnesium in the assay appears to lower the concentration of Fe2+ required 
for inhibition to 0.4 µM instead of 0.8 µM. 
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4.3 - Discussion 
As with other ferrochelatases, the HemH protein from S. aureus was shown to 
catalyse the insertion of metals other than iron into the coproporphyrin ring. With a 
similar structure to B. subtilis, including a tyrosine at residue 13 that appears to be 
unique to soluble ferrochelatases, it is likely that S. aureus would be able to utilise 
the same metals as this well-studied protein. Spectroscopic analysis of the insertion 
of Co2+, Cu2+ and Ni2+ into coproporphyrin III by the S. aureus protein showed 
similar patterns for modifications of the three peaks between 475 nm and 575 nm as 
was seen previously, although the magnitude change of the 560 nm peak did not 
increase as much as expected for Co2+ and Ni2+ (Figs 4.14, 4.16). Shifts in peaks 
could be seen as expected, which suggests that insertion of the metal has occurred. 
These data demonstrate that as well as iron insertion, S. aureus HemH can catalyse 
the insertion of zinc and cobalt, as well as catalysing less common chelatase 
reactions with copper and nickel. 
It has previously been shown that the HemH from S. aureus inserts iron into 
coproporphyrin III (Lobo et al. 2015), supporting the existence of the coprohaem 
pathway that was first proposed by the Dailey group (Dailey et al. 2015). This 
reaction is inhibited by the primary metal substrate in concentrations higher than 0.8 
µM, which causes a sharp decrease in activity, but does not totally abolish enzyme 
activity (Lobo et al. 2015). This inhibition could possibly explain the low levels of 
activity previously reported for the B. subtilis protein (Dailey et al. 2015), which has 
also been shown to be inhibited by high iron concentrations (Lobo et al. 2015), and 
may have masked the true maximal rate for the M. tuberculosis protein if it is also 
inhibited by the iron concentrations in the assays. An intriguing observation is that 
iron-mediated substrate inhibition has only been shown to occur when 
coproporphyrin III is used as a substrate, with successful assays utilising 
protoporphyrin seemingly unaffected by changes in iron concentration and 
producing classic Michaelis-Menten kinetics (Lecerof et al. 2003; Lobo et al. 2015). 
A similar pattern to previous work was seen in the reaction utilising coproporphyrin 
III during this work, with a sharp decrease in activity with an iron concentration 
above 0.8 µM (Figure 4.17). In our hands however, activity with protoporphyrin 
could not be measured (Figures 4.11 and 4.12). With coproporphyrin III as the 
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porphyrin substrate, our data reveal a kcat value of 10.5 ± 0.4 min-1 that is similar to 
published constants for other ferrochelatases, with slightly higher values being 
observed for C. crescentus and P. putida (see Table 4.1). Intriguingly, significant 
activity (kcat  = 15.3 min-1) has been reported for S. aureus with protoporphyrin IX 
(Lobo et al. 2015), although activity with this porphyrin could not be detected in our 
hands. 
Further kinetic analysis was performed, aimed at determining the optimal substrate 
binding order and an overall mechanism for the reaction. These assays (Section 
4.2.5.2) show that the Vmax values remain unchanged across several datasets but the 
Km values for both iron and porphyrin substrate change as the concentration of the 
accompanying substrate varies. When iron was varied (Figure 4.19) using fixed 
coproporphyrin concentrations, the Vmax values did not vary significantly (5.0 ± 0.26 
min-1, 5.7 ± 0.37 min-1 and 5.5 ± 0.22 min-1 for 0.3 µM, 0.5 µM and 0.7 µM  iron 
respectively). However, as the coproporphyrin concentration was increased, the Km 
value for iron decreased. This suggests that as the coproporphyrin levels increase, 
HemH can more readily utilise the iron substrate. When the coproporphyrin 
concentration was varied at three fixed iron concentrations (Figure 4.20), the Vmax 
values did not vary significantly, whilst the Km values for coproporphyrin increased 
as the iron concentration increased. This suggests that coproporphyrin binding is less 
efficient at higher iron concentrations.  
 
Overall it appears that the most efficient way for the reaction to take place is for the 
porphyrin substrate to bind to HemH first, with the iron binding second. Whilst this 
is unlikely to affect the overall maximal rate, at lower concentrations of iron, a 
higher proportion of HemH molecules will have bound iron resulting in a higher 
steady state rate. This kinetic model, which only applies for iron concentrations 






Figure 4.22 ± Kinetic model for S. aureus HemH at [Fe2+] < 0.8 µM. The green pathway represents 
the favourable route where coproporphyrin binds first. The red arrows show a less efficient 
mechanism where iron binds first. This mechanism would only apply to iron concentrations below 
0.8µM. 
At higher iron conditions (above 0.8 µM), it is hypothesised that bound iron at a 
second site may be acting as a noncompetitive inhibitor whereby saturation of this 
metal site results in a lower rate of metal chelation but does not completely abolish 
enzyme activity (Figure 4.22). This would explain the pattern of substrate inhibition 
that has been observed for both the S. aureus and B. subtilis HemH enzymes (Lobo 
et al. 2015). One possible molecular explanation for this phenomenon could be iron 
binding to an inhibitory metal site underneath the porphyrin which has been 
observed in studies with B. subtilis HemH using the inhibitor Cd2+
 
(Lecerof et al. 
2003).  Cd2+ was shown to bind to H262 in the B. subtilis enzyme, which corresponds 
to H261 in S. aureus HemH. 
Another explanation for this phenomenon could be linked to the stimulation effect of 
Mg2+ binding, where previously hypothesised repulsion between metal ions could 
stimulate the insertion of metal (zinc in this case) into the porphyrin (Lecerof et al. 
2003). Attempts to recreate this result using the natural substrates coproporphyrin III 
and iron with magnesium as a molecular probe for the outer metal site have shown 
that rather than stimulating the reaction, iron-mediated inhibition is exacerbated by 
magnesium: the inhibition occurred at approximately 0.4µM iron rather than 0.8 µM 
(shown in Figure 4.21). This could be explained by the presence of a metal at the 
outer binding site influencing binding at the catalytic metal binding site via potential 
conformational changes in the porphyrin binding cleft. This change may hinder the 
ability of coproporphyrin III to bind efficiently enough to allow for iron insertion to 
occur. This explanation seems plausible when it is assumed that the presence of 
magnesium in a saturating concentration will only occupy the outer metal binding 
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site, and therefore remove one of two potential iron binding sites. When this occurs, 
the concentration of iron needed for inhibition to occur drops to half of the 
concentration required when iron is the only metal present and two metal binding 
sites are available for iron to bind to. This would seem to suggest that the partial 
inhibition is due to the occupancy of both metal sites before coproporphyrin can 
bind, which causes a conformational change that slows down the ability of 
coproporphyrin III to bind deep enough in the active site for iron insertion to occur. 
Overall, the data in this chapter are consistent with iron being able to bind to more 
than one site on S. aureus HemH when it is present in high levels, resulting in partial 
inhibition of iron insertion into coproporphyrin III. This model (Figure 4.23) dictates 
that when ferrous iron levels elevate beyond 0.8 µM, iron would bind first to the 
inner metal binding site (labelled as A in Figure 4.23) with a second iron atom 
binding to the second binding site (either the inhibitory H261 or the Mg2+ binding 
site, labelled as B in Figure 4.23), resulting in a lower affinity for coproporphyrin 
and therefore a lower kcat value of 2 min-1. 
 
 
Figure 4.23± Kinetic model of the S. aureus ferrochelatase reaction and the proposed mechanism for 
the iron-dependent inhibition based on kinetic data. The green route represents the most efficient 
route, binding coproporphyrin III first, red represents a slightly less efficient route with iron binding 





Chapter V: Structural modelling and biochemical/kinetic 






































HemQ is an enzyme that is essential for haem synthesis in certain Gram-positive 
bacteria, and has recently been shown to catalyse the final step in the 
coproporphyrin-dependent pathway converting coprohaem III to protohaem IX 
(Dailey et al. 2015). HemQ has previously been shown to bind both protoporphyrin 
IX and protohaem IX (Mayfield et al. 2013) in addition to the presumed binding of 
its native substrate, coprohaem III. The coprohaem decarboxylase reaction has been 
shown to require the presence of either flavin mononucleotide (FMN) or hydrogen 
peroxide (H2O2) for activity (Dailey et al. 2015), with H2O2 being required at a five-
fold excess over coprohaem for complete conversion (Lobo et al. 2015).  In addition, 
a harderohaem intermediate has been shown to form during conversion of 
coprohaem III to protohaem IX (Celis et al. 2015). 
In the current work, further investigations into the HemQ enzyme provide functional 
insights beyond the published work described above. Fluorescence titrations were 
used to quantify binding affinities of protoporphyrin IX, protohaem IX, 
coproporphyrin III and coprohaem III. These data indicate that HemQ can bind non-
metallated porphyrins with a higher affinity than metalloporphyrins, with the 
surprising observation that coprohaem III has the weakest affinity out of the four 
tetrapyrroles tested. Subsequent kinetic analyses using discontinuous assays revealed 
that the reaction follows a Michaelis-Menten kinetic profile, with a Vapp of 1.74 ± 
0.12 min-1  and a Km(peroxide) of 90.4 ± 18.0 µM in the presence of 10 µM 
coprohaem. When the coprohaem concentration was varied it was not possible to 
estimate Vmax or Km, although the maximum measured rate was 2.5 min-1 which is 







5.1 ± Introduction 
HemQ is a protein that has only been discovered recently (Dailey et al. 2010) and 
has been determined to be a coprohaem decarboxylase, converting the propionate 
groups on rings A and B of coprohaem III to vinyl groups and forming protohaem IX  
(Dailey et al. 2015). This reaction is the final step in haem synthesis in organisms 
that utilise the coproporphyrin-dependent pathway, i.e. HemQ is the final protein in 
these organisms. Biochemical characterisation of this protein is at an early stage, and 
a crystal structure of HemQ is not yet available. 
5.1.1 ± Discovery and importance of HemQ 
HemQ was first discovered as a protein that was essential for haem synthesis in 
Gram-positive organisms, but with an unknown function. Initial studies on haem 
synthesis mutants of E. coli ǻhemG RU ǻhemH) showed that supplementing the 
haem defective strains with a plasmid encoding either hemY or hemH from Gram-
positive organisms did not restore the synthesis of haem (Dailey et al. 2010). From 
here it was deduced that either membrane associated HemY and HemH proteins 
were required, or an extra protein was required. Subsequent genomic analysis of 
Actinobacteria showed that an open reading frame for a protein, annotated as a 
chlorite dismutase-like hypothetical protein and now referred to as hemQ, was often 
found adjacent to either hemY or hemH. This gene was also found to be fused in 
frame with HemH in P. acnes, leading to speculation that this hypothetical protein is 
involved in haem synthesis in some way.  
A BLAST search of the amino acid sequence for this open reading frame identified 
chlorite dismutase-like hypothetical proteins as homologues, and formed a cluster of 
the orthologous proteins named group COG3253 (Dailey et al. 2010). This group 
was shown to have three sub-groups: proteins that have been shown to have chlorite 
dismutase activity, proteins without a defined function, yet are not chlorite 
dismutases, and proteins that are only present in Actinobacteria and had a completely 
unknown function at the time. Expression of this protein LQDǻhemG RUǻhemH E. 
coli mutant along with the Gram-positive hemY and hemH resulted in restoration of 
haem synthesis, but would not complement the mutants if expressed with just one of 
these proteins.  
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The deletion of hemQ from S. aureus, which is remote from other haem synthesis 
genes on the chromosome, has been shown to produce a small colony growth variant 
which is typical of a poorly respiring strain.  A similar phenotype has also been 
observed for strains with defective tetrapyrrole synthesis, by way of a deleted hemB 
gene (Von Eiff et al. 1997; Mayfield et al. 2013). This phenotype can be alleviated if 
the cells are grown with exogenous haem present, further strengthening the link 
between HemQ and haem synthesis (Mayfield et al. 2013). Furthermore, these 
VWXGLHV UHYHDOHG WKDW ǻhemQ mutants accumulate coproporphyrin III, with cellular 
levels of this porphyrin being five times higher than observed in wildtype S. aureus 
cells. 
5.1.2 ± Characterisation of recombinant HemQs 
Recombinant HemQs that have been studied have been shown to exist as multimeric 
proteins that have the ability to bind haem, with the S. aureus HemQ shown to be a 
homohexamer when haem is bound (Dailey et al. 2010; Mayfield et al. 2013). HemQ 
monomers appear to vary in size, but have been described as migrating on SDS-
PAGE at rates corresponding to proteins of 26 kDa and 30 kDa. 
Due to the similarities with haem-binding chlorite dismutases, initial studies 
focussed on the haem-bound form of HemQ rather than the native protein. Addition 
of haemin to the protein prior to purification resulted in a bright red protein and a 
vast increase in the amount of haem detected by UV/Vis spectroscopy when 
compared to the protein purified without haemin (Dailey et al. 2010). Initial attempts 
to determine the haem-binding affinity of M. tuberculosis HemQ via UV-vis 
spectroscopy suggested that haem bound poorly, with a Kd of 30-40µM, although the 
binding constant could not be accurately determined (Dailey et al. 2010). Subsequent 
analysis of the S. aureus HemQ using a fluorescence titration method revealed that 
haem binds with a Kd of 1.70 µM (Mayfield et al. 2013). This value is much lower 
than the estimated Kd for the M. tuberculosis HemQ but is still high when compared 
with some other haem binding proteins, which can reach as low as 0.88 x10-4 nM for 
sperm whale myoglobin (Culbertson & Olson 2010). Interestingly it was also 
discovered that HemQ can bind protoporphyrin IX as well, with a higher Kd of 
2.21µM (Mayfield et al. 2013).  
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The haem-bound form of HemQ has also been shown to have low levels of 
peroxidase and catalase activities, as has been seen with other members of the 
COG3253 family, with activities reported to be between 3 and 4 orders of magnitude 
lower than those for typical peroxidases and catalases (Dailey et al. 2010; Mayfield 
et al. 2013). The low affinity for haem and peroxidase/catalase activity has led to 
speculation that a catalytic role with H2O2 was unlikely for HemQ in vivo (Mayfield 
et al. 2013), although the use of H2O2 as an electron acceptor for coprohaem 
decarboxylation does now seem like a possibility. Chlorite dismutase activity was 
also assessed for S. aureus HemQ, although no activity could be detected with 
chlorite concentrations up to 20mM (Mayfield et al. 2013). Another interesting 
observation for the haem-bound form of HemQ was that addition of this protein to a 
P. acnes HemY protoporphyrinogen oxidase assay caused a stimulation of the 
reaction, as mentioned in Chapter III, which did not occur when unbound HemQ was 
added (Dailey et al. 2010). The lack of chlorite dismutase activity and low 
peroxidase/catalase activity, combined with the amount of evidence linking this 
protein with the final stages of haem synthesis, suggested that the true role of this 
protein was in the terminal steps of haem synthesis.  
5.1.3 ± HemQ catalyses the final reaction of the coprohaem 
pathway 
Further studies on HemQ were undertaken to elucidate a role in the haem 
biosynthetic pathway. Deletion of hemQ from S. aureus resulted in accumulation of 
coproporphyrin III (Mayfield et al. 2013) rather than protoporphyrin IX, which 
would have been expected should the other proteins of the classical haem synthesis 
pathway be working effectively. As mentioned in section 1.2.4, it appears that the 
gene annotated as hemN from Gram-positive organisms does not encode for an 
active coproporphyrinogen oxidase, and coproporphyrin III rather than 
protoporphyrin IX has been identified as an intermediate in these organisms (Dailey 
et al. 2015; Jacobs et al. 1971). This, along with the well-known observation that the 
B. subtilis HemY can oxidise coproporphyrinogen III (Hansson et al. 1997), 
suggested that other pathways that synthesise haem exist, bypassing protoporphyrin 
IX as a pathway intermediate.  
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HemH proteins from Gram-positive organisms had been shown to catalyse insertion 
of iron into coproporphyrin (see chapter 5), and HemY, HemH and HemQ were all 
required for haem synthesis to occur in E. coli ǻhemG RUǻhemH mutants (Dailey et 
al. 2010; Lobo et al. 2015). This led to the assertion that HemQ must be involved in 
converting coprohaem III into protohaem IX. This reaction had been observed in the 
alternative haem biosynthesis pathway, also as the final reaction, where the protein 
AhbD converts coprohaem to protohaem (Palmer et al. 2014). Assays involving 
HemY, HemH and HemQ, starting with coproporphyrinogen III and iron, were 
analysed by mass spectrometry and it was found that the products formed were 
protohaem and a monovinyl, monopropionyl haem intermediate (Dailey et al. 2015; 
Lobo et al. 2015), which was later revealed to be harderohaem isomers III and IV, 
with the main intermediate likely to be isomer III (Celis et al. 2015). The reaction 
only produced small amounts of protohaem when assayed without HemY and was 
determined to require the electron acceptors H2O2 or FMN to allow for full 
conversion of coprohaem to protohaem (Dailey et al. 2015). In assays containing 
HemY, HemH and HemQ, H2O2 could be produced by the HemY reaction and 
would likely be utilised by HemQ for the decarboxylation reaction. No differences to 
this reaction could be detected when FMN was present (Dailey et al. 2015).  
5.1.4 ± Model for the HemQ mechanism  
HemQ is one of two enzymes that have been shown to convert the propionates of 
coprohaem to the vinyl groups found in protohaem, with the other enzyme being 
AhbD in the alternative haem biosynthetic pathway (Bali et al. 2011). AhbD is a 
radical S-adenosylmethionine (SAM) enzyme and the cleavage of SAM by a [4Fe-
6@FOXVWHUFUHDWHV¶-deoxyadenosyl (dAdo) radicals that are used by the enzyme to 
sequentially cleave the propionate side chains on rings A and B to form vinyl groups 
(Lobo et al. 2014). This mechanism is similar to the process employed by HemN, the 
classical oxygen-independent coproporphyrinogen oxidase, which is also a radical 
SAM protein and cleaves the same propionate side chains in the same sequential 
manner, forming harderoporphyrinogen as an intermediate (Layer et al. 2002). The 
absorption spectrum of HemQ lacks spectral features that are characteristic of iron-
sulphur clusters, suggesting that HemQ enzymes do not have these clusters and 
therefore catalyse the reaction via a different mechanism (Dailey et al. 2010; 
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Mayfield et al. 2013; Celis et al. 2015). It has also been noted that the HemQ 
reaction does not occur when iron is absent from the porphyrin, as assays with Ni-
coproporphyrin III did not result in conversion to Ni-protoporphyrin IX, strongly 
suggesting that the central iron is vital for activity (Dailey et al. 2015). Considering 
the peroxidase activity and the requirement for H2O2, it was hypothesised that a 
radical mechanism was responsible for the decarboxylation, resulting from the 
breakdown of Compound 0 (a FeIII-OOH complex), although the precise nature of 
this reaction is not entirely clear (Celis et al. 2015). The breakdown of Compound 0 
is predicted to follow one of three paths: The first being a heterolytic breakdown 
following the input of a proton to form Compound I (FeIV=O) and a water molecule, 
with the second and third paths being either a homolytic or concerted breakdown of 
this compound to form FeIV 2ZDWHUDQGDȕ-carbon radical. It has been predicted 
that the Compound I path may not be used, as HemQ seems to lack the amino acid 
residues required for formation of this compound (a distal His-Arg and proximal 
His-Glu/Arg motif) that are usually found in peroxidases, and therefore the reaction 
may proceed via the homolytic or concerted breakdown of Compound 0, although 
the exact mechanism is not entirely clear (Celis et al. 2015). The overall mechanism 
for the decarboxylation of coprohaem seems to require a free radical, formed either 
as part of a peroxidase reaction by HemQ or as a dAdo radical produced in the AhbD 
radical-SAM based reaction. The existence of two enzymes that catalyse the same 
reaction in different ways is not unheard of in haem synthesis, as both 
coproporphyrinogen oxidase and protoporphyrinogen oxidase reactions have 
multiple enzymes catalysing the same reactions (see section 1.2.2). The coprohaem 
decarboxylases AhbD and HemQ seem to follow the same pattern as other branches 
in tetrapyrrole synthesis pathways, with AhbD catalysing a reaction that is anaerobic, 
due to being a radical-SAM protein (Lobo et al. 2014), and HemQ being able to 
function in the presence of oxygen (Dailey et al. 2015). Studies looking at the co-
occurrence of proteins that are involved in the decarboxylation of coproporphyrin-
based molecules (i.e. HemF, HemN, HemQ and AhbD) showed that HemQ and 
AhbD are almost always found in organisms that lack either HemF or HemN (Dailey 
et al. 2015). A comparison between organisms containing HemQ and AhbD shows 
that 62.7% of organisms that contain AhbD also contain HemQ, which represents 
27.6% of the 152 HemQ-containing organisms. It was also found that over 90% of 
both of these organisms also contain a HemY protein (Dailey et al. 2015). 
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5.1.5 ± Aims of this chapter 
The aims of this chapter were to investigate the ability of HemQ to bind different 
porphyrin ligands, determining binding characteristics by fluorescence titration. The 
hypotheses tested, based on the ability of HemQ to be purified with a variety of 
porphyrins bound, were: 
 
x HemQ can bind protohaem IX, protoporphyrin IX, coproporphyrin III and 
coprohaem III. 
 
x Metalloporphyrins will bind tighter than metal-free porphyrins. 
 
A kinetic assays, both continuous and stopped assays, were also devised and trialled 
to determine preliminary kinetic parameters for the HemQ decarboxylation reaction, 










5.2 ± Results 
5.2.1 ± Structural analysis of S. aureus HemQ 
5.2.1.1 ± Analysis of the primary structure of HemQ 
A NCBI protein BLAST search was performed using the protein sequence of S. 
aureus HemQ and it was found that there is high level of conservation between 
HemQ proteins within the Staphylococcus genus, with an average sequence identity 
of 82%. The BLAST search also showed that B. subtilis has a similar protein that has 
a 64% identity to the S. aureus HemQ. HemQ proteins from M. tuberculosis and P. 
acnes were also analysed, as they have been experimentally verified to decarboxylate 
coprohaem: S. aureus HemQ exhibits 22% and 24% sequence identity to the M. 
tuberculosis and P. acnes proteins, respectively. With the exception of the M. 
tuberculosis and P. acnes proteins, all other putative HemQ proteins are annotated as 
haem binding proteins in the NCBI protein database. The protein from M. 
tuberculosis is annotated as a chlorite dismutase and the protein from P. acnes is 
listed as a ferrochelatase, due to being fused with the HemH protein. S. aureus 
HemQ exhibits 44% identity with a haem-binding protein from the bacterium 
Thermus thermophilus, for which a crystal structure exists (Ebihara et al. 2005). This 
structure, listed as 1DVH in the protein databank, was originally annotated as a 
putative chlorite dismutase but has recently been changed to a novel haem binding 
protein and predicted to be a HemQ (Dailey et al. 2015).  
A multiple sequence alignment for these sequences is shown in Figure 5.1. The 
conserved residues appear to mainly be located in the C- terminal half of the protein 
across the S. aureus, S. epidermidis, B. subtilis and T. thermophilus proteins. This 
region contains the residues that are responsible for haem binding when the 3D 
structures of the T. thermophilus and the predicted S. aureus HemQ were analysed 
(see section 5.2.1.2).  This region is well-conserved, including a series of residues 
(Y145, P146, H172, Q185 and W198 in S. aureus) that are highly conserved in all 




Figure 5.1 ± Multiple sequence alignment of HemQ proteins from various organisms. Black shading 
represents identical residues whereas grey denotes functional similarity. The P. acnes sequence starts 
at residue 451 due to the native protein existing as a fusion with HemH, which is located at the N-
terminus. Highlighted in red are conserved residues that are thought to be important for the 
decarboxylase reaction. 





5.2.1.2 ± Analysis of a structural model for HemQ 
A predicted structural model for the HemQ from S. aureus was obtained using the 
amino acid sequence and the RaptorX software (Peng & Xu 2011), and was analysed 
using CCP4MG (McNicholas et al. 2011). The haem-binding protein from T. 
thermophilus (1VDH) was one of the structures selected by RaptorX as a template 
for the generation of a structural model for HemQ from S. aureus. This protein is 
predicted to be a HemQ (Dailey et al. 2015), and the crystal structure was solved 
without any ligands in the tetrapyrrole-binding cleft (Ebihara et al. 2005). A direct 
comparison of 1VDH and the S. aureus HemQ model is shown in Figure 5.2, which 
shows that the basic secondary and tertiary structures are very similar. The only 
obvious difference is the protein loop near the haem-binding site of the HemQ 
model, which has an extra helical structure and also a small insertion of three amino 
acids (bottom left of the structures in Figure 5.2). A coprohaem III molecule has also 
been modelled into the active site based on the position of a haem molecule in a 
similarly structured chlorite dismutase from Dechloromonas aromatica (Goblirsch et 
al. 2010), which has been used previously for comparison studies with the T. 
thermophilus HemQ structure (Celis et al. 2015). 
The active site of the T. thermophilus model is proposed to be comprised of a series 
RIUHVLGXHVEHWZHHQWKHĮ-KHOLFHVĮDQGĮDQGWKHȕ-VWUDQGVȕȕȕDQGȕD
(Ebihara et al. 2005). The main residues proposed to be involved in binding haem are 
H172, which is thought to co-ordinate the iron in the (copro)haem group, K149 and 
R218, which creates a positively charged environment, a typical feature of catalases 
and peroxidases, which stabilises the propionate groups on the haem molecule. Other 
residues that reside in this pocket are primarily hydrophobic in nature, which also 
supports the binding of a haem group (Ebihara et al. 2005). In addition to these 
residues, there is an aspartate residue that may form a hydrogen bond with H172, a 
common feature of peroxidase-like enzymes. Furthermore, the triad of hydrogen-
bonding residues opposite the H172 residue (N185, Y145, W198) are typical of a 
peroxidase-like distal pocket. These identified residues can be seen in Figure 5.3, 











Figure 5.2 ± Comparison of the predicted HemQ structure from S. aureus (blue) and the 
crystal structure that the model was based on, HemQ from T. thermophilus (purple). 





As mentioned in section 5.2.1.1, the active site is at the C-terminus of the protein, an 
area that is well-conserved between different HemQ proteins (Figure 5.1). The 
predicted model for S. aureus contains the majority of residues identified as being 
involved in haem binding in the T. thermophilus structure (Figure 5.3). These 
enzymes have been reported to lack a hydrogen bonding network that is normally 
present in the proximal haem-binding pocket of the closely related chlorite dismutase 
enzymes (Hofbauer et al. 2015; Hofbauer et al. 2016), although the µHemQ¶
structures analysed did not appear to belong to any of those that had been 
experimentally verified. Initial comparisons between the HemQ proteins that have 
been experimentally verified and chlorite dismutases is the lack of a conserved 
arginine, which in most HemQs is replaced by a glutamine residue (Q185 in S. 
aureus) but is occasionally occupied by an alanine residue (in M. tuberculosis and P. 
acnes, see Figure 5.1).  
Other conserved residues present in the haem binding pocket include a conserved 
tyrosine and proline doublet (Y145 and P146) and a tryptophan (W198) that is 
adjacent to the haem propionates. Aside from an adjacent glycine residue, there is a 
high level of variability close to the invariant axial histidine (H172). There is also a 
lysine/arginine residue (K149 in S. aureus) that could potentially stabilise the haem 
propionates and has the potential to contribute to a proximal hydrogen bonding 
network via water molecules. Other residues that are believed to be important to the 
HemQ proteins are W157, Y158, R165, E197 and R218, all of which are fully-
conserved in the HemQs that are analysed herein. Several of these residues are 
shown in Figure 5.3 where they are compared to their locations in the T. 
thermophilus crystal structure, with coprohaem III having been modelled into the 
cleft. Residue locations between the two proteins appear to occupy very similar 















Figure 5.3 ± The haem-binding sites of HemQ proteins from the T. thermophilus crystal structure 
(pink) and the S. aureus predicted model (blue) with coprohaem III modelled into the binding site 
(purple). Conserved residues believed to be important for binding the tetrapyrrole molecules are 







Due to a lack of HemQ structures with bound tetrapyrroles, it has been difficult to 
accurately predict the shape of the S. aureus HemQ pocket when ligands are bound. 
Surface models for the HemQ structures appear to show a closing of the active site 
pocket between where rings A and B of the haem molecule are predicted to be 
located. It is anticipated that this section of the pocket opens up upon substrate 
binding, allowing for the coprohaem to move to a position deeper in the pocket. 
Whilst not a HemQ, the chlorite dismutase from Dechloromonas aromatica (PDBid 
= 3Q08) has a similar tertiary structure to both the S. aureus and T. thermophilus 
HemQs (Figure 5.4 ± only S. aureus shown for clarity). This structure has also been 
solved with haem bound in the same location as the proposed active site for the 
HemQ protein, and was therefore used as a template for modelling coprohaem 
molecules into HemQ structures. The protohaem-bound 3Q08 structure has DQ Į-
helix that is not present in the HemQ structural model, which can be seen just above 
the ligand bound in Figure 5.4. It is possible that the movement of this helix, arises 
as the result of ligand binding, and may allow for the opening of the haem binding 
cleft. A multiple sequence alignment for D. aromatica, T. thermophilus and S. 
aureus can be seen in Appendix 3. 
Superposition of coprohaem III into the active site of HemQ was performed using 
the location of protohaem IX in the D. aromatica crystal structure. Using this 
structure as a potential model for tetrapyrrole binding to HemQ, only minor steric 





Figure 5.4 ± Structural comparison of the chlorite dismutase from D. aromatica (PDB 3Q08, brown) 
with protohaem IX bound (red) and the S. aureus HemQ structural model (blue). Coprohaem III 
(purple) has been modelled into the active site of S. aureus HemQ based on the location protohaem 
IX. 7KH EODFN DUURZ VKRZV WKH FKDQJH LQ ORFDWLRQ RI DQ Į-helix that may re-locate upon ligand 
binding. 
 
Figure 5.5 ± Surface representation of the active site of HemQ from S. aureus with coprohaem III 
(purple) and protohaem IX (red) present in the active site based on the protohaem IX location in the 
chlorite dismutase from D. aromatica.  
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5.2.2 ± Biochemical analysis of purified HemQ 
S. aureus HemQ was overexpressed and purified as described in section 2.4 and 
SDS-PAGE was performed to assess purity. The protein expressed very well, as 
evidenced by a large band at the expected molecular mass in the soluble cell extract 
(Figure 5.6). This band migrates at a rate corresponding to a 30kDa protein, which 
agrees with the predicted molecular mass for HemQ (29.4kDa). There is another 
significant band at 140 kDa in the purified protein lane, which is roughly five times 
larger than the HemQ protein. This may be due to an aggregation of multiple peptide 
chains, as HemQ has previously been predicted to form homotetramers or 
homohexamers (Mayfield et al. 2013), with other HemQs shown to crystallise as 
homopentamers (Ebihara et al. 2005; Dailey et al. 2015). There is also a smaller 
impurity at a lower molecular weight, which may be a result of degradation of the 
HemQ protein, although this is a minor contaminant in comparison to the main band 
at 30 kDa.  
 
A typical absorption spectrum of purified HemQ suggests that HemQ often purifies 
without a chromophoric cofactor, with the only absorbance peak being at 280 nm 
due to aromatic residues in the protein (Figure 5.7, grey trace). However, 
occasionally a minor peak at approximately 410nm is present (Figure 5.7, black 
trace). With the coproporphyrin-dependent pathway being absent in E. coli, it is 
likely that this peak is an artefact of the expression/purification system with HemQ 






Figure 5.6 ± SDS-PAGE analysis of HemQ following purification. A band corresponding to a protein 
of approximately 29kDa can be seen in all imidazole fractions, with the highest concentration being 
seen in the 300nM imidazole elution sample.  
 
Figure 5.7 ± UV/Vis spectra of two purified HemQ samples which have either a porphyrin bound 
(black) or nothing bound (grey). Inset shows a zoomed view between 375nm and 800nm. 
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HemQ that had been loaded with coproporphyrin III, protoporphyrin IX or 
protohaem IX was purified in the same way as the unloaded HemQ, the difference 
being that a concentrated porphyrin stock was added to the supernatant prior to being 
added to the purification column (Section 2.4). Any porphyrin that was not bound to 
HemQ was removed during the affinity chromatography and buffer exchange 
procedures. Absorption spectra were recorded for all of these proteins, which were 
subsequently used in HemY activity assays (Section 3.2.4.3). These spectra (Figure 
5.8) exhibit large peaks at 392nm, 405nm and 411nm, which correspond to 
coproporphyrin, protoporphyrin and protohaem, respectively. This shows that as 
well as the substrate and product of the in vivo HemQ reaction (coprohaem III and 
protohaem IX), non-metallated forms of these porphyrins can bind to HemQ. This 
also suggests that axial coordination of a central metal by the H172 residue is not 
essential for HemQ to bind tetrapyrroles.  
 
 
Figure 5.8 ± Absorption spectra of HemQ either unloaded (black) or loaded with coproporphyrin III 
(blue), protoporphyrin IX (green) or protohaem IX (red). Porphyrins were added to the sonicated cell 
extract prior to being added to the purification column. Presence of spectral characteristics for the 
relevant porphyrins shows that porphyrins are being bound by HemQ and are remaining bound during 
the purification process. 
 141 
 
5.2.3 ± HemQ can bind porphyrins and metalloporphyrins 
HemQ has the ability to bind porphyrins, but does not acquire a significant load of 
these molecules during purification (Figure 5.7). This would suggest that either 
HemQ expressed in E. coli does not have much opportunity to bind porphyrins that 
are produced in E. coli, or that it has a low affinity for these molecules. To 
investigate the affinity of HemQ for these ligands, in vitro fluorescence titrations 
were performed (Section 2.16) to analyse the binding of S. aureus HemQ with 
coprohaem III and protohaem IX as well as coproporphyrin III and protoporphyrin 
IX. The dissociation constants (Kd) for each tetrapyrrole was deduced from the 
change in fluorescence at 340nm (tryptophan fluorescence), which was fitted to the 
following equation:  
 
 
Where Fobs is the observed fluorescence (or observed change in fluorescence), F0 is 
the initial fluorescence, Fmax is the maximum fluorescence (or maximum change in 
fluorescence), [L]T is the total ligand (porphyrin) concentration, [E]T is the total 
enzyme concentration and Kd is the dissociation constant. Using this equation, the 
dissociation constants for coproporphyrin III, protoporphyrin IX, protohaem IX and 
coprohaem III were determined and are summarised in Table 5.1 with the fitted 













Ligand Kd (nM) 
Coproporphyrin III 86 ± 10 
Protoporphyrin IX 135 ± 24 
Protohaem IX 216 ± 41 
Coprohaem III 595 ± 127 
Table 5.1 ± Summary of Kd values for porphyrins 
binding to HemQ. 
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The binding data suggests that metalloporphyrins bind with a lower affinity than 
non-metallated porphyrins, with the substrate for the in vivo reaction, coprohaem, 
binding with the lowest affinity of all ligands tested. There was no obvious pattern to 
which tetrapyrrole bound with greater affinity, as HemQ had a greater affinity for 
coproporphyrin III compared to protoporphyrin IX, although protohaem was bound 
with a greater affinity than coprohaem. These data suggest that the presence of a 





Figure 5.9 ± Fluorescence titrations of HemQ with coproporphyrin III (blue), protoporphyrin IX 
(green), protohaem IX (red) and coprohaem III (purple) with their respective Kd values. Data for 
protoporphyrin IX (green) was offset by 100 fluorescence units for clarity. 75 nM of HemQ was used 




5.2.4 ± Coprohaem decarboxylase activity of HemQ 
With the discovery of a role for HemQ in the coprohaem branch of the haem 
synthesis pathway (Dailey et al. 2015) and the report of coprohaem decarboxylase 
activity for  S. aureus HemQ (Lobo et al. 2015), it was of interest to characterise the 
steady state kinetics of this reaction for S. aureus HemQ. Initial attempts to 
determine activity using a continuous method, looking for absorption changes that 
could be monitored, showed some promising results for future development of a 
continuous assay (Figure 5.10), yet due to time constraints a more simple assay 
detection system was required. Hence, a discontinuous method using HPLC was 
developed to track protohaem formation over time (see section 2.15). The 
chromatograms revealed three distinct peaks present in samples from HemQ 
reactions (Figure 5.11) which compare to single peaks observed for control 
reactions. These observations are consistent with  previous work (Dailey et al. 2015; 
Lobo et al. 2015; Celis et al. 2015), with two of these peaks corresponding to 
coprohaem III and protohaem IX. The third peak is predicted to be a harderohaem 
isomer which is reported to be an intermediate formed during the reaction (Celis et 
al. 2015). 
The HemQ reaction, as mentioned earlier, requires either H2O2 or FMN to function 
(Dailey et al. 2015) as an electron sink during the oxidative decarboxylation of 
coprohaem. With the HemY reaction producing hydrogen peroxide, it was decided 
that this electron acceptor would be used in experiments, as this is an obvious and 
readily available electron acceptor for the in vivo reaction. Basic kinetics constants 
were determined by varying each substrate independently whilst keeping the other at 
a constant initial concentration. It was anticipated that this approach might also 
reveal whether each substrate can influence the binding of the other, as was seen for 




Figure 5.10 ± Spectral kinetics of the coprohaem decarboxylase reaction catalysed by HemQ. The 
coprohaem III peak (at 390 nm) can be seen to decrease and red-shift. Inset shows an expanded view 
of the spectral changes between 375 nm and 410 nm. The changes in wavelength demonstrated here 
have potential for the development of a continuous spectroscopic assay for this reaction, following the 
change in absorbance at a particular wavelength. Further work would require identification of a 
suitable wavelength and reliable determination for an extinction co-efficient for this absorbance 
change. 
Preliminary kinetic analysis revealed two distinct concentration dependencies for the 
different substrates (Figure 5.12). When hydrogen peroxide was varied, using 10 µM 
of coprohaem III, the reaction kinetics for the tested range shows classical 
hyperbolic Michaelis-Menten kinetics, yielding an apparent Km(peroxide) of 90.4 ± 18.0 
µM and an apparent Vmax of 1.74 ± 0.12 min-1. However, when the coprohaem 
concentration was varied using H2O2 fixed at 250 µM, there appears to be a more 
linear relationship at concentrations up to 20 µM coprohaem, or perhaps a low 
affinity Michaelis-Menten relationship. The data were fitted to the Michaelis-Menten 
equation to provide an estimated Vmax of 6.6 ± 3.4 min-1 and an estimated Km(coprohaem 
III) of 37.4 ± 26.5 µM. Since the measured Kd for coprohaem is approximately 0.6  
µM (Table 5.1), these data perhaps suggest that the binding affinity of HemQ for the 







Figure 5.11 ± HPLC chromatograms of the HemQ reaction at t = 0 (red) and t = 1 min (pink). 
Chromatograms at these time points show the production of coprohaem III, a harderohaem isomer and 
protohaem IX at 13, 15.5 and 18.5 minutes respectively. Standards for coprohaem III (grey) and 
protohaem IX (black) have been offset for clarity with droplines showing the maximal point of the 
absorbance peaks.  HPLC conditions started with a solution containing 80% TFA (0.1% v/v) and 20% 
acetonitrile, rising to 100% acetonitrile in a linear gradient over 30 minutes with absorbance at 400 








Figure 5.12 ± Kinetic analyses of the HemQ reaction varying either hydrogen peroxide (A) or the 
coprohaem III substrate (B). Stopped assays performed with samples of  the reaction quenched, in a 
buffer containing 80% (v/v) Acetone and 0.02% (v/v) TFA, after 5, 10 and 15 seconds. Samples were 
analysed by HPLC, with sample peaks heights at 18.5 mins compared to a standard curve for known 
protohaem IX concentrations. Error bars represent SD values based on three repeats. Inset graphs 






5.3 ± Discussion 
Research into the HemQ protein has accelerated in recent years, culminating in the 
discovery that this enzyme is a coprohaem decarboxylase that catalyses the final step 
in coproporphyrin-dependent haem biosynthesis (Dailey et al. 2015; Lobo et al. 
2015; Celis et al. 2015). The HemQ protein from S. aureus has been suggested to be 
made up of five identical subunits of 29.4kDa and when overexpressed and purified 
can bind tetrapyrroles. However, only binding studies with non-native porphyrin 
substrates had been performed, and there was a notable lack of steady state kinetics 
to describe this enzyme-catalysed step. Hence, ligand binding and kinetic analyses of 
HemQ were undertaken. 
5.3.1 ± HemQ binds metalloporphyrins with a lower affinity 
than non-metallated porphyrins 
Binding experiments on S. aureus HemQ have been published before, although only 
protoporphyrin IX and protohaem IX were studied (Mayfield et al. 2013). This work 
reported a different pattern to the data presented herein, with protohaem binding with 
a greater affinity than protoporphyrin IX. However, these differences might be 
explained by variations in the experimental approach, as the pH of the samples was 
different to those used herein (pH 6.5 in Mayfield et al. (2013) compared with pH 
8.0 here). Measurement of cellular pHs have been difficult to accurately determine, 
yet values between 7.0 and 8.0 have been noticed for various mammalian cells types, 
and bacteria such as E. coli (Roos & Boron 1981; Booth 1985; Bright et al. 1987) 
although value ranges for S. aureus are currently not readily available. The above 
mentioned range would suggest that the data contained in this thesis is slightly more 
physiologically relevant, however it is more likely that they are equally distant from 
the physiological cytoplasmic pH and therefore neither dataset is physiologically 
relevant.  
Also, the published data do not appear to account for the absorption of the porphyrin, 
which has a significant affect upon fluorescence emission. In the experiments 
described herein, the fluorescent small molecule N-acetyltryptophanamide (NATA) 
was used in control experiments to account for loss of fluorescence resulting from 
ligand absorption: NATA will not bind the ligands so any decrease in fluorescence 
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can be attributed to absorbance of the ligand. Subtraction of this control gives a more 
specific change in fluorescence due to ligand binding. The current work suggests that 
HemQ binds non-metallated porphyrins with greater affinity than metalloporphyrins, 
an unexpected observation considering that the product and substrate for this enzyme 
are both metalloporphyrins. Another interesting observation is that the substrate for 
HemQ (coprohaem III) has a lower binding affinity than the product (protohaem IX). 
However, since free haem in the cell may react with hydrogen peroxide to produce 
reactive oxygen species, HemQ may have evolved to bind with moderate affinity to 
haem. In addition, it could be speculated that interaction of HemQ with a target 
protein may facilitate the release of this product. 
There is no obvious pattern that describes how the tested tetrapyrroles can bind to 
HemQ. When the central iron is absent, Kd values differ by only 49 nM (86 ± 10 and 
135 ± 24 for coproporphyrin III and protoporphyrin IX, respectively), although when 
a central iron is present the Kd values differ by 379 nM (216 ± 41 and 595 ± 127 for 
coproporphyrin III and protoporphyrin IX, respectively). Without structural data for 
ligand-bound  HemQ, it is difficult to reconcile these variations, although one might 
speculate that the presence of iron and the interactions with the protein that arise 
from this may affect the tertiary structure of the protein deeper in the active site 
pocket (i.e. closer to the substituents on rings A and B). 
5.3.2 ± HemQ kinetic analysis 
The most significant advancements in HemQ research are the identification of this 
protein as a coprohaem decarboxylase and identification of intermediates produced 
in the reaction (Dailey et al. 2015; Lobo et al. 2015; Celis et al. 2015). The current 
work provides additional insights into HemQ kinetics using coprohaem as the 
metalloporphyrin substrate and hydrogen peroxide as an electron acceptor. Kinetic 
parameters for the HemQ reaction were investigated using a discontinuous method 
with the substrates/products being detected by HPLC. Following the demonstration 
of coprohaem decarboxylase activity (Figure 5.11), a more detailed kinetic analysis 
was carried out varying each of the two substrates independently. Varying the 
hydrogen peroxide concentration with 10µM coprohaem present yielded classical 
Michaelis-Menten kinetics with an apparent Vapp of 1.7 ± 0.1 min-1 and an apparent 
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Km(peroxide) of 90.4 ± 18.0 µM. When coprohaem is varied in a constant initial 
hydrogen peroxide concentration (250µM) the data indicated a more linear 
depdendence upon this substrate. During these assays, concentrations of coprohaem 
up to 20 µM were used due to solubility issues anticipated for higher porphyrin 
concentrations. The data in the range tested shows a relationship that could be linear 
or would follow low-affinity Michaelis-Menten kinetics. Nonlinear regression 
analysis using the Michaelis-Menten equation yields poor estimations of apparent 
kinetic constants of Vmax  of 6.6 ± 3.4 min-1 and an estimated Km(coprohaem III) of 37.4 ± 
26.5 µM due to non-saturating concentrations of coprohaem. However, increasing 
the concentration did not seem sensible both due to solubility issues and avoiding 
concentrations that are not physiologically relevent: porphyrins are present in low 
(nmole/ng) levels in cells (Jacobs et al. 1971; Quintanilla-Vega et al. 1995).  
Whilst more precise estimations of the maximum enzymatic rate will require further 
experimental investigation, the rates obtained herein are comparable to those 
observed for the HemH and HemY proteins (see Chapters III and IV). The highest 
rate observed for HemQ during this work is 2.48 min-1 which is below the maximal 
rates observed for HemH and is higher than the values seen for the S. aureus HemY, 
which may indicate that oxidation of coproporhyrinogen is the limiting step in the 












































The aim of this work was to contribute to the pool of knowledge on the enzymes of 
the coproporphyrin-dependent pathway, which branches from the classical pathway 
at coproporphyrinogen III and does not form a protoporphyrin IX intermediate. As 
well as confirming previous reports of reactions catalysed by the HemY, HemH and 
HemQ enzymes from S. aureus (Lobo et al. 2015), detailed investigations have 
revealed novel insights into the mechanisms for HemY and HemH, whilst 
preliminary kinetic and binding data for the HemQ-catalysed reaction have been 
determined. 
6.1 ± Substrate utilisation by HemY provides insights 
into haem biosynthesis pathway evolution 
Both soluble and membrane-bound forms of HemY have previously been shown to 
be stimulated by haem-binding proteins (Dailey et al. 2010; Shepherd & Dailey 
2009). However, the current data reveal that soluble HemY from S. aureus, which 
catalyses the first reaction in the coprohaem pathway, is not stimulated when assayed 
with coproporphyrinogen III. This stimulation, specific to the protoporphyrinogen 
reaction, is due to radicals produced in the breakdown of H2O2 via a peroxidase 
mechanism (Figures 3.13, 3.16, 3.18). Another interesting observation is that 
presence of H2O2 inhibits HemY-mediated oxidation of protoporphyrinogen IX, but 
has no effect on coproporphyrinogen III oxidation (Figures 3.16). A look at the auto 
oxidation control rates (Figure 3.17) for these reactions shows that 
protoporphyrinogen oxidises faster in the presence of peroxide, whereas 
coproporphyrinogen oxidation is not noticeably affected. This, combined with the 
much higher much higher nonenzymatic oxidation of protoporphyrinogen compared 
to coproporphyrinogen, may provide some insight into the evolution of classical and 
coproporphyrin-dependent pathways. 
Since the HemQ component of the coproprophyrin pathway has been identified in 
evolutionarily early-branching (Acidobacteria and Planctomyces) and transitional 
(Deinococcus-Thermus group) diderm phyla (Dailey et al. 2015; Gupta 1998; Gupta 
2011), it is highly likely that this pathway is an evolutionary precursor to the 
classical protoporphyrin IX pathway. It has been predicted that the ancient 
coproporphyrin-dependent pathway may pre-date the production of atmospheric 
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oxygen, raising the question of how the oxygen-dependent HemY-mediated 
oxidation of porphyrinogens could take place (Dailey et al. 2015). The proposed age 
of the coproporphyrin-dependent pathway, combined with the lack of protoporphyrin 
intermediates in Actinobacteria and Firmicutes (Jacobs et al. 1971), the presence of 
haem synthesis proteins that have potential to be used in both pathways (HemY and 
HemH) and the lack of a functional HemN coproporphyrinogen oxidase (Lobo et al. 
2015; Dailey et al. 2015) raises the strong possibility that the ability to synthesise 
protoporphyrin intermediates was acquired after the coproporphyrin-dependent 
pathway was in common use. It is possible that a transitional period may have 
occurred whereby organisms may have utilised both pathway branches before 
selective pressures made it more advantageous to only use one pathway branch. 
These pressures may have influenced the usage of one intermediate over the other 
due to the apparent differences between the reactivity of the two porphyrin species. 
The higher reactivity of protoporphyrin intermediates, which has been shown to 
cause greater cellular damage than coproporphyrin (Aravind Menon et al. 1989), and 
the ability of peroxidase reactions to stimulate the protoporphyrinogen oxidase 
activity of HemY via a radical mechanism that does not appear to stimulate 
coproporphyrinogen oxidase reactions (see Sections 3.2.4.3) can all lead to the 
presence of cytotoxic compounds that could potentially damage the cell. The 
apparent inability of the HemY coproporphyrinogen oxidase to be stimulated by 
peroxidases (Figure 3.18) or to be affected by hydrogen peroxide (Figure 3.16) 
suggests that the coproporphyrin intermediates are more stable in harsh conditions, 
therefore less likely to break down and produce potentially toxic radicals. Obvious 
factors that could have influenced pathway evolution include the availability of 
oxygen and exposure to UV light, both of which potentiate the toxic effects of 
porphyrins: it seems likely that the coproporphyrin-dependent pathway would be 
better suited to exposure to these environmental factors. 
A good example of the dangers that the protoporphyrin pathway can pose is the 
condition erythropoietic porphyria in humans, where a build-up of protoporphyrin in 
cells leads to extreme photosensitivity resulting from the reaction of ultraviolet light 
with protoporphyrin creating free oxygen radicals as the porphyrin is broken down 
(Henderson et al. 1995; Balwani & Desnick 2012). The increased stability and 
decreased reactivity of coproporphyrin, compared to protoporphyrin, would lower 
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the amount of radicals that are produced and could allow for a greater survival than 
similar organisms using the classical protoporphyrin pathway. This hypothesis 
would hold true for some organisms that use the pathway today, such as S. aureus 
and P. acnes, which are cutaneous pathogens and have the potential to be exposed to 
high quantities of UV light. Staphylococcus species in particular are examples of 
organisms that would be exposed to high levels of light as they have been known to 
colonise the skin of a wide range of organisms (Kloos 1980). 
While it is unclear exactly how the pathways have evolved, the multi-functionality of 
the HemY coproporphyrinogen oxidase suggests that the classical pathway arose as 
an adaptation to use protoporphyrin IX instead of coproporphyrin III. HemY 
enzymes from organisms that use the coproporphyrin-dependent pathway were 
originally tested for activity with protoporphyrinogen IX, with coproporphyrinogen 
III often tested as an alternative substrate instead of the primary substrate (Hansson 
et al. 1997). The ability to accept either porphyrinogen as a substrate could be due to 
an adaptation to allow for either pathway to be used, with later modifications to 
promote the use of the single pathway. The real evolutionary divergence of the 
classical pathway over the coproporphyrin-dependent pathway would be the point at 
which HemF/N enzymes appear, as this is the point at which protoporphyrinogen is 
formed. However, it appears that identification of this point will be difficult as a 
large proportion of HemN enzymes are misannotated (Dailey et al. 2015).  
6.2 ± Inhibition of ferrochelatase may limit cellular 
concentration of free haem species 
It has previously been reported that ferrochelatases from both S. aureus and B. 
subtilis are inhibited at iron concentrations above 0.8µM (Lobo et al. 2015), an 
observation that would have been missed using the higher iron concentrations  that 
are conventionally used (Wu et al. 2001; Shepherd et al. 2006). This inhibition could 
explain the low enzymatic rates reported for HemY enzymes from M. tuberculosis 
and B. subtilis (Dailey et al. 2015). It is difficult to assess how this iron 
concentration compares to the amount of free iron present in the cell, as iron levels 
are tightly controlled due to high toxicity in an aerobic environment (Andrews et al. 
2003). An approximate estimate of the total cellular iron concentrations, based on 
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106 atoms of iron per cell in E. coli (Andrews et al. 2003) and a volume of 0.6µm3 
(Kubitschek 1990), gives a concentration of 155 mM which includes iron present in 
proteins (such as in iron sulphur clusters or in ligands such as haem). Hence, it is 
conceivable that iron is available for ferrochelatase at concentrations above 0.8µM 
(probably associated with a delivery protein), making the inhibition effect potentially 
important for limiting the amount of free haem species (either coprohaem or 
protohaem) available in the cell.  
Magnesium ions clearly influence HemH activity as the presence of Mg2+ in the 
regulatory metal binding site reduces the inhibitory iron threshold concentration to 
0.4µM, half of what is needed to cause inhibition without magnesium. With the 
magnesium concentrations used (4mM) being in the physiological range for many 
types of cell (Cowan 1991), it is conceivable that the regulatory metal site could be 
occupied by this metal in vivo, causing ferrochelatase to be inhibited at cellular free 
iron concentrations above 0.4µM. However, as is the case with iron, magnesium is 
seldom found as a free ion in biological systems (e.g. Mg2+ is often complexed with 
adenosine triphosphate (ATP)), so the potential interaction with HemH would be 
dependent upon complex dissociation as well as removal of the hydration shell. 
Furthermore, the relative affinity for magnesium and iron at low metal 
concentrations will also dictate which ion will occupy the HemH regulatory metal 
site in vivo. 
The HemH kinetics described herein that were conducted below the inhibitory iron 
concentration threshold suggest that the reaction proceeds most efficiently if 
coproporphyrin III is the first substrate to bind as this appears to facilitate iron 
binding to the catalytic metal binding site (Fig. 4.22). Conversely, when iron is more 
abundant and presumably binds first to HemH, coproporphyrin binding is slightly 
hindered (Fig 4.23). A potential explanation for this hindrance is a conformational 
change in the porphyrin binding cleft as a result of iron binding, perhaps constricting 
the site and preventing the bulky propionate side chains on rings A and B of 
coproporphyrin III from accessing the active site. This model is consistent with 
previous observations that high iron concentrations do not cause inhibition when 
protoporphyrin IX is used as a substrate (Lobo et al. 2015).  
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While there is reduction in coproporphyrin III chelatase activity caused by the 
presence of the metals in the regulatory binding site, the residual activity of HemH 
§PLQ-1 LV VWLOO DW D OHYHO WKDW LV FRPSDUDEOH WR+HP<§PLQ-1) and HemQ 
(max observed = 2.48 min-1). This suggests that elevated iron would not necessarily 
result in a build-up of coproporphyrin III. In fact the rate limiting step in the pathway 
at this point, assuming for an equal amount of each enzyme in vitro, would appear to 
be the HemY reaction, which may limit the supply of coproporphyrin for HemH and 
potentially restrict the supply of H2O2 as an electron acceptor for HemQ. However, 
in vivo, other factors will arise that will also affect the amounts of the pathway 
intermediates, highest among these being the relative amounts of each pathway 
enzyme that is present in the cell and the actual substrate concentrations present in 
the cell at any particular time. Further research into the relative native expression 
levels of all of the haem synthesis enzymes would be needed to give insights into the 
rate limiting steps of haem synthesis for this newly discovered pathway branch. 
Porphyrin levels could also be analysed, however with the reactivity of certain 
SDWKZD\LQWHUPHGLDWHVPDLQO\&¶JHQIII which would oxidise to CIII) it may be hard 
to gain true readings for each enzymes substrate. 
The regulation of HemH by the occupancy of the regulatory metal site by Mg2+, Fe2+ 
or other ions that are able to occupy this site, could serve to control the amount of 
coprohaem produced to limit the potential for ROS generation by metalloporphyrin-
mediated Fenton chemistry (this hypothesis assumes that excess free iron is 
complexed to bacterioferritin whereas excess metalloporphyrins remain free). 
However, the lack of iron-mediated inhibition when protoporphyrin IX is used as a 
substrate (Lobo et al. 2015) indicates that during the evolution of the classical 
pathway, the lack of this regulation may render the cell susceptible to protohaem 
accumulation and subsequent ROS generation. This may provide an explanation why 
organisms such as S. aureus have evolved steps of the classical pathway (presumably 
adapted from the ancient coproporphyrin-dependent pathway) yet no longer utilise 
the classical pathway: elevated ROS produced by pathway intermediates have 
exerted a selection pressure to dispense with the classical pathway. 
   
 156 
 
6.3 ± The coprohaem decarboxylase: HemQ 
Characterisation of coprohaem decarboxylase activity for HemQ provides the final 
piece of the puzzle for the elucidation of the coproporphyrin-dependent pathway for 
haem biosynthesis (Dailey et al. 2015). As a recently characterised protein, limited 
kinetic/binding data exists for HemQ enzymes and this work is ongoing. Recent 
investigations have reported that the decarboxylation of coprohaem III to protohaem 
IX occurs via a two-step radical-based mechanism producing one of two possible 
intermediates, harderohaem III or IV (Celis et al. 2015). It has also been noted that 
this protein is able to bind protoporphyrin IX and haem (Dailey et al. 2010; Mayfield 
et al. 2013), with the haem-bound form able to influence the HemY 
protoporphyrinogen oxidase reaction (Dailey et al. 2010). A novel kinetic analysis 
reported herein reveals the stimulation of HemY by haem-bound HemQ is due to a 
peroxidase activity of HemQ resulting in superoxide generation that aids in the 
oxidation of protoporphyrinogen IX (see Chapter III). This data demonstrates that 
the maximal rate for the enzyme when H2O2 is used with 10 µM coprohaem is 1.74 
min-1, with evidence to suggest that the reaction could progress more rapidly at 
higher coprohaem concentrations. The highest observed rate of 2.48 min-1, obtained 
at concentrations of 17.5µM coprohaem and 250µM H2O2, suggests that this reaction 
can operate at similar rates to the HemH enzyme, with an estimated maximal rate of 
6.6 min-1. However, the maximal rate of S. aureus HemY coproporphyrinogen 
oxidase activity (§  PLQ-1) may limit the amount of coproporphyrin III (and 
therefore coprohaem) available to the terminal enzymes in this pathway, assuming 
for a equal amount of each protein in vitro. The concentrations of these enzymes in 
the cell will have a large role in the amount of substrate available, and would be a 
big indication into the rates that HemH and HemQ operate at in vivo. 
As well as binding coprohaem, protohaem and the harderohaem intermediates, it has 
been shown through fluorescence titrations and by reconstitution during purification 
that HemQ is also able to bind the metal-free porphyrins coproporphyrin and 
protoporphyrin. Interestingly, the binding affinities for these porphyrins are tighter 
than for the metalloporphyrins that serve as the substrate and product, with 
coprohaem III itself having the lowest affinity out of these four ligands. It is a little 
surprising that HemQ is often purified from E. coli without bound ligand, although 
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the lack of coproporphyrin and coprohaem in E. coli and the tight regulation of 
classical haem synthesis is likely to limit the amount of tetrapyrrole ligands 
available. In S. aureus, the potential for protohaem to be retained by HemQ 
following the coprohaem decarboxylase reaction could serve to control the amount 
of free haem species in the cell. The tight binding of protoporphyrin and 
coproporphyrin to HemQ is unexpected, although  since HemY catalysis is a likely 
limiting step in the coproporphyrin-dependent pathway, HemQ is unlikely to 
encounter copropophyrin in vivo and S. aureus does not make protoporphyrin IX at 
all (Jacobs et al. 1971).  
6.4 ± Conclusions and Future Work 
This work provides new insights into the coproporphyrin-dependent pathway in S. 
aureus. Firstly, the radical-mediated stimulation of HemY activity by HemQ may 
explain why an organism ancestral to S. aureus once evolved the classical pathway 
and subsequently dispensed with it. Futher insights into how the radicals are 
interacting directly with the protoporphyrinogen substrate may provide crucial 
insights into why these organisms retained the coproporphyrin-dependent pathway 
instead of the classical route. Introduction of a functional HemN/HemF enzyme into 
S. aureus would be exciting approach to engineer a bacterium with both pathways 
that could be used to investigate how environmental conditions (e.g. light intensity, 
oxygen tension) could have influenced pathway evolution. 
The HemH kinetics herein provide a working hypothesis for how iron and other 
metals could influence flux through the haem pathway in vivo. Future investigations 
would include site-directed mutagenesis of the metal binding residue (i.e. E272S 
mutation previously used (Lecerof et al. 2003)) and introduction of this protein in a 
hemH strain of S. aureus. It would be very interesting to use this mutation as a tool 
to investigate how extracellular and intracellular metals affect the accumulation of 
coprohaem in vivo. In addition, HemH from S. aureus was shown to catalyse the 
insertion of a variety of divalent metals (Zn2+, Co2+, Ni2+ and Cu2+), and further in 
vitro kinetic characterisation will be necessary to contribute to an in vivo model for 
metal chelation. Furthermore, crystallographic and NMR studies on coproporphyrin-




This thesis reports for the first time the basic kinetic parameters for the HemQ 
enzyme from S. aureus, and these data demonstrate that HemQ has comparable kcat 
and Km values to the HemY and HemQ enzymes of S. aureus. The true in vivo 
electron acceptor has not yet been confidently assigned as the enzyme can reportedly 
utilise both H2O2 and FMN (Dailey et al. 2015), although the possibility that H2O2 is 
utilised is an attractive hypothesis considering that the HemY reaction produces this 
molecule. The process for obtaining kinetic parameters can be optimised in the 
future, as current techniques rely upon stopped assays and analysis via HPLC. In 
future, a continuous spectroscopic assay may be possible due to the differences in 
spectroscopic properties of coprohaem and protohaem (the beginnings of which can 
be seen in Figure 5.10). A potential problem with this method would be how the 
spectral characteristics of the harderohaem III and IV intermediates interfere with the 
spectral transitions between coprohaem and protohaem. Complexes of HemQ with 
all four of these isomers (Celis et al. 2015) suggest that harderohaem III and IV have 
very similar absorption spectra, so careful consideration of this would have to be 
made during the development of an absorbance-based assay.  
Crystal structures of HemQ proteins currently do not contain bound ligands. Future 
co-crystallisation studies will provide insights into the positioning of aromatic 
residues in the active site that could participate in radical formation during the 
decarboxylase reaction, which combined with electron paramagnetic resonance 
(EPR) could provide detailed mechanistic insights into this unique reaction.  
Detailed research into the evolution of the coproprophyrin-depdendent pathway is 
still in its infancy. Research so far has focussed upon the individual reactions in the 
pathway in vitro, and there has been a limited focus upon pathway analysis in whole 
cells. While there is plenty more work to be done on purified enzymes (e.g. 
investigating substrate channeling), some evolutionary aspects such as phototoxicity 
of pathway intermediates should be investigated further using genetic tools. The 
characterisation of coproporphyrin-dependent haem biosynthesis has revolutionised 
the central dogma on how haem is synthesised in nature. It is an exciting time to 
work in this area, and with the emergence of large bioinformatics/phylogenetics 
datasets on haem pathway enzymes (Dailey et al. 2015), there will be a need for 
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Appendix 1 ± DNA primers used during the cloning of S. aureus hemH 
Primer 





























105 pTrcHis-RSE TCAGGTGGGACCACCGCGCT 
Checking for 





































Appendix 2A ± Alignment of hemH sequencing data (lines 2-7) against the desired plasmid sequence 




Appendix 2B ± Alignment of hemH sequencing data (lines 2-7) against the desired plasmid sequence 




Appendix 2C ± Alignment of hemH sequencing data (lines 2-7) against the desired plasmid sequence 





Appendix 3 ± Sequence alignment of HemQ proteins from S. aureus, T. thermophilus and a chlorite 





Appendix 4 ± Haem standard curve for concentrations of haem between 0 and 5 µM analysed by 
HPLC. Data points represent the peak heights at the relevent concentrations. 
